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1. Introduction 
 
Perfluoroalkylated substances (PFASs) is the name of a vast and complex group of 
compounds consisting of a hydrophobic alkyl chain, whose length varies from C4 to 
C16, and a hydrophilic end group. 
The hydrophobic part may be partially or fully fluorinated: if fully fluorinated, meaning 
that all hydrogen atoms have been replaced by fluorine atoms, molecules are called 
perfluorinated compounds (PFCs) (EFSA, 2011). 
Depending on the charge of the hydrophilic group, which can be neutral, or negatively 
or positively charged, these amphiphilic compounds are non-ionic, anionic or cationic 
surface active agents. 
PFASs manufacturing is mainly based on two processes, electrochemical fluorination 
and telomerisation, the latter becoming the most employed after the announcement 
by the major world producer of the termination of electrochemical fluorination 
production process by 2002 (EFSA, 2008). 
The beginning of PFASs manufacturing dates back to the late 40s and from then on 
these molecules have been used in a wide range of industrial and commercial 
applications due to their chemical and physical properties. In fact, the chemical and 
thermal stability given to the perfluoroalkyl moiety by carbon-fluorine bounds, 
together with its hydrophobic and lipophobic nature, give these compounds useful and 
enduring features. Examples of their applicability include packaging, fire-fighting 
foams, insecticide formulations, impregnation agents for textiles, cleaning agents and 
floor polishes (EFSA, 2008; Buck et al., 2011). 
The extensive use of PFASs led to their wide distribution into the environment, 
including animals and humans, as substances of anthropogenic origin. They hardly 
exist in nature: monofluorinated compounds can be produced by some moulds, as well 
as various perfluorinated compounds can be originated during some geochemical 
processes (such as volcanic activities), but in negligible amounts. 
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These contaminants have been detected in several environmental matrices, even in 
regions without anthropogenic activities as the arctic environment, due to the global 
ocean and atmospheric circulation (Butt et al., 2010; Schiavone et al., 2009). 
Because of their amphiphilic properties, PFASs don’t accumulate in fatty tissues, as 
other persistent halogenated compounds, but rather bind to proteins. They 
accumulate in the food chain and have been frequently found in human and plasma: 
diet is considered the main exposure route for the population, especially through 
seafood consumption, but also exposure via drinking water and inhalation must be 
taken into account. 
The effects of these substances on human health haven’t been fully ascertained yet, 
but the increasing interest of the scientific community for these emerging 
contaminants during the last ten years led to important discoveries on their toxic 
potential. Several animal studies proved that PFASs can be related to a wide range of 
pathologies in the exposed organisms, such as hepatotoxicity, developmental toxicity, 
neurobehavioral toxicity, immunotoxicity, reproductive toxicity, lung toxicity and 
hormonal effects (EFSA, 2011). 
An important subset of PFASs is constituted by the perfluorinated organic surfactants, 
to which perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) belong. 
Due to their large employment, these two compounds are the most investigated 
PFASs, and their salts and precursors have been found in the environment, fish, birds 
and mammals. Furthermore, PFOS was recently added to the Stockholm Convention 
list of persistent organic pollutants. 
The concern about potential PFASs impact on environmental and human health has led 
various authorities all over the world to launch research programs to better 
understand their fate in the environment and to evaluate their presence in food, 
collecting useful data for an accurate estimation of human exposure. 
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1.1  Perfluorinated compounds (PFCs) 
 
1.1.1  Chemical identity 
 
Perfluorinated compounds are PFASs presenting a fully fluorinated carbon chain; this 
can be linear or branched and its length generally varies between 4 and 16 carbon 
atoms. 
The hydrophilic part can give the molecule negative, positive or neutral charge. Anionic 
end groups are, for example, the carboxylates (-COO-, including PFOA), the sulfonates 
(-SO3
-, to which PFOS belongs) and the phosphates (-OPO3
-). Many among the neutral 
PFASs (thus considering not only perfluorinated but also partially fluorinated 
compounds) can be potential precursors of PFOA, for example 8:2 fluorotelomer 
alcohol, or PFOS, for example perfluorooctane sulfonamide and perfluorooctane 
sulfonamido ethanols. 
Due to the high energy of the covalent carbon-fluorine bonds, PFCs are resistant to 
hydrolysis, photolysis and biological degradation; they are hardly metabolized, 
polymers can eventually degrade to lower molecular weight PFCs, such as PFOS (EFSA, 
2008; Buck et al., 2011).  
Since the names of perfluorinated compounds are quite long and complex, it is 
common to refer to them with abbreviations, deriving from the chemical structure of 
the molecule: 
- type of molecule (“PF”, which stands for “PerFluoro”) 
- number of fluorinated carbons (e.g. “O” when chain is made of 8 carbon atoms) 
- hydrophilic end group (e.g. “A” for carboxylic acid, or “S” for sulfonate)  
So, “PerFluoroOctanoic Acid” is also known as “PFOA” and “PerFluoroOctane 
Sulfonate” is rather called “PFOS”. 
As previously described, PFOA and PFOS are the most important and widespread PFCs 
and the final degradation products of most of fluorinated compounds: for this reason 
this chapter will be focused mainly on these two molecules.   
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PFOA 
Molecular formula: C8HF15O2 
It’s a completely fluorinated organic acid, constituted by an eight carbons alkyl chain 
and a carboxylate group (see Figure 1.1). 
 
Figure 1.1 PFOA, perfluorooctanoic acid 
In water, the free acid dissociates almost completely, while the perfluoroalkyl chain 
remains on the surface and the anionic carboxylate in the water; PFOA molecules are 
reported to associate on the water surface partitioning between the air/water 
interface (US EPA, 2005). 
Some studies also reported water solubility for PFOA, but it’s unclear whether it’s due 
to a microdispersion of micelles rather than true solubility (3M, 2003a). 
According to Prevedouros et al., the dissociated acid (PFO) has negligible vapor 
pressure, high solubility in water and moderate sorption to solids, thus being expected 
to accumulate in surface waters. 
PFOA presence in the environment can derive directly from its production and use, or 
indirectly from degradation of related compounds: the transformation pathways 
include biodegradation, reaction with OHx, ozonolysis (EFSA, 2008). 
Property Value 
Appearance at normal P and T° White powder / waxy white solid 
Molecular weight 414.07 g/mol 
Vapour pressure 0.1 kPa (20 °C) 
Water solubility (at 20 °C) 3.4 g/L 
Melting point 45-50 °C 
Boiling point 189-192 °C 
pKa 2.5 
Table 1.1 Physical and chemical properties of PFOA  
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PFOS 
Molecular formula: C8F17SO3
- 
It’s a fully fluorinated anionic compound, presenting an alkyl chain with eight carbon 
atoms and a sulfonate group (see Figure 1.2). 
 
Figure 1.2 PFOS, perfluorooctane sulfonate 
PFOS is generally used in salt form (potassium, sodium, ammonium), but can also be 
incorporated in bigger polymers. In water solution, at pH values form 3 to 8, it’s 
completely dissociated. 
PFOS is extremely stable: it resists to hydrolysis (estimated half-life >41 years), to 
photolysis (estimated half-life >3.7 years) and to biodegradation (several weeks). The 
only known degradation mechanism is incineration at high temperature (3M, 2003b). 
Besides its industrial production, this compound can derive from degradation of 
various precursors, the so-called “PFOS-related substances”, operated by 
environmental microorganisms or by the metabolism of higher organisms. The number 
of substances belonging to this family isn’t clearly defined yet, but it’s proven that 
there are lots of molecules having the potential to break down to PFOS (EFSA, 2008). 
Among all PFCs, PFOS is by far the most frequently detected compound in food 
products, and at the highest concentrations. 
Property Value 
Appearance at normal P and T° White powder 
Molecular weight 538.22 g/mol 
Vapour pressure (at 20 °C) 3.31×10-4 Pa 
Water solubility (at 20 °C) 519 mg/L 
Melting point >400 °C 
Boiling point Not measurable 
pKa -3.3 (calculated value for acid) 
Table 1.2 Physical and chemical properties of PFOS potassium salt (EFSA, 2008)  
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PFCs precursors 
Since perfluorinated compounds presence in food has become of public concern, 
increasing attention is being given also to their precursors, as Recommendation 
2010/161/EU demonstrates. With this document, issued on March 17 2010, the 
European Commission expresses the need to investigate also compounds like 
perfluorooctane sulfonamide (FOSA), N-ethyl perfluorooctane sulfonamido ethanol  
(N-EtFOSE) and 8:2 fluorotelomer alcohol (FOET). 
 FOSA (perfluorooctane sulfonamide) 
Molecular formula: C8F17S02NH2; Molecular weight: 499.15 
FOSA can enter the environment both being synthesized and as a metabolic by-
product of perfluorooctane sulfonamido ethanols (Lehmler, 2005). 
Oxidation of FOSA can result in the formation of PFOS. 
 FOSEs (perfluorooctane sulfonamido ethanols) 
The end group bound to the nitrogen atom can be a methyl or an ethyl, thus giving: 
 N-MeFOSE (N-Methylperfluorooctane sulfonamido ethanol) 
Molecular formula: C8F17S02N(CH3)CH2CH2OH; Molecular weight: 557.23 
 N-EtFOSE (N-Ethylperfluorooctane sulfonamido ethanol): 
Molecular formula: C8F17S02N(CH2CH3)CH2CH2OH; Molecular weight: 571.25 
PFOS is the final product of FOSEs degradation. 
 
  
 
 
 
 
 
 
 
Figure 1.3 N-EtFOSE can degrade to FOSA, and then to PFOS 
FOSA 
N-EtFOSE 
PFOS 
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 FTOHs (fluorotelomer alcohols) 
They are fluorotelomers presenting an alcohol functional group. 
Depending on the length of the fluorinated carbon chain, the resulting compounds 
can be, for example: 
 FHET (6:2 fluorotelomer alcohol, also called Perfuorohexyl ethanol) 
Molecular formula: C6F13CH2CH2OH; Molecular weight 364.11 
 FOET (8:2 fluorotelomer alcohol, also called Perfuorooctyl ethanol) 
Molecular formula: C8F17CH2CH2OH; Molecular weight 464.12 
 FDET (10:2 fluorotelomer alcohol, also called Perfuorodecyl ethanol) 
Molecular formula: C10F21CH2CH2OH; Molecular weight 564.14 
FTOHs are volatile compounds, which being vulnerable to hydrolysis and microbial 
enzymes can break down to give perfluorinated carboxylic acids: FHET degrades to 
PFHxA and FOET to PFOA (as shown in Figure 1.4), FDET to PFDA. 
 
 
 
Figure 1.4 Degradation of 8:2 FTOH to PFOA 
 
 
1.1.2  Production 
 
PFCs are mainly produced by two processes: electrochemical fluorination (EF) and 
telomerisation (TM). 
The EF process is based on the electrolysis of a hydrogen fluoride solution containing 
organic compounds, whose effect is that all the hydrogen atoms of the molecule are 
replaced by fluorine atoms. This reaction results in a 35-40% straight chain molecules 
and a mixture of various byproducts and waste. Moreover, due to variable conditions 
in the manufacturing process, the final product is a mix of isomers and homologues (of 
even or odd number of perfluorocarbons, depending on the variable length of the 
FOET PFOA 
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initial compound’s chain), consisting of approximately 70% linear and 30% branched 
molecules (3M, 1999; Brooke et al., 2004). 
PFOS production is based on EF process (see Figure 1.5): octanesulfonyl fluoride reacts 
giving perfluorooctanesulfonyl fluoride (POSF), which is the intermediate product in 
the synthesis of PFOS and two PFOS-related substances, FOSA and N-EtFOSE (EFSA, 
2008). 
 
 
 
 
 
Figure 1.5 Electrochemical fluorination process 
Similarly, electrochemical fluorination was employed also in PFOA manufacturing, 
mainly in the ammonium salt form. The process yields to a mixture of four to nine long 
carbon chains including linear and branched isomers (Prevedouros et al., 2006). 
Introduced in the late 40’s, EF has been widely employed during the following decades 
for the synthesis of perfluorinated compounds, also thanks to its low costs; 
nevertheless, the major world producers using this technique recently announced its 
termination, thus making telomerisation the main alternative. 
Telomerisation is a process based on the reaction between tetrafluoroethylene (TFE) 
and iodine pentafluoroethyl iodide (PFEI), which produces perfluoroalkyl iodide (PFAI). 
This is often further reacted with the insertion of an ethylene, giving fluorotelomer 
iodide (FTI), which is characterized by a linear and even numbered chain. PFAI and FTI 
are intermediate products in the synthesis of fluorotelomer-based surfactants and 
polymers (Buck et al., 2011) (see Figure 1.6). 
As far as PFOS and PFOA are concerned, this process can be only applied for the 
synthesis of the latter, but the advantage in comparison with EF is that the high purity 
of the starting material results in extremely pure (≥99%) linear PFOA (EFSA, 2008). 
POSF 
PFOS N-EtFOSE FOSA 
C8H17SO2F 
C8F17SO2F 
C8F17SO2NH2 C8F17SO2N(Et)CH2CH2OH 
e
-
, HF 
C8F17SO3X 
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Figure 1.6 Telomerisation process: production of FTOH (left) and PFOA (right) 
 
 
1.1.3  Applications 
 
Perfluorinated compounds are extremely stable substances, presenting hydrophobic 
and oleophobic character as well as strong resistance to different types of degradation. 
Due to their properties, PFCs have been widely employed for more than fifty years in 
industrial applications and consumer products. 
Until the year 2000, when the termination of its production was announced, PFOS was 
the most employed PFC. OECD (Organisation for Economic Co-operation and 
Development) grouped PFOS (and its related substances) applications in three 
categories: surface treatments, paper protection and performance chemicals. 
Surface treatments, undertaken by textile mills, leather tanneries, finishers, fiber 
producers and carpet manufacturers, have the purpose to give water, oil and soil 
resistance to products like personal apparel and home furnishings. In addition, PFOS-
related chemicals are also employed in aftermarket treatments by both general public 
and professional applicators. 
TFE 
C2F4 
FTOH 
F(CF2)nCH2CH2OH 
 
PFOA 
F(CF2)7CO2H 
 
CH2CH2 
 
CO2 
FTI 
PFEI 
PFAI 
C4F5I 
F(CF2)nI 
F(CF2)nCH2CH2I 
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Concerning paper protection treatments, these chemicals are included in sizing agent 
formulations providing grease, water and oil repellency to paper and paperboard, 
which are used in food contact products (such as plates, food containers, bags and 
wraps) as well as in other applications (like folding cartons, containers, carbonless 
forms and masking papers). 
The third category includes several PFOS salts that are commercialized as finished 
products in a variety of applications, like fire fighting foams, mining and oil well 
surfactants, acid mist suppressants for metal plating and electronic etching baths, 
photolithography, electronic chemicals, hydraulic fluid additives, alkaline cleaners, 
floor polishes, photographic film, denture cleaners, shampoos, chemical intermediates, 
coating additives, carpet spot cleaners and insecticides (OECD, 2002). 
PFOA has many applications too, mainly as a chemical intermediate. Its ammonium 
salt is mainly employed for the emulsion polymerization of fluoropolymers like 
polytetrafluoroethylene (PFTE) (whose most known brand name is Teflon) and 
ployvinilydene fluoride (PVDF), due to the high surface activity of fluorinated 
surfactants (Lehmler, 2005). 
PFTE has an extremely low coefficient of friction and is very non-reactive: for these 
reasons this molecule is used for several applications, as non-stick coating, lubricant, 
water-resistant coatings for fabrics and many more. 
Other PFOA applications include its use in the manufacturing of electronic 
components, as extraction agent in ion-pair reversed-phased liquid chromatography, 
as additive in oil and moisture resistant paper coatings used for food packaging, (EFSA, 
2008; US EPA, 2002). 
Concerning some PFCs precursors specific applications, fluorotelomer alcohols are 
involved in the production of acrylate polymers and fluorosurfactants, while FOSA was 
mainly used as a key ingredient in the original 3M’s Scotchgard formulation. FOSA was 
also extensively employed for its water and oil repellent properties, as well as              
N-MeFOSE, mainly used on carpets and textiles, and N-EtFOSE, mainly used on paper 
(Boulanger et al., 2005; Martin et al., 2009; Rhoads et al., 2008). 
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1.1.4  Occurrence 
 
During the second half of 20th century PFCs have been used in an ever larger number 
of applications, subsequently their production has continuously increased. 
According to OECD, the manufacturing of PFOS and PFOS-related substances (almost 
entirely in Europe, United States and Japan) prior to the year 2000 amounted to 
around 4500 t per year, of which 50% for surface treatment applications and 30% for 
paper protection applications. Few information is available on PFOS production 
wastes; however, data collected by 3M on its biggest manufacturing plant (located in 
Alabama, USA) were used to make an estimation, expressed as PFOS equivalents (i.e. 
the amount of PFOS that could derive from the breakdown of fluorochemical products 
and residuals). Considering that about 90% of wastes were in solid form and that two 
thirds of this solid matter were disposed through incineration while the remaining 
fraction was sent to waste landfills, given an estimated total production of 96000 t 
between 1970 and 2002, global wastes were quantified in 26500 t, of which 24500 t 
solid, 435-575 t released to air and 230-1450 t to water (Paul et al., 2009). 
With regard to PFOA, the estimated global production during the period 1951-2004 
was around 3600-5700 t, with a value of 260 t in 1999. The majority of PFOA 
production (80-90% in 2000) derived from electronic fluorination process, while the 
remaining 10-20% was synthesized from about 1975 to present by telomerisation 
(Prevedouros et al., 2006). 
At the beginning of the new millennium the major global producer of PFCs (3M 
Company) voluntarily decided to stop using the electrochemical fluorination process 
by 2002, thus phasing out the production of perfluoroalkyl sulfonate substances. 
As a consequence of this decision and of the restrictions laid down by the European 
Union, the use of PFOS has significantly decreased and in some areas even ceased, 
being replaced by alternative substances providing the same functions or by other 
technologies (Brooke et al., 2004). Figure 1.7 shows a comparison between PFOS 
equivalents production trends between 1970 and 2002 reported by four different 
studies. 
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Figure 1.7 Estimated total global PFOS equivalents production volumes 
(Paul et al., 2009) 
 
The termination of the electrochemical fluorination process led also to an increase in 
the production of PFOA by telomerisation, with the result that global direct emissions 
due to its manufacturing decreased from about 45 t in 1999 to about 15 t in 2004, with 
prospect of further reduction in the following years. 
However, when talking about emissions to the environment, also indirect sources must 
be considered. In fact, in the case of perfluoroalkyl carboxylic acids (PFCAs, to which 
PFOA belongs), their presence in the environment is not only a consequence of their 
manufacture, use and disposal, but it’s also partly due to the fact that PFCAs impurities 
are contained in perfluorooctyl sulfonyl-based products made by EF process, as well as 
they can be present at trace levels in fluorotelomer-based products as unintended 
reaction by-products. Degradation of these two groups of products and of relative raw 
materials is a further potential indirect source of PFCAs in the environment. More in 
details, estimated global PFCAs emissions in the year 2000 amounted to around 237 t, 
of which 200 consisting of PFOA (Prevedouros et al., 2006). 
Degradation of perfluorooctyl sulfonyl-based products is an indirect source for PFOS 
too, as well as the synthesis of perfluorooctane sulfonyl fluoride itself. According to 
Paul et al., 85% of PFOS indirect emissions are associated to losses during use and 
disposal of consumer products, while the remaining 15% results from manufacturing 
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releases during secondary applications, such as start-up and shutdown operations or 
losses from production wastes. 
The extensive use of perfluorinated compounds caused their global diffusion: PFCs are 
present in both urban areas with high population density and industrialization and 
regions far from anthropogenic activities, including the Arctic environment. Recent 
studies proved the presence of PFOS and PFOA (as well as their salts and precursors) in 
water, air and soil in many different geographical areas (Recommendation 
161/2010/EU). 
These substances can contaminate waters in many ways and virtually everywhere, 
thus their presence can involve also waters directed to human consumption: for this 
reason monitoring is important in order to prevent potential exposure due to 
contaminated drinking water. 
Twelve PFCs have been investigated in surface waters collected by Skutlarek et al. from 
the rivers Moehne, Ruhr, Rhine and some of their tributaries, in Germany. PFOA was 
the compound detected at the highest concentrations, but, depending on the point 
where samples had been collected, other components were found as well and at 
different concentrations. The sum of the seven most detected PFCs didn’t exceed 100 
ng/L for the Rhine river and the lower reaches of the Ruhr river, but levels of 
contamination increased significantly in the upper part of the Ruhr and the Moehne 
river (which is an affluent of the Ruhr), reaching values of 446 and 4385 ng/L, 
respectively. Surveys on the causes of this situation proved that the widespread use of 
contaminated organic and inorganic material as fertilizer in various agricultural areas 
around the river Moehne was the source of its waters contamination. Also, further 
investigations reported high concentrations of PFCs in plasma samples collected from 
the local population (Skutlarek et al., 2006). 
In light of the above, it’s clear how PFCs presence in the soil can represent a source for 
contamination of surface waters. A later program of analysis carried out on 916 field 
samples collected in that area indicated levels of contamination between 100 and 500 
µg/kg in just 8% of the processed samples, but in two farms (which have been 
subsequently sanitized) measured values exceeded 1500 µg/kg. The analysis of 199 
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samples collected in a non-contaminated area (Bavaria, Germany) showed PFOS 
concentrations always lower than 10 µg/kg. 
In similar circumstances, increased PFOS soil concentrations were reported in Alabama 
in a 2007 study. Anyway, data on PFCs presence in soil are lacking to this day, 
therefore some Authors suggest the importance of monitoring soil and surface waters 
sampled in the same locations, in order to better understand the transfer of these 
contaminants (van Asselt et al., 2011). 
In a recent study, Awad et al. focused the attention on the long-term persistence of 
PFOS following an accidental release of fire fighting foams which happened in 2000 in 
the area nearby Toronto airport. They collected samples of sediment, water and fish 
from 10 different locations between Etobicoke and Spring Creeks in 2003, 2006 and 
2009. Even after ten years, PFOS levels were relevant in Spring Creek, but only in a 
confined area, due to Etobicoke’s diluting action and to the pond’s storm water 
management nature. In 2003 PFOS concentration in fish samples had decreased by 
70%; in 2009 contamination levels had declined by 85% in fish and by >99.99% in 
waters collected downstream of Spring Creek. This drop was probably a consequence 
of the interruption of PFOS production and of the regulations on the use of this 
compound in fire fighting foams, resulting in a reduction of PFOS introduction in the 
environment. Anyway, the 2009 levels were 2-10 times higher than values measured in 
upstream locations, likely because of both the urbanization and the long-term 
consequences of the spill (Awad et al., 2011). 
In order to verify the impact of fluorochemical producing facilities on measured 
environmental PFCs levels, Hansen et al. analyzed 40 samples collected in a stretch of 
the Tennessee river close to a manufacturing site. Mean PFOS concentrations were 
found significantly higher downstream the plant, increasing from around 30 to around 
110 ng/L, thus confirming the effects of effluent from manufacturing on waters 
contamination (Hansen e al., 2002). 
As reported by van Asselt et al., in samples collected in the Yodo River, next to Osaka 
airport (Japan), PFOS concentrations resulted relevant, reaching in 2004 the value of 
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526 ng/L. This was probably due to the closeness of a local source of contamination, 
presumably constituted by the use of aqueous film-forming foams (AFFF).  
In a monitoring on the presence of PFOS and PFOA in the water environment of 
Singapore, the analysis of more than a hundred samples from coastal waters, rivers, 
reservoirs and wastewater treatment plants (WWTPs) reported significant variations 
between the different areas of the city. PFOS concentrations in the coastal area and in 
surface waters were in the range of 1.9-8.9 and 2.2-87.3 ng/L respectively, while for 
PFOA they were between 2.4-17.8 and 5.7-91.5 ng/L, respectively; wastewaters 
showed considerably higher values, ranging from 5.8 to 532 ng/L for PFOS and from 
7.9 to 1060 ng/L for PFOA, with the highest levels given by effluents released by two 
WWTPs. This study remarked the role of WWTPs as key point in PFCs access to the 
oceans (Hu et al., 2011). 
Data collected in the Netherlands, Germany, Sweden, Norway, Italy and other 
European locations showed levels of contaminations in surface water ranging from 
0.02 to 56 ng/L for PFOS and from 0.65 to 57 ng/L for PFOA. The most relevant 
concentrations of PFOA were found in samples collected in Germany and the 
Netherlands, while Italian Alpine river and spring waters were the less contaminated; 
as for PFOS, Loos et al. reported close to non-detectable values (up to 0.1 ng/L) in 
Italian Alpine rivers, whereas in nearby Lake Maggiore its presence was in the range 
7.2-8.6 ng/L (EFSA, 2008). 
PFCs have been detected in different kinds of animals, including fish, mammals and 
birds. High concentrations of PFOS have been measured in apex predators of the food 
chain (including polar bears, seals and eagles) as well as in the lowest levels of the 
trophic chain, regardless of the distance from sources related to human activities. 
A study published by Giesy and Kannan in 2001 investigated the presence of various 
PFCs (PFOS, FOSA, PFOA and PFHxS) in a wide number of wild animal species, including 
bald eagles, albatrosses, polar bears, seals and various species of fish. Samples were 
collected in multiple areas of the globe, from urbanized locations, such as the Great 
Lakes region and other coastal areas and rivers in North America and Europe, to less 
anthropized zones, like North Pacific Oceans and the Arctic. PFOS proved to be globally 
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present, while the other PFCs were detected less frequently and at minor 
concentrations. In more detail, it was observed that measured values of PFOS in serum 
depended on the area of origin, being significantly higher in animals living close to 
populated and industrialized locations than in those living in remote places far from 
human activities (10-230 against 5-50 ng/mL). Moreover, PFOS was present at 
different levels of concentration in fish from all the monitored areas, as well as in 
several bird species, but the highest values were detected in fish eating predators as 
minks (970-3680 ng/g wet weight of liver), bald eagles (1-2560 ng/mL of plasma), river 
otters (34-990 ng/g wet weight of liver) and polar bears (180-680 ng/g wet weight of 
liver). These results suggest that this contaminant is likely to accumulate in the highest 
food chain’s levels (Giesy and Kannan, 2001). 
This trend was confirmed also by a more recent study on PFCs presence in animals 
belonging to the food chain of the Great Lakes area. The monitoring indicated first of 
all a BCF (bioconcentration factor) for benthic invertebrates of around 1000, meaning 
that PFOS contamination in these animals was about 1000 times higher compared to 
that measured in the surrounding water. These invertebrates showed concentrations 
2-4 times lower than those of fishes preying on them, which, in turn, were 10-20 lower 
than values measured in predator fishes, as lake whitefish and Chinook salmon. Also, 
PFOS was detected in minks and bald eagles at levels 5-10 times greater than their fish 
prey. These results confirmed the existence of PFOS biomagnification in liver and blood 
of higher trophic-level animals; as for PFOA, it was found in water as well, but showed 
a significantly lower biomagnification potential (Kannan et al., 2005). 
Furthermore, in another study carried out in the New York State area, concentrations 
of various perfluorinated compounds, including PFOS and PFOA, were measured in a 
number of lake waters, in two species of sport fish and in ten species of waterfowl. 
While PFOA was detected in waters at higher levels of contamination (up to 173 ng/L) 
than PFHxS and PFOS (around 30 ng/L), this latter was more abundant in all fish and 
bird livers sampled. In addition, PFOS concentrations in birds reached 882 ng/g wet 
weight, up to 3-fold greater than fish, and piscivorous birds showed values around 2.5 
times higher than those of the non-piscivorous species (Sinclair et al., 2006). 
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Perfluorinated compounds have been measured also in the air during several studies in 
different areas of the world. The range of monitored compounds often included, 
besides PFOS and PFOA, their volatile precursors fluorotelomer alcohols (FTOHs) and 
perfluorooctane sulfonamido ethanols (FOSEs). Because of the methyl groups present 
in their chain, these molecules are more vulnerable than perfluorinated compounds, 
thus representing a potential PFCs source when subjected to degradation in the 
atmosphere, as well as after inhalation or ingestion. According to the so called 
“precursors hypothesis”, the extreme volatility of these precursors would allow 
indirect wide-range PFCs transport towards even the most remote areas of the planet, 
to be added to directly released perfluorinated compounds globally spread by oceanic 
currents (Jahnke et al., 2009; Barber et al., 2007; Ellis et al., 2004). 
In a study conducted in 2007, PFCs presence was monitored in outdoor air samples 
collected in four different locations in the United Kingdom, Ireland and Norway. PFOA 
was generally the mainly detected compound in the particulate, with values ranging 
between 1-818 pg/m3, while in the gas phase the highest levels were reported for 
fluorotelomer alcohols, in particular 8:2 FTOH (5-243 pg/m3) and 6:2 FTOH (5-189 
pg/m3). Also, some perfluorooctane sulfonamido ethanols were found, mainly             
N-MeFOSE and N-EtFOSE, with concentrations ranging between 36-54 pg/m3 and      
16-33 pg/m3, respectively. Even if the obtained data were significantly lower than 
those reported in literature for indoor air, the Authors underlined that, for some 
compounds, levels of contamination exceeded usual measured values of POPs 
(Persistent Organic Pollutants) (Barber et al., 2007). 
This aspect was confirmed also by Jahnke et al., who measured neutral volatile 
perfluoroalkylated substances in environmental air samples collected in Hamburg and 
Waldhof, comparing contamination levels in respectively a metropolitan location and a 
rural site in northern Germany. Collected data were in-line, sometimes exceeding, with 
those found in the same area for POPs. More in details, 8:2 FTOH and 6:2 FTOH were 
reported to be the major pollutant ever measured in Waldhof, with the total measured 
values for fluorotelomer alcohols in that site varying between 64-311 pg/m3 and 
between 150-456 pg/m3 in Hamburg’s urban area. Similarly, the highest FOSEs 
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concentrations were reported in the most anthropized environment, with values in the 
range of 29 to 151 pg/m3 against 12 to 54 pg/m3 of the rural area (Jahnke et al., 2007). 
In another 14 months survey carried out in the Hamburg area, high concentrations 
were observed in air coming from highly populated and industrialized areas south of 
the town. 8:2 FTOH was the contaminant most found in the air, reaching 
concentrations of 600 pg/m3, while PFOS was detected at a maximum of 13 pg/m3 in 
the particle phase. In addition, higher concentrations in the gas phase were reported in 
summer compared to winter, probably due to temperature-dependent emissions of 
these volatile substances (Dreyer et al., 2009). 
Stock et al. investigated volatile PFASs in North America, monitoring the environmental 
air of six big cities in the United States and Canada. Both fluorotelomer alcohols and 
perfluorinated sulfonamido ethanols were detected, with measured values ranging 
between 11-165 pg/m3 for FTOHs and up to 359 and 199 pg/m3 for N-MeFOSE and     
N-EtFOSE, respectively. Such high values were observed in only two towns, presumably 
because of the release of these substances by industrial plants in the nearby areas, 
suggesting the relevant role of point sources for their global diffusion (Stock et al., 
2004). 
The same Authors reported in a 2007 study the presence of fluorotelomer alcohols 
also in air samples from three arctic lakes in Canada, with mean concentrations 
between 2.8 and 29 pg/m3 (Stock et al., 2007). 
Another comparison between volatile PFASs presence in urban and rural environments 
was presented by Martin et al., who measured FTOHs and FOSEs in Toronto (highly 
populated area) and in Long Point (less anthropized zone). Reported environmental 
concentrations were 2 to 3 times higher in samples collected in the metropolis, with a 
maximum concentration of 87 pg/m3 for 6:2 FTOH (Martin et al., 2002). 
In Japan, an air sampling carried out in 33 different locations during 3 months for a 
monitoring of fluorotelomer alcohols proved that 8:2 FTOH was the dominant 
compound (up to 2466 pg/m3, with a mean of 241 pg/m3), followed by 6:2 FTOH (up to 
768 pg/m3, mean value 52 pg/m3) and 10:2 FTOH (up to 113 pg/m3, mean value          
27 pg/m3) (Oono et al., 2008). 
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Volatile PFCs concentrations have been measured also in a comparative study between 
samples coming from the Okinawa Island (Japan) and samples collected in Oregon 
(United States). Once more, fluorotelomer alcohols were the most detected 
contaminants, but with significantly greater concentrations in Oregon than in Okinawa. 
According to the Authors, taking into account the relative absence of high levels of 
FTOHs in trans-Pacific air masses compared to the air surrounding highly urbanized 
areas, this difference was due to a more relevant direct emission of pollutants from 
the western US region. FOSEs were found as well in both sites, but at lower 
concentrations and with minor frequency (Piekarz et al., 2007). 
Harada et al. investigated PFOS and PFOA presence in air samples from Kyoto and 
Iwate, in Japan. These locations were chosen on the basis of the results of previous 
monitoring on serum, indicating the first as a typical extremely contaminated area and 
the second as a low polluted zone. The reported annual geometric means of the 
concentrations of PFOS and PFOA in the air were respectively 262.8 and 5.2 pg/m3 in 
the urbanized area and respectively 2.0 and 0.7 pg/m3 in the rural region (Harada et al. 
2005). 
Current information regarding the environmental sources of PFCs is incomplete, but 
the contamination of several different animal species and habitats suggests the 
existence of multiple sources. 
Given its widespread presence, persistence and toxicity, in 2009 PFOS was included as 
POP (Persistent Organic Pollutant) in Annex B of the Stockholm Convention, which 
means that its employment is allowed exclusively for a limited list of applications. 
Although PFOS doesn’t tend to accumulate in lipids as other persistent halogenated 
compounds, in general its behavior is very similar to that of POPs: its concentration in 
blood is linked to its intake via food products and the measured values increase in 
relation to the age of the observed subject (Haug et al., 2010b). 
The estimated half-life in the environment is 41 years for PFOS and 8 years for PFOA, 
therefore their presence and the subsequent contamination of multiple media will 
keep being of public interest in the decades to come (D’Hollander et al., 2010).  
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1.2  Exposure 
 
Even if their production started around sixty years ago, it’s only during the last decade 
that perfluorinated compounds have become of public concern, due to their high 
diffusion and persistence in the environment, resulting in multiple sources of human 
exposure, and to the first discoveries on their potential toxic effects. 
As previously reported, PFCs are ubiquitous contaminants, being detected in the 
environment, in wildlife and in humans. However, exposure source for the population 
haven’t been completely defined (EFSA, 2008). 
Diet seems to be the major route of exposure, but the contribution of the different 
types of food still isn’t clear (Haug et al., 2010b); according to EFSA opinion issued in 
2008, data collected through the monitoring of food are insufficient and to this day it’s 
not possible to characterize the levels of contaminations of the various foodstuffs. 
During the recent past, different categories of food products have been investigated in 
various Countries to assess the eventual presence of perfluorinated compounds. 
Fish products represent an important food source for humans and, being essential 
elements in various aquatic ecosystems such as rivers, lakes and seas, they are at the 
same time useful bio-indicators. Chronic exposure to high levels of contaminants by 
eating fish can be a risk for human health: according to Haug et al., fish consumption 
has proved to be one of the major causes of PFCs intake. However, also contaminated 
drinking waters can contribute to human exposure, especially in highly polluted areas 
(Fromme et al., 2009). 
Besides food and drinking water, as reported by some Authors, a further potential 
route is represented by inhalation of outdoor air, indoor air and dust (EFSA, 2011). 
PFOS is the most frequently found PFC in food, generally at higher concentrations than 
others. Non-food sources contribution to total PFOS exposure is estimated to be less 
than 2%, while for PFOA it could be as high as 50% compared to the predicted average 
dietary intake; for both compounds these values tend to decrease when moving from 
childhood into adulthood (EFSA, 2008). 
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1.2.1  Food sources 
 
A number of studies have been carried out in the last decade on various categories of 
food from different parts of the world. 
An evaluation of the exposure to PFCs through the diet was conducted monitoring 36 
food samples collected in the Tarragona area (Spain). PFOS, PFOA and PFHpA were the 
only compounds detected; the most contaminated food resulted fish and, secondly, 
meat and dairy products, contributing to around 70% of the total intake. The Authors 
suggested a dietary intake of PFOS between 0.89 and 1.06 ng/kg b.w. per day (Ericson 
et al., 2008). 
This value is significantly lower than that previously reported by a TDS (Total Diet 
Study) performed in the UK, in which PFOS and PFOA (and to a lesser extents other 
PFCs) had been found only in certain samples, mainly of foods containing potatoes, 
and the estimated intake of PFOS was around 100 ng/kg b.w. per day. In this survey, an 
average adult daily intake was calculated also for PFOA, corresponding to 70 ng/kg 
b.w. (UK Food Standard Agency, 2006). 
Another survey was conducted more recently in the UK, monitoring 11 different 
perfluorinated compounds in 252 samples of multiple sorts of food. PFOS, FOSA and 
PFOA, were the most present contaminants, even if just in traces in almost 75% of the 
samples. They were found mainly in fish, crab, liver and kidney samples, while their 
presence in potato products was not reported. On the basis of the collected data, the 
combined estimated dietary intake via the diet of PFOS and PFOA adults was 20 ng/kg 
b.w. per day (Mortimer et al., 2009). 
Tittlemier et al. analyzed 54 food samples part of a Canadian TDS, including fish, 
seafood, meat, fast-food and popcorn. The predominant presence of PFOS and PFOA 
was confirmed; a total dietary intake of all the detected PFCAs and PFOS equal to 250 
ng/day was suggested (Tittlemier et al., 2007). 
In a work by Zhang et al., the daily intake due to consumption of meat, meat products 
and eggs in China was estimated. Chicken meat showed the highest level of 
contamination (12.7 ng/g), followed by pork, pig liver and beef (6.38, 4.47 and 4.43 
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ng/g, respectively), while low concentrations were reported in eggs (0.38 to 1.21 ng/g). 
Estimated dietary intakes of 6-9.64 ng/day for PFOS and 254-576 ng/day for PFOA 
were suggested (Zhang et al., 2010). 
A study evaluating the presence of perfluorinated compounds in food in the 
Netherlands reported the detection at quantifiable levels of 6 different substances 
(PFHpA, PFOA, PFNA, PFDA, PFHxS and PFOS). The highest total values were found in 
crustaceans and lean fish (825 and 481 ng/g, respectively), while in fatty fish, butter, 
eggs, flour and cheese the measured concentrations were smaller (20-100 pg/g), and 
even lower in milk, pork, chicken, bakery products and vegetable (<10 pg/g). PFOS and 
PFOA median dietary intake were estimated of 0.3 and 0.2 ng/kg b.w. per day 
(Noorlander et al., 2011). 
According to Panel CONTAM, indicative daily dietary exposure to PFOS, calculated on 
the data on fish products available when the 2008 report was issued, would be around 
60 ng/kg b.w. for the average population, increasing up to 200 ng/kg b.w. for high 
consumers. Based on these values, the Panel suggested that daily exposure is below 
the TDI (150 ng/kg b.w.), even if highly exposed subjects could reach and also exceed 
this value. As for PFOA, EFSA suggested a mean daily intake of 2 ng/kg b.w., with a 
maximum of 6, not statistically related to individual fish consumption (EFSA, 2008). 
Observing the studies available in literature, it’s evident that there is a significant 
variability between the results obtained. This can be due to various factors, such as the 
area where the monitoring was conducted or the performances of the employed 
analytical methods. Also, it must be considered that the importance of certain 
categories of food in the diet is not constant, depending on the eating habits of the 
various Countries and regions, and consequently also their contribution to the intake 
of these contaminants can vary. For all these reasons it’s quite difficult to define 
representative values of exposure through the diet for the population. 
However, fish and sea-food seem to be the most important contributors to the total 
dietary intake of these contaminants. In particular, PFOS is generally present at higher 
concentrations than PFOA and has been shown to accumulate in fish with a kinetic 
bioconcentration factor in the range 1000-4000, mainly in liver (EFSA, 2008). 
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In the recent past, an increasing number of works focused on the evaluation of PFCs 
contamination in this category of food: based on the data collected during the 2008 
and 2009 monitoring in Europe, EFSA reported that PFOS and FOSA were the two most 
detected compounds in fish, being found at the highest concentrations in fish offal (47 
and 15 µg/kg, respectively) but also, even if at lower levels, in fish meat (4.9 and 2.7 
µg/kg, respectively). Concentrations similar to those measured in fish meat were 
observed also in crustaceans and mollusks, even if only a limited number of samples 
were analyzed (EFSA, 2011). 
Domingo et al. reported that a survey on fish and seafood in Catalonia region (Spain) 
indicated the presence of PFOS (which resulted the predominant compound, 
representing 73% of the total), PFOA and PFHpA in this food item. Based on the results 
obtained, they estimated a mean dietary intake for adults living in that area of about 
97 ng/day, largely deriving from sardine and red mullet (31.4 and 27.4 ng/day, 
respectively) (Domingo et al., 2011). 
Within a recent ecological monitoring on river waters in a northern Germany region 
involved in a massive PFCs release a few years ago, 37 fish filet samples belonging to 6 
different species were analyzed: PFOS and PFDA were detected in all samples, at 
concentrations up to 63.8 ng/g the former and 19.1 ng/g the latter. Other PFSAs and 
PFCAs, including PFOA, were found only in few samples and at relatively low levels, 
often close to the limits of quantification (Ehlers et al., 2011). 
PFOS was the most detected compound (up to 121 ng/g) also in trout samples from 
the Great Lakes, in the United States, showing correlations between measured level 
and body weight. Also PFDS was present in most of cases, at a maximum of 9.8 ng/g, 
while various PFCAs were found in all samples, with a highest total concentration of 19 
ng/g. Based on data concerning lake waters levels of contamination, the Authors 
calculated BAFs (Bio-Accumulation Factors) of 4.1 for PFOS, 3.9 for PFDA, 3.8 for FOSA 
and 3.2 for PFOA (Furdui et al., 2007). 
Various studies evaluated the presence of PFCs also in fish and seafood from Asia. For 
example, the analysis of samples of seven types of seafood from China allowed the 
identification of several PFCs, among which PFOS was the most detected in terms of 
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both frequency (it was found in all 27 samples) and concentration (with the highest 
level of 13.9 ng/g measured in mantis shrimps) (Gulkowska et al., 2006). 
A study focused on the occurrence of perfluorinated compounds in marine coastal 
ecosystem was conducted in an estuarine area in the south of Japan. PFOS and PFOA 
showed the highest frequency, but they showed different exposure and 
bioaccumulation trends: while the former was the most abundant contaminant in 
animals living in shallow waters, the latter was mainly detected in tidal flat species. 
PFNA, FOSA and PFHpS as well were found in lots of the analyzed samples (Nakata et 
al., 2006). 
Even if at significantly lower concentrations, PFCs levels in seafood have been 
measured also in remote and allegedly less contaminated areas such as Sri Lanka, 
where the maximum concentrations measured for PFOS, PFHxS and FOSA were 0.012, 
0.310 and 0.231 ng/g, respectively (Manage et al., 2005), and even the eastern Arctic, 
where the reported values for PFOS didn’t exceed 1.4 ng/g and were consistently 
lower for PFOA (Tomy et al., 2004). 
Based on the results of a multi-site monitoring of various farmed species in Europe, 
South America and Southeast Asia, van Leeuwen et al. observed interesting aspects 
concerning PFCs contamination. Concentrations were sensibly higher in fish than in 
shrimps, and in carnivorous species (salmon and trout) compared to omnivorous 
species. In addition, concentrations found in farmed salmon and trout were greater 
than those measured in lean wild marine fish, while levels detected in farmed shrimp, 
tilapia and pangasius were generally lower. Finally, within the group of considered 
species, salmon was believed to be responsible for 97% of human exposure to a range 
of pollutants, because of the much higher contamination levels and average 
consumption compared to the other species (van Leeuwen et al., 2009). 
Within a study conducted in Norway on 21 samples of local foods, the highest levels of 
PFCs were detected in cod, cod liver, meat, canned salmon and mackerel. This 
underlines once more the importance of fish as source of exposure for the population, 
which is even more significant considering the wide fish consumption in this Country. 
On the basis of the collected data, a rough total PFCs average dietary intake of 100 
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ng/day was suggested, higher in male subjects compared to females (Haug et al., 
2010a). A further survey by the same Authors investigated the relations between the 
consumption of certain categories of food (mainly seafood) and serum concentrations 
of 19 PFCs in 175 subjects, showing that measured levels were associated with the 
estimated dietary intake of these contaminants. After a 12 months monitoring, it was 
proved that fish and shellfish were the main responsible for PFCs seric concentrations, 
contributing to 38% and 93% of total intake, respectively for PFOA and PFOS. 
Measured levels depended also on other factors, including age and place of origin of 
the subject: concentrations were higher increasing the age of the observed subjects 
and in those living in areas near the coast, probably due to direct fishing in more 
contaminated waters. This fish, in fact, presented greater levels of contamination 
compared to that caught in open sea for commercial purposes. The estimated dietary 
intakes of PFOA and PFOS were 0.6 and 1.5 ng/kg b.w. per day, respectively, and were 
significantly related to the corresponding serum concentrations (Haug et al., 2010b). 
Various other studies had already suggested the role of diet as major route of 
exposure, but in the two investigating on a potential correlation between estimated 
PFCs intake through diet and seric concentrations no tendency was observed: this was 
probably due to the limited period of observation (7 days in the work by Fromme et 
al., 2007a; 1 day in the work by Kärmann et al., 2009), not sufficient to highlight trends 
in concentrations, which are the consequence of several years of exposure. 
The increasing concern on diet-related exposure to these contaminants resulted in the 
production of specific investigations also for other, apparently less relevant, sources of 
PFCs, which proved their wide diffusion in several food products. 
A recent monitoring explored the presence of perfluorinated compounds in chicken 
eggs produced in Belgium, highlighting that home-produced eggs contained higher 
levels of contaminants than commercially produced eggs. Considering that the average 
egg consumption of people who own chickens is about twice the mean value reported 
for the Belgian population (20.3 and 10.0 g/day, respectively), the Authors estimated a 
median intake for home-produced eggs consumers of 142 ng/kg b.w. per day, but this 
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value was higher for those subjects living near a perfluorochemical production site 
(D’Hollander et al., 2011). 
PFCs have been detected also in tomatoes and grown lettuce, with higher 
concentrations in the roots compared to leaves and fruits, and it was observed that 
short-chain compounds were better transferred from the roots to the leaves compared 
to longer molecules (Felizeter et al., 2011). 
Even game animals have been recently indicated by EFSA as significantly contaminated 
by perfluorinated compounds. High concentrations of PFOS (up to 216 ng/g), PFNA (up 
to 10.3 ng/g), PFOA (up to 7.1 ng/g), PFDA (up to 6.0 ng/g) and PFDoA (up to 3.7 ng/g) 
were measured in edible offal of these species, while lower levels of PFOS and PFOA 
were observed in their meat. These matrices resulted significantly more contaminated 
in game animals, both birds and mammals, compared to farmed ones. However, from 
the dietary exposure point of view, it must be considered that they represent a not 
very significant component of the diet for the general population. Moreover, analysis 
were conducted only on a small number of samples, so it’s difficult to make firm 
deductions on the real contamination levels in this food (EFSA, 2011). 
Since diet is likely to be the most important factor when estimating human exposure 
to PFCs, their concentrations should be monitored not only in the final food products, 
but also through all the food chain. Figure 1.8 summarizes how PFOS can enter the 
food chain and being then transferred from one step to the other, influencing the total 
consumer intake. 
 
Figure 1.8 PFOS transfer through the food productive chain (van Asselt et al., 2011) 
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Moreover, it must be considered that food products, even at the end of the food chain, 
can be contaminated by the same packaging in which they are contained, as well as by 
the cookware in which they are prepared. In fact, grease and water repellent coatings 
applied on these items are often manufactured using PFCs precursors, which can 
transfer to food and then, through degradation, contribute to increase human body 
burdens of substances like PFOS (Fromme et al., 2009). 
In a total diet study carried out in Canada during the 1992-2004 period, individual 
perfluorooctane sulfonamides were detected in food contained in treated paper 
packaging, such as pizza and French fries. However, concentrations of these molecules 
in food are reported to have decreased during the sampling period, being replaced in 
these applications by fluorotelomer alcohols after the termination of perfluorooctyl 
sulfonyl compounds production (Tittlemier et al., 2006). 
A recent survey on fluorinated and perfluorinated compounds in food contact 
materials from the Munich area, in Germany, proved the high FTOHs content in these 
items. After analyzing 47 paper-based packaging samples previously identified as 
containing fluorine, the Authors observed fluorotelomer alcohols (6:2, 8:2, 10:2 FTOH) 
concentrations ranging from 9 to 29500 ng/g, as well as lower levels of contamination 
for PFCAs, mainly PFNA (up to 1500 ng/g), PFOA (up to 619 ng/g) and PFDA (up to 390 
ng/g) (Wolz et al., 2010).  
A study conducted in 2009 by Jogsten et al. tried to assess the effects of some food 
processing and packaging on the exposure to perfluorinated compounds through the 
diet: PFOS and PFHxA were detected in various food items, but the obtained data were 
not sufficient to understand if these factors can actually influence human exposure. 
An investigation on potential migration from PTFE containing items reported a PFOA 
concentration in cookware in the range 4-75 ng per g of coating (Begley et al., 2005). 
Perfluoroalkyl surfactants and fluorotelomer alcohols contained in nonstick cookware 
and food packaging can also be released to the air while cooking. Testing 4 different 
nonstick pans, it has been measured a pan-to-gas-phase transfer for PFOA of up to  
337 ng, detecting also 6:2 FTOH and 8:2 FTOH; a decrease of PFOA and FTOH release 
was observed after the fist use. Moreover, high amounts of 6:2 FTOH (up to 223 ng per 
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bag) and 8:2 FTOH (up to 258 ng), as well as lower quantities of PFOA (5-34 ng) were 
found in the vapors produced by microwave popcorn bags and on the packaging 
internal surface. According to the Authors, these results indicate that residues of the 
cited contaminants remained on the surface of treated coatings may migrate to the 
gas phase at normal cooking temperatures (Sinclair et al., 2007). 
The French Food Safety Agency (AFSSA) investigated the potential risks for the 
population associated to the residual PFOA presence in cookware provided with non-
stick coatings, concluding that this represents a minor route of exposure for the 
consumers (EFSA, 2011). 
Milk 
Milk has been treated in this specific sub-section, being the matrix investigated in the 
present work and representing a particular issue when it comes to perfluorinated 
compounds exposure through the diet. In fact, milk and dairy products (mostly from 
cow, buffalo, sheep and goat but, in certain areas, also from other animal species such 
as camel) are important components of the diet for adults and particularly for children, 
while human breast milk represents virtually the only source of nutrition for newborns. 
Based on the above aspects, the importance of evaluating the role of PFCs as potential 
contaminants also in this matrix is evident. 
PFOS has been reported to have strong affinity, as well as for albumin, also for             
β-lactoglobulin, therefore contaminated milk and dairy products constitute a possible 
source of exposure (Wang et al., 2010). 
A first multi-city monitoring performed by 3M in 2001 on a wide range of food 
products (with a LOQ of 0.5 ng/g) reported PFOS presence only in 4 milk and 1 ground 
beef samples, with concentrations reaching 0.85 ng/g (EFSA, 2008). 
During the following years a number of works have been published, using more 
sensitive methods and providing data on a larger number of samples. 
According to EFSA’s report on the 2008-2009 monitoring of PFCs in food, including 121 
milk samples, 87 fermented milk samples and 43 cheese samples, PFOS 
contaminations was observed only in 2 (out of 18) sheep milk samples, with 
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concentrations of 140 and 260 pg/mL (LOQ 20 pg/mL). However, it was highlighted 
that the animals from which milk was collected were usually grazing near an industrial 
settlement (EFSA, 2011). 
Within the previously mentioned survey on food products available on the Catalan 
market conducted by Ericson et al., also milk and dairy products were monitored. 
More specifically, whole milk, semi-skimmed milk, 3 kinds of cheese, yogurt, creamy 
yogurt, cream caramel and custard samples were analyzed, reporting PFOS presence 
mainly in dairy products, at mean concentration of 121 pg/g. PFOA and PFHpA were 
detected in two samples of whole milk, at mean levels of 56 and 15 pg/g, respectively, 
and at even lower levels in the other products. Based on the collected data, the 
Authors estimated the daily intake of PFOS for the local population: it was suggested a 
value ranging between 1.3-3.7 ng/day for milk and from 8.4 to 16.5 ng/day for dairy 
products, depending on the age and sex of the subjects (Ericson et al., 2008a). 
A monitoring performed in the United Kingdom on a wide range of food products 
included also 11 milk samples, showing PFOS and PFOA concentrations below the limit 
of detection, which corresponded to 1 ng/g (Mortimer et al., 2009). 
Wang et al. recently evaluated the presence of 9 perfluorinated compounds in milk, 
milk powder and yogurt from China. PFHpA and PFNA were found in 68% of the 84 
milk samples at mean concentrations of 54 and 67 pg/g respectively, while PFOS and 
PFOA were present at lower frequencies (<50%) and concentrations (24 and 26 pg/g). 
Concerning milk powder, PFOA was found in 12 of the 36 samples with a mean level of 
46 pg/g, while PFOS and PFNA were less frequently detected (mean concentrations 22 
and 30 pg/g respectively). As for yogurt, only PFOA was significantly present, with a 
mean concentration of 32 pg/g. Considering a mean milk and dairy products 
consumption for a Chinese adult of 59.2 g/day, the Authors calculated a daily intake 
for PFOS and total PFCs of 23 and 167 pg/kg b.w., assuming that milk was the only 
contributor (this value would decrease if also dairy products were considered as 
contributors to the daily consumption) (Wang et al., 2010). 
Eleven different brands of milk (12 total samples) purchased in retail stores from the 
United States were analyzed, showing concentrations below the limits of detection for 
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all the PFCs investigated a part for 8 sample presenting extremely low levels of PFHXs 
(up to 4 pg/mL); similarly, among 21 samples of 5 different infant formula brands 
collected in the same Country, in only few cases low concentrations of PFOS (up to 11 
pg/mL) and PFHxS (up to 4 pg/mL) were found (Tao et al., 2008a). 
Among the samples included in their mentioned monitoring conducted in Norway, 
Haug et al. analyzed also 1 sample of milk and 1 sample of cheese, detecting only few 
of the 12 target compounds. The most abundant in milk was PFOS (7 pg/g), followed 
by PFOA (5 pg/g) and PFDA (4 pg/g); in cheese, PFNA showed the highest 
concentration (16 pg/g) and slightly lower levels were measured for PFOS (13 pg/g) 
and PFOA (0.012 ng/g). A total intake through milk and dairy products was estimated 
of 4.7 ng/day for PFOS and of 4.4 ng/day for PFOA and PFNA (Haug et al., 2010a). 
The data available so far on milk are not many; however they seem to prove that this 
food doesn’t represent a significant source of PFCs for the population, even if it must 
be considered that, in general, milk consumption is sensibly higher in children. In this 
context, the risk of exposure is even more relevant for breastfed infants, whose major 
source of food is human breast milk.  
Several works have demonstrated the presence of various PFCs in blood and milk of 
breastfeeding women and, even if the transfer mechanism from the former to the 
latter isn’t clear, it has been reported that PFOS levels in milk are about 100 times 
lower compared to blood (Kärrman et al., 2007). This is probably due to the fact that 
these compounds have great affinity for the protein fraction of blood, which is higher 
compared to the lactalbumin and casein content of breast milk, resulting in limited 
migration and accumulation into milk (Völkel et al., 2008; Fromme et al., 2009). 
The risk that persistent contaminants can reach a newborn through breastfeeding, 
after the in-utero exposure due to transplacental passage, has raised the concern on 
the topic, leading to a number of studies on PFCs presence in human breast milk. 
Kärrman et al. analyzed 12 breast milk samples collected from as many Swedish 
mothers during the third week after delivery. PFOS was present in all the samples with 
concentrations between 60 and 470 pg/mL (median 166 pg/mL), showing a positive 
association with values measured in the corresponding serum. Also PFHxS was 
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detected (range 31-172 pg/mL, median 70 pg/mL), while FOSA, PFNA and PFOA were 
present in 8, 2 and 1 samples, respectively. A total PFCs intake by lactation of around 
200 ng/day was estimated (Kärrman et al., 2007). 
Völkel et al. analyzed 57 human breast milk samples from Germany and 13 from 
Hungary, detecting PFOS in all 70 samples but at significantly different levels between 
the two Countries. In fact, while samples from Germany showed concentrations 
between 28-309 pg/mL (median 119 pg/mL), those from Hungary presented levels of 
contaminations ranging from 96 to 639 pg/mL (median 330 pg/mL). As for PFOA, it was 
detected less frequently, with only 11 German samples showing concentrations 
between 201 and 460 pg/mL. The Authors calculated a PFOS mean daily intake through 
breast milk of 100 ng for 5 kg infants, based on the data from Germany (Völkel et al., 
2008). 
Another study conducted in Germany monitored 203 human breast milk samples from 
women living in the North Rhine-Westphalia region, where a soil improver containing 
highly contaminated PFCs industrial waste had been previously used by local farmers 
on their fields. PFOS was found in 99 samples, with median and maximum 
concentrations of 82 and 284 pg/mL, respectively; PFOA was detected in 120 samples, 
with median and maximum levels of 137 and 610 pg/mL. PFHxS was present only in 
two cases, at low concentrations (Bernsmann and Fürst, 2008). 
Fromme et al. collected breast milk samples from German women during the first 5 
months of newborn’s life (201 samples in total) to investigate PFCs presence. PFOS 
showed the highest frequency (72%), with concentrations in the range <30-110 pg/mL 
(median 40 pg/mL); PFOA and PFHxS were found in 2 and 3% of samples, respectively, 
with maximum concentrations of 25 pg/mL for the former and 30 pg/mL for the latter. 
In addition, 4 infant formulas were analyzed as well, but none of the compounds was 
measured above its correspondent LOQ (Fromme et al., 2010). 
A monitoring conducted in Barcelona (Spain) included 20 breast milk samples and 3 
powder milk-based infant formulas. PFOS was found in 95% of breast milk samples, 
with concentrations generally between 28 and 865 pg/mL ; PFOA was detected in only 
40% of samples, but often presented high concentrations (up to 907 pg/mL). 
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Concerning powder milk, PFDA showed the highest concentrations, ranging from 693 
to 1289 pg/kg, followed by PFOS, PFOA and PFNA (Llorca et al., 2010). 
Tao et al. measured the concentrations of 9 PFCs in 45 breast milk samples from 
Massachusetts. The mean levels of PFOS and PFOA (the two predominant substances) 
were 131 and 438 pg/mL, respectively, and a total average daily PFCs intake of 23.5 
ng/kg b.w. was estimated (highest intake = 87.1 ng/kg b.w. per day). Comparing the 
ratio PFOS/PFOA resulting from the analysis of these samples with that reported for 
human serum in the US female population, the Authors suggested a preferential 
transfer of PFOA to milk. Also, it was observed that PFOA concentrations were greater 
in samples originating from primiparous mothers (Tao et al., 2008b). 
Various surveys have been carried out in Asian Countries as well. The results of a 
monitoring performed in China on 19 primiparous mothers revealed that PFOS and 
PFOA were the most present PFCs, with concentration ranging from 45 to 360 pg/mL 
for PFOS and from 47 to 210 pg/mL for PFOA. Other PFCs were detected at lower 
levels, with maximum measured levels of 100 ng/mL for PFHxS, 62 pg/mL for PFNA, 56 
pg/mL for PFUnA and 15 pg/mL for PFDA (So et al., 2006). 
A Japanese study reported PFOS presence in all the human breast milk samples 
analyzed (51), with concentrations ranging between 8 and 401 pg/g, evidencing how 
these outcomes suggest an important exposure for infants. Even if only in certain 
samples, also PFOA, PFNA and PFHxS were detected, at maximum concentrations of 
339, 150 and 25 pg/mL, respectively (Nakata et al., 2007). 
The analysis of a large number of breast milk samples from 7 different Asian Countries 
was carried out by Tao et al. in 2008. PFOS was present in 178 of the 184 samples (only 
in 6 out of 39 samples from India it was not detected), showing significant variability in 
the mean concentrations between the different Countries: the lower value was 
reported for India (461 pg/mL) while the highest for Japan (232 pg/mL). PFOA was 
detected in almost all samples from Japan (mean 777 pg/mL), but rarely in breast milk 
coming from the other 6 Countries. Great variability was reported for PFHxS frequency, 
whose levels didn’t exceed 158 pg/mL (Tao et al., 2008a). 
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Another monitoring was recently performed in China on 24 pools originating from 
1237 individual human breast milk samples. A mean concentration of 46 pg/mL was 
reported for both PFOS and PFOA, but a significant variability depending on the area of 
sampling was observed: Samples from subjects living in the Shanghai region resulted 
the most contaminated, with PFOA concentrations up to 814 pg/mL. The Authors 
estimated mean and highest dietary intakes of total PFCs of 178 and 129 pg/kg per 
day, respectively; moreover, they highlighted that their estimated PFOA intake of   
88.4 ng/kg b.w. per day resulted close to some proposed TDIs (Liu et al., 2010). 
Human milk contamination by PFCs was investigated in pooled milk samples from 19 
developing Countries as part of a WHO project. PFOS was detected in almost all 
samples, with the highest concentrations measured in Moldova (65 pg/mL). PFOA was 
found less frequently, with the highest concentration equal to 192 pg/mL and obtained 
from Antigua, but it must be observed that this compound had a sensibly higher LOD 
(80 pg/mL) (Kärrman et al., 2011). 
Some Authors investigated the trends of PFCs content in human breast milk and serum 
during lactation. Thomsen et al. observed that PFOA and PFOS concentrations in milk 
decreased by 94 and 37%, respectively, during 12 months of breastfeeding (Thomsen 
et al., 2010). Similarly, Haug et al. indicated that breastfeeding for a period longer than 
4 months considerably reduced levels of various PFCs in serum (Haug et al., 2010b). In 
the light of the above, lactation history can represent a useful instrument in studies on 
both mother and child exposure. 
An interesting study recently published by Haug et al. presented further interesting 
aspects. After monitoring PFCs presence in milk and serum of 19 Norwegian women, 
they investigated the partitioning between the two media, observing positive 
correlations: PFOS and PFOA mean concentrations were 1.4% and 3.8%, respectively, 
of the corresponding values measured in serum. This suggested that PFOA migration 
from blood to milk is about two times greater than that of PFOS, which is in agreement 
with what previously reported by Thomsen et al. Moreover, considering also the 
potential exposure of infants through house dust inhalation, the Authors calculated 
that maximum estimated intakes were quite close to proposed TDIs (even if it must be 
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observed that these TDIs are set for lifelong exposure) and demonstrated that breast 
milk consumption contributes to more than 94 and 83% of total exposure to PFOS and 
PFOA, respectively (Haug et al., 2011a). 
Based on the above information, it’s clear that postnatal exposure to these pollutants 
can have a relevant impact on health, therefore further surveys employing more 
sensitive and precise analytical techniques are needed to assess the risks for infants 
deriving from lactation. 
 
 
1.2.2  Non-food sources 
 
In a wide perspective, to produce accurate estimations of global exposure to these 
contaminants it’s important to evaluate, other than diet, also significant sources 
related to the environment where humans live. These include drinking water, indoor 
air and house dust (Haug et al., 2010b). 
Although drinking water is subjected to many controls on various contaminants, there 
are no regulations concerning perfluorinated compounds, thus it may represent a 
relevant route of exposure for the population. 
Drinking water is estimated to contribute to less than 16% of total PFOA intake and to 
a more modest extent (<0.5%) of PFOS exposure (EFSA, 2008). 
Even if activated carbon adsorption is a promising technique for the removal of PFOS 
from dilute aqueous streams, this treatment is not so common (van Asselt et al., 2011); 
the slight differences found by Loos et al. between PFCs levels in drinking water 
generated from Lake Maggiore (Italy) and those measured directly in the lake indicated 
the inefficiency of chlorination and sand filtration processes operated by the local 
waterworks. Therefore, surveys are required to detect possible drinking waters 
contaminations. 
A number of studies on drinking water contamination by perfluorinated compounds in 
Europe reported values in the range 0.4-9.7 ng/L for PFOS and between 1-4 ng/L for 
PFOA (EFSA, 2008). 
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A survey conducted in Spain to assess the role of drinking water as contributor to 
dietary intake of perfluorinated compounds for the population of Tarragona revealed 
the presence of various compounds belonging to this family. In tap water samples 
PFOA was the most detected analyte, with levels in the range 0.32-6.28 ng/L; PFOS was 
also detected (between 0.39 and 0.87 ng/L), as well as PFHxA, PFHpA and PFNA. 
Concentrations were sensibly lower in bottle water, with reported values for PFOA     
<1 ng/L and PFOS not detected at all. Assuming a water consumption of 2 L per day, 
the Authors calculated a potential intake of around 12.6 ng/day for PFOA and of 0.78-
1.74 ng/day for PFOS (Ericson et al., 2008b). 
Similarly, after analyzing several drinking waters from public fountains in Catalonia 
region (Spain) Domingo et al. identified water consumption as one of the predominant 
PFCs source for people living in that area. Various PFCs were identified: PFOA and PFOS 
showed the greatest mean concentrations (2.42 and 1.95 ng/L, respectively), with 
samples from the highly populated and industrialized Barcelona resulting 3-4 times 
more contaminated than those from the other observed areas, reaching peak 
concentrations of 9.60 ng/L for PFOA and 6.20 ng/L for PFOS (Domingo et al., 2011). 
In the previously mentioned monitoring in the Ruhr river area, Skutlarek et al. reported 
the presence of various PFCs also in local drinking water. PFOA and PFOS were 
detected at maximum concentrations of 519 and 22 ng/L respectively, but also PFPA 
(up to 77 ng/L), PFHxA (up to 56 ng/L) and PFBS (up to 56 ng/L) were found. The 
relevance of these results is evident when compared to data collected from the 
analysis of drinking waters outside the Ruhr area, in which maximum PFOS and PFOA 
concentrations were in the order of 5 ng/L (Skutlarek et al., 2006). 
3M Company investigated PFOS and PFOA levels in drinking water in four American 
cities where these compounds were produced or industrially employed (Columbus, 
Decatur, Mobile and Pensacola) and in two other cities, used as control (Cleveland and 
Port St. Lucie). Data indicated PFOS and PFOA contamination only in Columbus (up to 
59 and 27 ng/L, respectively) and in Pensacola (only PFOS detected, with 
concentrations ranging between 0-45 ng/L) (EFSA, 2008). 
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A monitoring on drinking water treatment facility samples from different locations in 
the United States was performed by Quiñones and Snyder. Depending on the sampling 
site, total detected PFCs concentrations and profile were variable. The highest global 
concentration reported was around 80 ng/L, with measured levels of PFOS and PFOA 
of 29 and 25 ng/L respectively; in some cases significant amounts were observed for 
some other PFCs as well, including PFHxA (up to 29 ng/L) and PFHxS (up to 12 ng/L) 
(Quiñones and Snyder, 2009). 
Perfluorinated compounds have been measured also in drinking waters from the Rio 
de Janeiro area, in southeast Brazil, showing profiles different from those commonly 
reported. PFOS levels were in fact comparable, or even higher, to those of PFOA and a 
relevant contribution to total PFCs contamination was given by PFHxS: these three 
compounds were detected in all the analyzed samples, at concentrations ranging 
between 0.58-6.70, 0.35-2.82 and 0.15-1.00 ng/L, respectively for PFOS, PFOA and 
PFHxS (Quinete et al., 2009). 
Mak et al. performed between 2006 and 2008 a large-scale investigation on drinking 
water sampled in the United States, Canada, China, Japan and India in order to 
evaluate levels of contamination by 20 PFCs. Samples from China showed the highest 
concentrations of PFOA (mean value in Shanghai water was 78.4 ng/L) and PFOS (mean 
value in Shenzhen was 10.6 ng/L, while in Chinese tap water in general it was 3.9 ng/L), 
as well as the presence of various short-chain perfluoroalkyl carboxylic acids, which 
might have been employed as replacements for PFOS and PFOA. In all the other 
Countries measured concentrations were lower than those from China and certain 
compounds were not detected at all. However, also in the United States and Canada 
the composition profiles of PFCs was dominated by PFOS and PFOA (Mak et al., 2009). 
A monitoring on tap water and bottle water samples collected in Örebro (Sweden), 
Vancouver and Calgary (Canada), and various Asian locations was conducted by Tanaka 
et al. in 2006. The Authors reported tap water PFOS and PFOA average concentrations 
in Sweden equal to 1 and 0.4 ng/L, respectively, while in samples from Canada PFOS 
was not detected and PFOA mean concentration was around 0.2 ng/L. Measured 
values in Malaysia, Thailand and Singapore were in the range between 0 and 2.5 ng/L 
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for both contaminants, while in Vietnam they weren’t detected at all. PFOA was 
detected at a mean of 7 ng/L in two Japanese towns, while the highest values were 
observed in China, with average concentrations of 6.3 ng/L for PFOS and 3 ng/L for 
PFOA (Tanaka et al., 2006). 
In a work published in 2003, Harada et al. measured PFOS concentrations in drinking 
waters in four cities treating fresh water from the Tama river (Japan), which had 
proved to be contaminated by sewage plant discharges, into drinking water: in most of 
cases PFOS levels were lower than 4 ng/L, but in one case it was measured at 50.9 ng/L 
(Harada et al., 2003). 
A research conducted in the Osaka area (Japan) to evaluate PFCs contaminations in 
drinking water reported the presence of PFOA at concentrations in the range 5.4-40.0 
ng/L and of PFOS with values up to 12 ng/L (Saito et al., 2004). 
In another study in the same town, a comparison between raw and treated tap waters 
collected from 14 different drinking water treatment plants was performed. PFOA 
concentrations were in the range 5.2-92.0 ng/L in raw waters, decreasing to values 
between 2.3-84.0 ng/L after being treated; measured levels of PFOS were in the range 
0.26-22.0 ng/L before treatment and between 0.16-22.0 after. On the basis of the 
observed correlations between PFCs levels in raw and tap waters, the Authors 
highlighted the inefficiency of the removal treatment applied, even if no risks were 
expected in relation to such a limited PFOA contamination (Takagi et al., 2008). 
Qiu et al. monitored 8 different PFCs in tap water from 12 locations near Lake Taihu, in 
the eastern part of China. Again, PFOA and PFOS were the dominant PFCs in all 
samples, but a significant difference was reported in their concentrations depending 
on the sampling location: in fact, measured levels in Shanghai area (22-260 ng/L for the 
former and 0.62-14.0 ng/L for the latter) were on average around 10 times higher than 
in Nanjing (2.1-2.4 and 0.33-0.38 ng/L, respectively) (Qiu et al., 2010). 
A survey was recently carried out in order to estimate for the first time human 
exposure to PFCs through drinking water in Australia, by the analysis of 62 samples 
collected from 34 different locations across the Country. PFOS and PFOA were 
detected in about half of the samples and also PFHxS was often detected (27% of the 
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samples, generally at higher concentration than PFOA but lower than PFOS). Total PFCs 
concentrations were in the range 1-5 ng/L for the majority of sampling sites, but in the 
Sidney area values up to 36 ng/L were reported (Thompson et al., 2011). 
On the basis of the available data, drinking water doesn’t seem to be a significant 
source for human exposure. However, water contribution can become relevant in 
those areas close to sources of contamination and in case of local pollution events (van 
Asselt et al., 2011). For this reason, advisory guidelines on PFOS and PFOA presence in 
drinking water have been set by certain authorities in the United Kingdom, Minnesota 
and Germany. 
 
Figure 1.9 Domestic environment-related PFCs pathways to humans 
(Shoeib et al., 2011) 
As previously reported, besides food and drinking water, a potential route of exposure 
to perfluorinated compounds for the population is represented by inhalation, 
especially of indoor air and house dust (see Figure 1.9). 
During the last decade Shoeib et al. conducted different surveys on the presence of 
perfluoroalkylated substances (mainly volatile precursors of PFOS and PFOA) in these 
matrices, highlighting significant differences compared to outdoor air. 
In a 2004 study the Authors reported mean indoor air concentrations of 2590 pg/m3 
for N-MeFOSE and of 770 pg/m3 for N-EtFOSE, calculating a ratio compared to 
environmental air of 110 for the former and 85 for the latter (Shoeib et al., 2004). 
These data were confirmed by a monitoring performed the following year on a larger 
number of air and dust samples, collected in 59 houses in Ottawa (Canada) and in 7 
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outdoor locations in the same town. Measured levels of contaminations for FOSEs in 
indoor air were around 10-20 times higher than outdoor concentrations, with mean 
values of 1490 and 740 pg/m3 for N-MeFOSE and N-EtFOSE respectively. Concerning 
indoor dust, reported geometric mean concentrations were of 110 ng/g for N-MeFOSE 
and 120 ng/g for N-EtFOSE (Shoeib et al., 2005). 
In a recent study the same group performed an even more accurate investigation, 
simultaneously monitoring PFOS, PFOA and their volatile neutral precursors, including 
FOTHs and FOSEs, in 152 houses in Vancouver (Canada). Between neutral compounds, 
8:2 FTOH was widely the most present in air samples, with a mean concentration of 
2900 pg/m3, while N-MeFOSE was found at a mean concentration of 380 pg/m3. PFOA 
was measured in all indoor air samples (mean value 28 pg/m3), while PFOS was not 
detected. On the contrary, high concentrations were reported for ionic PFCs in house 
dust, reaching 4700 ng/g for PFOS and 1400 ng/g for PFOA. Concerning their 
precursors, 8:2 FTOH was the most abundant in house dust as well, with a geometric 
mean of 88 ng/g. According to the Authors, while inhalation of contaminated air 
represents a more relevant route of exposure in adults, dust ingestion (e.g. by contact 
with hands) can be a consistent source of PFCs for children (Shoeib et al., 2011). 
A Norwegian study estimated the contribution of various routes of exposure in a group 
of 41 women, proving the role of the indoor environment as a relevant source to be 
added to diet. In fact, if on the one hand diet was responsible for 88-99% and 67-84% 
of the total intake of PFOS and PFOA, on the other hand for certain subjects the 
contribution of indoor environment reached about 50% of the total. The highest values 
in house dust were reported for PFHxA (28 ng/g), PFNA (27 ng/g), PFDoA (19 ng/g) and 
PFOS (18 ng/g), while fluorotelomer alcohols were the most detected in the air, with 
concentrations of 5173, 2822 and 933 pg/m3, respectively for 8:2, 10:2 and 6:2 FTOH. 
Also, the Authors observed correlations between levels of contamination of house dust 
and corresponding concentrations in blood, as well as between the age of the house 
and measured values in both indoor air and dust (Haug et al., 2011a and b). 
An interesting research compared the presence of several perfluoroalkylated 
substances in air samples collected in residential and non-residential indoor 
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environments. Data obtained reported great variability between the different samples, 
with total concentrations ranging between 8.2-458 ng/m3, but a deeper analysis 
highlighted that the highest concentrations (both individual and total) were found in 
shops selling outdoor equipment, furniture and carpets (Langer et al., 2010). 
A recent study investigated the content of PFOA and FTOHs in various consumer 
products which can be employed in households, suggesting that impregnating sprays 
for shoes and textiles, generating inhalable aerosols, can contribute to the 
environmental distribution of these contaminants, thus resulting an additional source 
for people using them (Schramm et al. 2010). 
Fromme et al. produced an exposure assessment collecting data on all the significant 
media for human exposure: food (which confirmed to be the most relevant source), 
drinking water, indoor air and house dust. Average and upper daily intake values of 1.6 
and 8.8 ng/kg b.w. for PFOS and of 2.9 and 12.6 ng/kg b.w. for PFOA were reported. In 
addition, they estimated mean global dietary and non-dietary intakes of volatile 
precursors equal to 0.14 ng/kg b.w. per day for FTOHs and 1.6 ng/kg b.w. per day for 
FOSEs (Fromme et al., 2009). 
Also Haug et al. estimated total intakes for PFCs within the previously cited study on 41 
Norwegian women, including all the potential sources of exposure, i.e. food, water, 
dust and air; dermal uptake was discarded, having been reported to be a negligible 
route. Three different scenarios were used to estimate house dust intake, since there’s 
still little information on the real contribution of this route and on volatile precursors 
biotransformation. PFOS median total intakes varied, depending on the scenario, 
between 0.64 and 0.77 ng/kg b.w. per day; similarly, those of PFOA ranged from 0.27 
to 0.36 ng/kg b.w. per day (Haug et al., 2011a). 
In order to obtain more representative and consistent data, there’s need for further 
monitoring on perfluorinated compounds, extending the variety of products and 
matrices examined and investigating a wider range of analytes, including as well their 
precursors.  
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1.2.3  Occurrence in humans 
 
Following the increasing interest towards the global spread of perfluorinated 
compounds and the related risks for health, several studies have been conducted in 
order to evaluate human exposure to these contaminants measuring their levels in 
blood, plasma or serum. 
If on the one hand it has been demonstrated that PFCs concentrations in plasma and 
serum are comparable, on the other hand reported ratios between those two media 
and whole blood levels are not consistent. According to some Authors, the median 
plasma to whole blood ratios for PFOS and PFOA are 2.3 and 2.0, respectively, while 
lower values (1.2 and 1.4, respectively) have been suggested by others (Fromme et al., 
2009). 
Various studies suggested sex-related differences in blood levels of PFOA and PFOS: 
higher concentrations were observed in male compared to women, even if measured 
levels in women seemed to increase with age. However, other experiments didn’t 
confirm this aspect. Some works reported also differences in PFOA and PFOS serum 
levels related with the place of origin of the donor, but it’s difficult to ascertain if this 
variability was due to ethnic differences or rather to a combination of factors, 
including also lifestyle and diet (Fromme et al., 2009; EFSA, 2008). 
Kannan et al. conducted an extended investigation, monitoring the presence of PFOS, 
PFOA, FOSA and  PFHxS in 473 human blood, serum and plasma samples from Italy, 
Belgium, Poland, United States, Brazil, Colombia, India, Malaysia and Korea. PFOS 
resulted the predominant substance, with the highest concentrations found in samples 
from the United States and Poland (>30 ng/mL) and the lowest in those from India    
(<3 ng/mL, in only 51% of which at levels >1 ng/mL). The other analytes showed 
smaller frequencies and concentrations. PFOA, the second most abundant compound, 
was generally found at levels 2-7 times lower than PFOS; however, in lots of serum 
samples from Korea it resulted the most detected analyte, suggesting the existence of 
specific sources of exposure in that area. The highest concentrations of PFHxS were 
found in samples from the United States, Japan and Korea, ranging between 1.5 and 3 
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ng/mL in these Countries; a significant variability of the ratios between PFHxS serum 
levels and those measured for PFOS was observed among the various Countries 
(Kannan et al., 2004). 
60 human blood samples collected in the Gulf of Gdañsk area (Poland) were analyzed 
by Falandysz et al. within a monitoring on exposure for people living on the Baltic 
Coast. The results evidenced that PFOS and PFOA had the highest concentrations, in 
the range 5.2-84.0 and 1.2-8.7 ng/g, respectively, but also other PFCs were present, 
even if at lower concentrations (for PFHxS between 0.2 and 3.7 ng/mL; for PFNA 
between 0.16 and 3.8 ng/mL) (Falandysz et al., 2006). 
A survey carried out in Germany evaluated concentrations of PFOS and PFOA in 105 
plasma samples, reporting median concentrations of 22.3 ng/mL for the former and 
6.8 ng/mL for the latter. Higher levels were observed in men compared to women 
(Midasch et al., 2006). 
Slightly lower values were obtained analyzing 356 samples of human plasma collected 
in southern Bavaria (Germany), whose PFOS concentrations were between 2.5 and 
30.7 ng/mL (median 10.9 ng/mL) and those of PFOA between 1.5 and 16.2 ng/mL 
(median 4.8 ng/mL). Again, the Authors reported higher concentrations in male 
subjects (Fromme et al., 2007b). 
Hölzer et al. evaluated the levels of PFCs in 170 children, 317 women and 204 men 
who had been exposed to PFCs through contaminated drinking water in the Arnsberg 
area (Germany). The Authors reporting PFOA levels in plasma 4.5-8.3 times greater 
than concentrations measured in the reference population. One year after this 
monitoring, a follow-up survey was conducted on a large portion of the subjects, 
showing a slow decline of PFOA levels: mean concentrations decreased by around 
21.3% in children, 19.7% in women and 7.5% in men (Hölzer et al., 2008 and 2009). 
During a monitoring conducted by Kärrman et al. in Sweden, 12 different PFCs were 
investigated in 66 whole blood samples collected from the local population. PFOS, 
PFOA, FOSA, PFHxS and PFNA were present in 92-100% of cases and showed higher 
concentrations in men compared to women; PFOS showed the highest concentrations, 
ranging between 1.7-37.0 ng/mL (median 17.1 ng/mL). PFDA and PFUnA were found in 
 43 
65% of the samples, while the other analytes were detected sporadically. Assuming a 
plasma to whole blood ratio of 2, the Authors suggested that calculated plasma 
concentrations of PFOS and PFOA based on their data were similar to those reported in 
other studies (Kärrman et al., 2004). 
Ericson et al. tried to investigate potential correlations between PFCs levels in blood of 
48 people living in Catalonia (Spain) and their age and gender. PFOS showed the 
highest mean concentration (7.6 ng/mL), but significant levels were observed also for 
PFHxS and PFOA (mean concentrations 3.6 and 2.8 ng/mL, respectively). Once again, 
samples collected from male subjects resulted more contaminated; PFHxS levels 
presented age-related differences, being higher in the 25±5 years group (Ericson et al., 
2007). 
Both PFOS and PFOA were found in 56 serum samples collected in Athens (Greece), at 
median concentrations of 13.7 ng/mL in males and 7.0 ng/mL in females the former 
and of 3.1 and 1.7 ng/mL the latter. PFOS values were significantly higher in samples 
belonging to the “over 40” group, while no age-related trend was observed for PFOA 
(Vassiliadou et al., 2009). 
An increase of PFOS seric levels with age was indicated as well by Ingelido et al., who 
highlighted the same situation also for PFOA after the analysis of 230 serum samples 
from two Italian cities, Brescia and Rome. More precisely, measured concentrations of 
both PFOS (range 0.06-29.6 ng/g, median 6.3 ng/g) and PFOA (range 0.2-51.9 ng/g, 
median 3.6 ng/g) were higher in the 36-50 and 51-65 years ranges, with a significant 
increase in females belonging to the 51-65 years group. Moreover, PFOS and PFOA 
levels showed a strong correlation, with the former always significantly more present 
than the latter (Ingelido et al., 2010). 
The previously mentioned survey by Haug et al. on 175 serum samples from Norway 
reported the presence of PFOA, PFNA, PFDA, PFUnA, PFHxS and PFOS in all samples; 
PFHxS and FOSA were almost always detected as well. PFOS was the most found 
(mean 32 ng/mL, significantly higher than any other analyte; maximum 133 ng/mL), 
followed by PFOA, PFHxS and PFNA (means 4.1, 2.2 and 1.1 ng/mL, respectively) (Haug 
et al., 2010b). 
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In 2001, Hansen et al. performed a monitoring on 65 serum samples collected in the 
United States, detecting PFOS in all the samples, while PFOA and PFHxS in 52% and 
47% of cases, respectively. Mean and maximum measured concentrations were 
respectively 28.4 and 81.5 ng/mL for PFOS, 4.8 and 35.2 ng/mL for PFOA, 5.1 and 21.4 
ng/mL for PFHxS (Hansen et al., 2001). 
The analysis of 20 serum samples collected in Atlanta (United States) reported 
comparable values: PFOS ranged between 3.6 and 164.0 ng/mL, PFOA between 0.2 
and 10.4 ng/mL, PFHxS between 0.4 and 11.2 ng/mL (Kuklenyik et al., 2004). 
A number of surveys have been presented by Olsen et al. on PFCs presence in serum of 
the Unites States population. A monitoring on 645 Red Cross blood donors from six 
different centers showed PFOS mean concentration of 34.9 ng/mL (maximum value 
1626 ng/mL), while other detected PFCs were present at 10-fold lower levels (Olsen et 
al., 2003a). Similar values were reported in a survey on 238 aged subjects (65-96 years 
old) from Seattle: PFOS mean concentration was 31 ng/mL, with a maximum level of 
175 ng/mL. No sex-related differences were observed (Olsen et al., 2004). In a more 
recent work, the Authors analyzed 100 serum samples collected in Minneapolis in 
2000 and 40 plasma samples collected in the same town in 2005, in order to evaluate if 
PFCs levels had decreased after the termination of the electrochemical fluorination 
process by 3M Company. The mean concentration decreased from 33.1 to 15.1 ng/mL 
for PFOS and from 4.5 to 2.2 ng/mL for PFOA (Olsen et al., 2007a). 
The same Authors have also conducted investigations on the levels of PFCs in 
occupationally exposed workers from various production sites, highlighting extremely 
higher concentrations in these subjects compared to the general population. A 
monitoring on 263 3M Company employees from the Decatur (United States) plant 
and 255 from the Antwerp (Belgium) plant showed 2 times higher concentrations in 
subjects working in the American site, with PFOS and PFOA concentrations ranging 
between 60-10060 and 40-12700 ng/mL, respectively, and mean values of 1320 ng/mL 
for PFOS and 1780 ng/mL for PFOA (Olsen et al., 2003b). Another survey on 126 
workers reported mean concentrations of 941 ng/mL (range 787-1126 ng/mL) for PFOS 
and 899 ng/mL (722-1220 ng/mL) for PFOA (Olsen et al., 2003c). The analysis of other 
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506 serum samples from exposed subjects showed PFOA levels between 7 and 92030 
ng/mL, with a mean concentration of 2210 ng/mL (Olsen and Zobel, 2007). 
Two survey projects have been carried out by Calafat et al. on serum samples collected 
from United States residents belonging to three major ethnic groups (non-Hispanic 
whites, non-Hispanic blacks and Mexican Americans), in order to evaluate potential 
ethnicity-depending differences in PFCs levels. The analysis of 54 pooled samples (from 
1832 donors) collected between 2001-2002 reported significantly higher mean 
concentrations of PFOS in non-Hispanic white subjects (40.2 ng/mL in males and 24.0 
ng/mL in females) compared to non-Hispanic black subjects (18.3 and 18.0 ng/mL, 
respectively); as for Mexican Americans, mean levels were even lower, being            
13.7 ng/mL in men and 10.4 ng/mL in women. Similar trends were observed for PFHxS 
as well (Calafat et al., 2006a). In a similar investigation, 1562 samples collected 
between 1999-2000 showed the constant presence of PFOS, PFOA, PFHxS and FOSA, 
with significantly lower levels in Mexican American donors. Sex-related trends were 
observed, while no age-related variations resulted (Calafat et al., 2007). In another 
research by the same Authors, serum samples collected in the United States were 
compared to serum samples from Peru, which showed extremely lower PFCs 
frequencies and concentrations. In particular, PFOS and PFOA were detected in all the 
US samples while in only 20 and 25%, respectively, of the Peruvian samples; also, 
median concentrations of PFOS and PFOA were 31.1 ng/mL and 11.6 ng/mL for the US 
residents, while 0.7 mg/mL and 0.1 ng/mL for the Peruvians (Calafat et al., 2006b). 
A preliminary monitoring in Canada on 56 serum samples showed results similar to 
those of the majority of studies, with PFOS detected in all samples with concentrations 
between 3.7 and 65.1 ng/mL (mean 28.8 ng/mL). PFOA was present at significantly 
lower concentrations and only in 29% of cases (Kubwabo et al., 2004). 
An extended survey, involving 3802 serum samples collected in Australia between 
2002-2003, reported the highest mean concentrations for PFOS, PFOA, PFHxS, PFNA 
and FOSA (20.8, 7.6, 6.2, 1.1 and 0.7 ng/mL, respectively). Increase of PFOS levels with 
age was highlighted in both genders; curiously, PFNA showed higher values in female 
pools (Kärrman et al., 2006). 
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Another huge monitoring was conducted in Australia between 2006-2007 collecting 
2420 serum samples, subsequently pooled based on donor’s age. The most detected 
PFCs were, in descending order, PFOS (mean concentration 15.2 ng/mL), PFOA         
(6.4 ng/mL), PFHxS (3.1 ng/mL) and PFNA (0.8 ng/mL). Gender differences were 
observed (men concentrations were higher compared to those of women) except for 
the <12 years pool; an interesting difference was observed between PFOS, which 
showed the highest concentrations in adults >60 years, and PFOA, PFNA, PFDA and 
PFHxS, which on the contrary were higher in children <15 years (Toms et al., 2009). 
More recently, Toms et al. integrated the results of these two studies with further 
samples collected in Australia between 2008-2009, in order to evaluate PFCs trends in 
the population during an 8 years period. Based on the data obtained, concentrations 
had significantly decreased during that span of time in both adults and children. 
Moreover, some interesting trend differences were observed: no age-related trend 
was found in the earlier data for PFOS, while the most recent samples indicated that its 
level increases with age; at the same time, the early samples suggested a decrease of 
PFOA from youngest age groups towards oldest age groups, which was absent in the 
2008-2009 samples. According to the Authors, these differences may be due to a faster 
response to changing exposure profiles in younger subjects (Toms et al., 2010). 
Concerning Asian Countries, a monitoring carried out in the Tokyo area on 10 whole 
blood samples indicated a mean concentration of PFOS of 8.3 ng/mL, while PFHxS and 
PFBS were not detected (Taniyasu et al., 2003). 
Again in Japan, Harada et al. observed significant differences between serum levels 
measured in Miyagi (lowest), Akita and Kyoto (highest): mean levels of PFOS were in 
the range 5.7-28.1 ng/mL in males and 3.5-13.8 ng/mL in females; as for PFOA, ranges 
were 3.3-12.4 and 2.5-7.1 ng/mL, respectively (Harada et al., 2004). 
Within a wide monitoring in China, 1437 serum samples were collected from different 
locations. PFOS and PFOA showed correlated mean concentrations, equal to 4.3 and 
3.6 ng/mL, respectively; however, a significant zone-related variability was observed: 
PFOS mean levels varied from 0.3 ng/mL in a rural area to 18.8 ng/mL in a big town; 
similarly, PFOA ranged between 0.5 and 25.4 ng/mL (Jin et al., 2011).  
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1.3  Toxicity 
 
Several investigations have been conducted during the last decade in order to deepen 
the knowledge on the toxic effects caused by perfluorinated compounds. 
Most of the available information concerns PFOS and PFOA, which have been reported 
to have a rather long half-life and to accumulate in liver and blood. Studies on these 
substances proved their immunotoxicity and hepatotoxicity, negative effects on 
reproductive, respiratory and nervous systems, as well as potential to cause 
development and hormonal alterations (OECD, 2002; EFSA, 2011). 
Adverse effects have been studied mainly on rats, but some data are available also on 
rabbits and non-human primates. Moreover, in a recent study Sonne observed a 
negative impact on health related to exposure to this these contaminants also in 
animals from the Arctic Circle, such as polar bears, sled dogs and arctic foxes (Sonne, 
2010). 
Some epidemiological studies have been conducted on exposed populations, such as 
workers from plants producing fluorinated substances, but collected data are still 
fragmented and incomplete. 
OECD published in 2002 a hazard assessment on PFOS and its salts, concluding that it’s 
a persistent and bioaccumulative pollutant, with toxic potential towards mammals. 
Consequently, a NOAEL (No Observed Adverse Effect Level) was set at 0.1 mg/kg/day, 
based on the results of a 2-generation reproductive toxicity study performed on rats 
(OECD, 2002). 
In 2003, the United States Environmental Protection Agency (US EPA) issued a 
preliminary evaluation on the toxic effects on development associated with exposure 
to PFOA and its salts, declaring a NOAEL for females and males of 10 and 3 mg/kg/day, 
respectively. 
EFSA’s Panel on Contaminants in the Food Chain (CONTAM) in the 2008 report 
indicated the lowest NOAEL value for PFOS at 0.03 mg/kg b.w. per day and for PFOA at 
0.06 mg/kg b.w. per day. Concerning PFOA, the Panel observed also that in various 
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studies in rats the 95% lower confidence limit of the values for the benchmark dose for 
a 10% increase in effects on the liver (BMDL10) was in the range 0.3-0.7 mg/kg b.w. 
per day. Based on these values, Tolerable Daily Intakes (TDIs) for these substances 
were estimated, resulting of 150 and 1500 ng/kg b.w., respectively for PFOS and PFOA 
(EFSA, 2008). 
Based on the available data, CONTAM panel concluded that there’s little likelihood 
that adverse effects due to these compounds are occurring in the population, but 
more data are needed to ascertain this statement (EFSA, 2008). 
This opinion was shared also by other authorities. The Bundensinstitut für 
Risikobewertung (BfR, the German Federal Institute for Risk Assessment) expert panel 
estimated a provisional TDI of 100 ng/kg b.w. for both compounds and confirmed that 
PFCs exposure through diet is very low, adding that suggested intake levels could be 
indicated for those groups of people living in highly contaminated areas (BfR, 2010). 
The UK Committee on Toxicity of Chemicals in Food, Consumer Products and the 
Environment, based on the effects on liver, kidney, hematological and immune 
systems, recommended a TDI of 3000 ng/kg b.w. for PFOA and 300 ng/kg b.w. for PFOS 
(Committee on Toxicity, 2009 and 2010). 
According to data reported by Haug et al., dietary exposure to PFOS and PFOA is 
respectively 100 and 2500 times lower than their relative TDIs indicated by EFSA, but 
this margin could be smaller for people consuming high amounts of fish products; it 
must also be highlighted that these values didn’t take into account non-food sources 
(Haug et al., 2010b). 
Fromme et al. (2007a), who referred to both food and non-food sources, assessed that 
global daily intakes are significantly lower than even the lowest recommended TDI 
values, at least for adults, since children exposure profile isn’t well defined yet. 
However, it must be noticed that most of the epidemiological studies on humans 
available in literature have been conducted by the major manufacturer of fluorinated 
chemicals and may thus report tendentious results. Further studies will clarify the 
potential correlations between PFCs exposure and risks for human health. 
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1.3.1  Toxicokinetics 
 
1.3.1.1  PFOS 
In animals 
PFOS kinetics has been evaluated through oral administration of PFOS-14C in rats. After 
48 h, around 5% of the radioactivity was found in the feces and the intestine, therefore 
it was assumed that 95% was absorbed. Measured PFOS concentrations after 89 days 
reported significant levels only in liver (20.6 μg/g, corresponding to 25.21% of the 
dose) and plasma (2.2 μg/g, corresponding to 2.81% of the dose); less significant 
amounts were found in kidney (1.1 ng), lung (1.1 ng) and other tissues, and they were 
probably due to residual blood in these organs when homogenized (OECD, 2002; EFSA, 
2008). 
Seacat et al. demonstrated, through daily repeated PFOS administration to rats, that it 
tends to accumulate, showing 31-42% higher serum levels in female rats and no 
relevant differences as regards values measured in the liver (Seacat et al., 2003). 
Several studies in mice and rats reported PFOS transfer from dam to fetus during 
pregnancy and indicated that fetal liver content of PFOS was about 50% compared to 
maternal liver, while serum levels were similar (EFSA, 2008). 
PFOS is not metabolized, after absorption it binds to serum proteins (mainly albumin) 
and distributes in serum and liver; on the contrary, precursors N-MeFOSE and             
N-EtFOSE are reported to be metabolized to PFOS (3M, 1999). 
PFOS is mainly eliminated through the kidney and partially in the feces; its half-life was 
estimated of >90 days in male rats after a single oral dose and of around 200 days in 
monkeys after a 183 days administration (EFSA, 2008; OECD, 2002). 
In humans 
A 2004 study on Japanese pregnant women proved that PFOS can partially transfer 
from maternal to fetal circulation; more recently, it was demonstrated that it can 
reach the fetus also slowly crossing the placenta (EFSA, 2008). 
 50 
Renal elimination has been demonstrated to be negligible in humans; several studies 
evaluated the elimination half-life of PFOS, with quite variable results. According to 3M 
Company survey on 3 former workers, it would be almost 4 years, while an 
investigation on other 9 former employees reported a value of 8.67 years, with a 
relevant variability between the subjects. According to EFSA Panel, the most reliable 
estimation is that proposed by Olsen et al., suggesting a value of 5.44 years (EFSA, 
2008, Olsen et al., 2007b). 
 
1.3.1.2  PFOA 
In animals 
Also to determinate PFOA kinetics a single oral dose of radioactive-labeled molecule 
on rats was used, which resulted in absorption of 93% after 24 h. Similarly to PFOS, it 
mainly distributed in serum, due to its interaction with albumin, and in liver (in female 
rats also in kidneys), due to its affinity for liver fatty acid-binding protein (L-FABP). 
PFOA is not metabolized, but precursors 8:2 FTOH can metabolize to PFOA, which has 
the potential to accumulate (EFSA, 2008; Luebker et al., 2002). 
It was reported that PFOA can be transferred to the fetus via the placenta, with 
measured concentrations in fetal plasma around 50% of those in maternal plasma; also 
dam-to-pup transfer by lactation was proved, reporting PFOA levels in milk 
corresponding to about 10% of the plasmatic concentrations (Hinderliter et al., 2005). 
A significant difference concerning the urinary elimination of this compound was 
observed in rats depending on the gender: during the first 24 h after administration, in 
fact, female rats eliminated 91% of the dose, while male rats only 6%. These resulted 
in sex-related elimination half-life values, calculated in less than 1 day for female rats 
and 15 days for male rats (Vanden Heuvel et al., 1991). 
This difference was due to a hormone-depending secretory mechanism involving 
organic anion transporters, which testosterone was supposed to competitively inhibit. 
A demonstration was given by the fact that in castrated male rats and female rats renal 
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elimination was comparable and, if they were all treated with testosterone, it was 
reduced in both genders (Kudo et al., 2002). 
A Butenhoff et al. study on monkeys feed a 26 weeks diet containing PFOA reported 
high variability in measured levels in liver; however, estimated half-life was around 30 
days for female monkeys and 21 for male monkeys (EFSA, 2008). 
In humans 
As for animals, also in humans PFOA rapidly distributes in serum (according to Han et 
al., 2003, more than 90% is transported by albumin), but in this case its renal excretion 
is irrelevant compared to rats and monkeys. Also, it was observed that PFOA plasmatic 
concentrations in 20-50 years old people were more significant in males, while in >50 
years old subjects there was no difference between genders, but it must noticed that 
the reported Japanese study was conducted on a small number of people and 
therefore its statistical values is not certain. Although only little information is 
available, PFOA can cross the placenta and bioaccumulate in the fetus (EFSA, 2008). 
A study concerning serum half-life of PFOA reported highly discordant values (between 
1.5 and 13.5 years), with a mean of 4.37 years (EFSA, 2008). With less variability on the 
26 subjects in his survey, Olsen et al. calculated a half-life for elimination from serum 
equal to 3.8 years (Olsen et al., 2007b). According to a monitoring on 138 subjects who 
had been exposed to PFOA contaminated drinking water few years ago in Arnsberg 
(Germany), mean half-life of this contaminant in plasma would be 3.26 years. Also, a 
recent study investigated PFOA trends in the serum of 200 subjects from two highly 
contaminated locations in Ohio and West Virginia, after the beginning of activated 
carbon water filtration: the obtained data allowed the Authors to estimate a PFOA 
half-life of 2.3 years (Bartell et al., 2010). 
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1.3.2  Mechanisms of action 
 
Even if the mechanisms by which PFCs generate toxic effects are not well known, these 
compounds have been proved to be responsible for adverse effects such as 
peroxisome proliferation and changes in enzymatic activity. 
Various Authors indicated that PFOS and PFOA are capable of activating peroxisome 
proliferator-activated receptors α (PPARα), which are ligand dependent transcription 
factors acting on genes implicated in lipid metabolism, lipid and glucose homeostasis, 
inflammation, cell proliferation and differentiation. In animals exposed to these 
contaminants, also production of cytokines, reduction of lymphoid organs weight, 
altered inflammatory response and antibody synthesis were observed. Some of these 
effects have been demonstrated to be PPARα independent (Shipley et al., 2004; De 
Witt et al., 2009). 
PFCs can affect the metabolism of fat acids interfering with their β-oxidation, probably 
due to their chemical structure being very similar to that of endogenous fat acids. It 
has been shown that PFCs cause alterations in some hepatic enzymes activities, 
including acyl-CoA oxidases and dehydrogenases, resulting also in decreased amounts 
of triglycerides and cholesterol in the blood circle and in oxidative DNA damage. (Hu et 
al., 2005; EFSA, 2008). 
PFOS and PFOA are suspected endocrine disruptors, whose interference on sexual 
hormones causes increased levels of oestradiol and decreased levels of testosterone; 
PFCs have shown oestrogenic effects on cell cultures (Jensen and Leffers, 2008). 
It has been also observed in some tests, performed in vitro on rat liver and dolphin 
kidney epithelial cell lines and in vivo on rats treated with PFCs, that they can be 
incorporated into the cellular membrane and reversibly inhibit gap junction 
intercellular communication (Hu et al., 2002). 
Since no genotoxicity for these compounds has been reported by neither in vivo nor in 
vitro studies, it’s probable that their carcinogenicity is related to an indirect 
mechanism (EFSA, 2008). 
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1.3.3  Toxic effects of PFOS 
 
1.3.3.1  Effects on animals 
Acute toxicity 
Acute studies have been observed by various studies in rats and rabbits. 
In a 1979 work, a lethal concentration (LC50, i.e. the dose causing the death of half the 
treated animals) of 5.2 mg/L was estimated administering PFOS through inhalation to 
several groups of rats, generating also signs of toxicity, as emaciation, breathing 
problems and nasal secretion; moreover, post-mortem examination showed a variable 
liver discoloration. In another study rats were treated with a single dose through 
feeding tube, showing alterations in the nervous system and a LD50 of 271 and 251 
ng/kg, respectively for male and female rats. Skin and eye irritation possibly caused by 
PFOS was investigated on rabbits, but without significant results (OECD, 2002). 
Subacute toxicity 
During administration of PFOS through a 14 weeks diet, significantly increased 
glycemia and liver weight (mainly in male rats) were observed; histological analysis 
highlighted hypertrophy and vacuolization of the hepatocytes (Seacat et al., 2003). 
Other studies on rats showed also a reduction in body weight, as well as, in some 
cases, decreased levels of cholesterol and tryglicerides in blood. 
Monkeys appeared to be more sensitive to PFOS than rats: they seemed to present a 
steep dose-response curve, which in some cases led them to death if treated with 
doses of few mg/kg/day. Alterations in thyroid hormones were also observed in these 
animals (EFSA, 2008). 
Chronic toxicity 
A study on male and female rats being given PFOS in the diet for 104 weeks reported 
hepatotoxicity in both genders within the highest doses groups (but in male rats also at 
lower administered concentrations) and carcinogenicity, being responsible for raised 
incidence of hepatocellular and thyroid follicular cells adenomas. Also for mammary 
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adenomas and fibroadenomas increased incidences were observed, but the obtained 
data were not sufficient to ascertain if this was due to PFOS exposure (EFSA, 2008).  
Based on the results concerning liver toxicity, a NOAEL for PFOS was estimated of 0.5 
and 2 ppm for male and female rats, respectively (OECD, 2002). 
Developmental and reproductive toxicity 
Experiments conducted on rodents evaluated the effects of exposure to PFOS on dam, 
fetus and newborn. Female rats and mice received PFOS at different doses via feeding 
tube during the entire gestation, resulting in a dose-dependent maternal weight gain 
decline and in a decrease of T3 and T4 in plasma after the first week. PFOS levels in 
maternal circulation increased with dosage and were around 25% of the hepatic 
concentrations, which in turn were twice higher than those measured in fetal liver. At 
the highest doses (10 mg/kg b.w. per day in rat, 20 mg/kg b.w. per day in mouse), the 
Authors observed reduction of fetal body weight and higher incidence of anasarca, 
heart defects and cleft palate, with pups becoming pale and inactive after birth and 
dying in 4-6 h. Subjects whose dams had been treated with lower concentrations 
survived for a longer time (8-12 h). PFOS plasmatic concentrations in newborns were 
comparable to those in dams at day 21, decreasing in the following days. In surviving 
pups, persistent growth and eye-opening delays were observed, as well as 
hypothyroxinemia (Thibodeaux et al., 2003; Lau et al., 2003). 
In another study, reduced duration of the gestation and pup viability were observed in 
female rats treated with PFOS from 6 weeks before mating till the fourth day of 
lactation (Luebker et al., 2005). 
Delays in physical development were observed also in rabbits, as well as in both 
generations during a two-generation reproductive study in rats (EFSA, 2008). 
Neurotoxicity 
One dose of PFOS (of 0.75 or 11.3 mg/kg) was given by gavage to a group of 10 days 
old male mice, in order to evaluate its neurotoxic potential. Alterations of the 
behavior, mainly resulting in hyperactivity, were observed during experiments carried 
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out when they were 2 and 4 months old: further tests proved that these alterations 
were due to the involvement of the cholinergic system (Johansson et al., 2008). 
 
1.3.3.2  Effects on humans 
Developmental toxicity 
Due to PFOS wide diffusion, capacity to cross the placenta and long half-life in humans, 
and to the outcomes concerning its adverse effects on the development in animals, a 
number of studies have been conducted in order to verify the occurrence of similar 
alterations in the population. 
In a 2009 review by Olsen et al., the results of different epidemiological studies on 
general population and on occupationally exposed population were summarized. 
Potential correlations were studied in the general population between PFOS presence 
in maternal blood or umbilical cord and anthropometric parameters of the newborns, 
such as birth weight, birth length, head circumference and ponderal index. The 
investigations conducted on occupationally exposed population focused on 
associations between PFOS exposure of female workers from a perfluorochemical 
production facility and the birth weight of their sons. According to the Authors, the 
results of the mentioned works were inconsistent and, due also to the weakness of the 
epidemiological analysis (relevant factors as sex of the newborn or mother’s age often 
weren’t taken in account), couldn’t prove the real existence of any of these 
associations (Olsen et al., 2009a). 
Data collected by the Danish National Birth Cohort (DNBC) during a 1996-2002 
monitoring were used to verify whether PFOS exposure could influence fecundity in 
humans. Blood concentrations of this contaminant were measured in 1240 women in 
early pregnancy and compared to their TTP (time to pregnancy, a commonly used 
surrogate of follow-up studies to estimate fecundity), defining infertility as a reported 
TTP of at least 12 months. Based on the results obtained, PFOS exposure at levels 
commonly found in the developed Countries seemed to reduce fertility (Fei et al., 
2009). 
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A recent work on 123 paired samples of maternal and cord blood from Norwegian 
women showed the presence of various PFCs. Concentrations in cord blood 
corresponded to 30-79% of those in maternal blood, proving placental passage; 
however, a more efficient transfer to the fetus was observed for short-chain 
compounds and non sulfonated molecules, but also for branched PFOS isomers 
(Gützkow et al., 2011). 
Other effects on health  
A monitoring on 2083 3M Company workers in Alabama suggested that those whose 
job implied a relevant exposure to PFOS based substances had higher risk of death 
from bladder cancer, but this assertion was grounded on only 3 cases. A further follow-
up study on those subjects identified 11 cases of bladder cancer, but without any 
significant correlations with PFOS exposure. Occupationally exposed employees were 
also subjected to cross-sectional analysis, which showed a positive correlation 
between exposure to these substance and increased serum T3 and triglycerides 
concentrations. Moreover, episodes of medical care in that plant had been more 
frequent in the most exposed workers. However, it’s quite difficult to make firm 
deductions, due to various shortcomings of these investigations, related for example 
to the low number of participants and the lack of information on potential concurrent 
exposure to other compounds (EFSA, 2008). 
The consequences of fetal exposure to PFCs on atopic dermatitis (AD) and levels of 
immunoglobulin E (IgE) were recently evaluated in Taiwan. Data were collected from 
several 2 years old children, correlating their serum IgE and PFCs levels and the 
potential development of AD with previously measured cord blood IgE and PFCs 
concentrations. A relation between pre-natal PFOS exposure and cord blood levels of 
IgE was observed, while it seemed not to have significant association with AD (Wang et 
al., 2011). 
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1.3.4  Toxic effects of PFOA 
 
1.3.4.1  Effects on animals 
Acute toxicity 
Studies conducted in rats suggested a lethal concentration (LC50) by inhalation of 980 
mg/m3, as well as an oral LD >500 mg/kg for male rats and >250 mg/kg for female rats, 
causing moderate acute toxicity. Symptoms observed after 4 h of exposure to PFOA via 
inhalation included increased liver size and opacity of the cornea; upon prolonged 
treatment (10 days), increased liver weight and reduction of body weight gain were 
observed. A feeble skin irritation was reported in rabbits, which resulted more 
sensitive than rats (EFSA, 2008). 
Subacute toxicity 
PFOA concentrations of 30 mg/kg through diet and of 50 mg/kg through drinking water 
during 28 days resulted in increased liver weight and limited body weight gain (and 
sometimes death) in rats and mice. In more extended studies, increased activity of 
hepatic palmitoyl CoA oxidase (marker for peroxisome proliferation) was reported 
after a 90 days oral administration of PFOA. At the histological level, hepatocellular 
hypertrophy and necrosis of liver cells were observed (EFSA, 2008). 
An investigation was conducted on the different responses of mice and rats exposed to 
linear (now in use), 80% linear/20% branched (used in the past) and branched 
(synthesized for this study) PFOA via feeding tube during 14 days. The three forms 
showed similar toxicity, even if completely branched PFOA resulted less potent 
compared to the others (Loveless et al., 2006). 
In monkeys, oral PFOA administration of up to 30 mg/kg b.w. per day for 26 weeks 
(during which weight loss and decreased food consumption were observed) caused 
dose-dependent increases in liver weight, resulting from mitochondrial proliferation, 
and the death of two subjects; no further macroscopic nor microscopic alterations 
were observed (Butenhoff et al, 2002). 
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Chronic toxicity 
Two different 2 years-long studies were carried out on rats to evaluate chronic toxicity 
of PFOA. A first test on 50 male rats and 50 female rats, treated with doses of up to 
14.2 and 16.1 mg/kg b.w. per day, respectively, showed dose-related decrease in body 
weight gain in both sexes (but more relevant in male rats) and increase in ataxia in 
female rats. Blood analysis showed decreased hematocrit, red blood cells count and 
hemoglobin values in the high-dose subjects, as well as increased levels of some 
enzymes in male rats. From the histological point of view, lesions and nodules were 
mainly observed in the liver (including also hepatomegalocytosis, hepatocellular 
necrosis, portal mononuclear cell infiltration and hepatic cystoids degeneration), testis 
(with a remarkably increased incidence of Leydig cell adenomas), mammary tissue and 
ovary. Based on the collected data, NOAELs of 1.3 and 1.6 mg/kg b.w. per day were 
calculated for male and female rats, respectively (US EPA, 2005). 
A second experiment, involving 153 male rats subjected to a dietary exposure to PFOA 
of 14 mg/kg b.w. per day, confirmed the higher incidence of Leydig cell adenomas but 
highlighted also a significant rise in the incidence of liver adenomas and pancreatic 
acinar cell tumors. Concerning this last aspect, further investigations on pancreatic 
acinar cells revealed that PFOA was responsible for increasing the incidence of 
hyperplasia but not of tumor onset (EFSA, 2008). 
Developmental and reproductive toxicity 
Pregnant mice treated by oral gavage with PFOA doses of up to 40 mg/kg b.w. per day 
during the entire gestation showed increased liver weight; dams exposed to the 
highest concentration reabsorbed their litters, while those receiving medium or low 
concentrations had decreased percentage of live fetuses. These latter, in turn, showed 
reduced postnatal survival and body weight, as well as dose-dependent growth deficits 
and delayed eyes opening (Lau et al., 2006). 
Later works by other Authors reported the same results and indicated that, in addition 
to intrauterine exposure, also lactation can contribute to the occurrence of the 
symptoms described in newborns. NOAELs were calculated of 30 mg/kg b.w. for 
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reproductive function, 10 mg/kg b.w. for pup mortality, birth weight and sexual 
maturation, <1 mg/kg b.w. for male body weight and organ weight changes (EFSA, 
2008). 
Neurotoxicity 
In the previously mentioned study by Johansson et al. on PFOS neurotoxicity, also a 
single dose of PFOA (of 0.58 or 8.7 mg/kg) was administered to 10 days old mice, 
monitoring the effects when they were 2 and 4 months old. Observed symptoms 
included hyperactivity and lack of habituation; tests on the response to nicotine 
showed that these alterations were mediated by the cholinergic system (Johansson et 
al., 2008). 
 
1.3.4.2  Effects on humans 
PFOA effects on the population were investigated at the same time as PFOS in all the 
previously described works concerning the toxicity of this last. Lots of these studies 
were conducted on 3M Company workers occupationally exposed to PFOA, reporting, 
as for PFOS, potential correlations of this contaminant with the occurrence of various 
symptoms, sometimes inconsistent with each other and often quite poor in terms of 
statistical relevance. 
However, similarly to PFOS, PFOA may be responsible for reduced fecundity in subjects 
exposed to average environmental levels and to increased levels of IgE in cord blood 
(Fei et al., 2009; Wang et al., 2011). 
Also, PFOA showed a more efficient transfer to cord blood than PFOS during the study 
conducted by Gützkow et al. in Norway, which results in a more relevant fetal 
exposure to this compound. 
Examining potential correlations of PFOA and PFOS concentrations in cord blood with 
gestional age and anthropometric parameters of the newborn in 293 subjects, 
Apelberg et al. suggested an association between these substances and birth weight 
and birth size (Apelberg et al., 2007). 
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According to EFSA, further investigations are needed to ascertain the actual 
responsibilities of PFOA and other PFCs for the described adverse effects on human 
health, since other factors may contribute significantly (EFSA, 2008). 
 
 
1.3.5  Other PFCs and precursors toxicity 
 
Besides PFOS and PFOA, other PFSAs (perfluoroalkyl sulfonates) and PFCAs (carboxylic 
acids) were included by some Authors in the range of analytes investigated but, due to 
their less relevant presence compared to the two most found PFCs, the scientific 
community has given minor attention to the potential adverse effects of these 
compounds. However, in many cases they have been associated to the same effects 
observed for PFOS and PFOA. 
Half-life time is a specific parameter for each individual compound and, according to 
various Authors, in all the species it resulted sensibly shorter in shorter-chain 
molecules: therefore, PFBS and PFBA (whose chain is made of 4 carbon atoms) showed 
much shorter half-lives than those of the correspondent perfluorooctane-compounds, 
as well as values reported for PFNA and PFDA (9 and 10 carbon atoms, respectively) 
were higher than those observed for PFOA (Ohmori et al., 2003; Olsen et al., 2009b; 
Wilhelm et al., 2010). 
This aspect was reflected also on the expression of the toxic potential: the longer the 
chain of the molecule, the greater were the effects observed. Experiments on rats 
indicated that PFBS and PFHxS, similarly to PFOS, increase the acyl CoA oxidase 
activity, even if a 50 times higher concentration of PFBS compared to the other two 
compounds was needed to generate similar effects; it was proved that PFHxA (only on 
male rats), PFNA and PFDA induce peroxisomal β-oxidation and hepatomegaly, 
depending on their concentrations in the liver (Lau et al., 2007). 
Probably due to the fact that precursors FTOHs and FOSEs can be metabolized, 
representing a further source of PFCAs and PFSAs, respectively, only few studies 
investigated the direct toxicity of these compounds. 
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Some studies proved that 8:2 FTOH is a peroxisome proliferator and produces the 
same alterations as PFOA on the hepatic metabolism and enzymatic activity; FTOHs 
seem to interact with estrogen receptors. An in vitro research on hepatocytes showed 
that FTOHs are extensively metabolized in rats and mice, while clearance rate is 
significantly lower in humans (EFSA 2008; Harrad, 2009). In addition, assays performed 
on daphnia suggested that intermediate metabolites of their degradation are up to 
10000 times more toxic than the correspondent PFCAs.  
FOSA resulted more toxic than other PFCs, significantly suppressing DNA production 
and causing cellular oxidative stress. Its higher toxicity may be due to its potential to 
easily cross cell membranes, being more hydrophobic than other compounds. Similarly 
to certain PFCs, FOSA was found to inhibit gap junctional intercellular communication 
(Fields, 2007; Hu et al., 2002). 
Toxic effects on development and enzymatic activity in animals were reported also for 
N-EtFOSE but, unlike PFOS, it doesn’t apparently induce peroxisome proliferation. 
Moreover, according to in vivo and in vitro studies, also the carcinogenic activity of 
FOSEs seems related to an indirect (non-genotoxic) mechanism (Xie et al., 2009; EFSA 
2008). 
 
 
1.4  Legislation 
 
An assessment made by OECD (Organization for Economic Cooperation and 
Development) in 2002 according to information available at that time concluded that 
PFOS is a persistent contaminant, presenting bioaccumulative potential and toxic 
effects on mammals. 
On the basis of these statements, confirmed also by SCHER (Scientific Committee on 
Health and Environmental Risks), in order to safeguard human health and the 
environment the European Union decided to establish restrictions in the use and 
marketing of PFOS, issuing on December 12, 2006, Directive 2006/122/EC. The 
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measures contained in this document, which is a modification of Council Directive 
76/769/EEC concerning restrictions that must be applied to various dangerous 
substances and preparations, should have been applied by Member States starting 
from June 27, 2008. These restrictions concern all those non-food products to which 
PFOS is added on purpose (also considering that it could have been used only in 
singular parts of a finished item) and refer exclusively to new products. More in details, 
it’s not allowed to sell or use this compound in concentrations greater than 0.005% by 
mass; also, it’s not allowed to place on the market semi-finished items, or parts, 
containing concentrations of PFOS higher than 0.1% by mass. However, some minor 
uses of PFOS are not subjected to these limitations, because they don’t seem to be a 
risk and since no alternative substances are available: these applications include 
coatings for photolithography processes, photographic coatings, plating processes 
(which should anyway be minimized) and hydraulic fluids for aviation. In addition, the 
use of existing stocks of fire-fighting foams containing PFOS was allowed until June 27, 
2011. Lastly, this Directive pointed out the need to focus the attention also on PFOA 
and its salts, which are believed to have a risk potential similar to PFOS. 
What reported above was subsequently included in Commission Regulation (EC) No 
552/2009 of June 22, 2009, on the Registration, Evaluation, Authorization and 
Restriction of Chemicals (REACH). 
There are currently no restrictions set by the European Community on PFCs presence 
in food and their use in plastic and paper used for food packaging is allowed in 
Germany and the Netherlands. 
After issuing a first opinion on PFOA ammonium salt food contamination deriving from 
non-stick cookware, in 2008 EFSA (European Food Safety Authority) published a 
scientific opinion on PFOS and PFOA. This document, besides being a complete and 
updated source of information on perfluorinated compounds, reported the 
conclusions drawn by the CONTAM Panel: the risk for humans related to exposure to 
these contaminants was considered moderate, but potential effects on the 
development aren’t clear yet. Moreover, it was recommended to collect further data 
on PFCs concentrations in food and in the population. 
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In 2009 PFOS and its salts were included in Annex B of the Stockholm Convention, 
which lists persistent organic pollutants (POPs) subjected to restrictions in use and 
production. 
All these factors induced the European Commission to call Member States (through 
Recommendation 2010/161/EU, released on March 17, 2010) to monitor during 2010 
and 2011 the presence of perfluoroalkylated substances in a wide variety of foodstuffs 
of both animal and plant origin, in order to allow a reliable estimation of human 
exposure. The monitoring should be directed towards PFOS and PFOA and, when 
possible, their precursors (including FOSA, N-EtFOSE and 8:2 FTOH) and similar 
compounds, such as homologues with different chain length and PAPS (polyfluoroalkyl 
phosphate surfactants). Member States are also recommended to periodically provide 
the collected data to EFSA, including available monitoring from previous years, in order 
to expand the European database. 
In January 2011, EFSA published an intermediate report on the monitoring, 
summarizing the collected data and making recommendations to adjust current 
investigations. The final report will be available in 2012. 
Concerning the United States, in 2002, after the termination of PFOS manufacturing by 
3M Company, the Environmental Protection Agency (US EPA) issued two SNURs 
(Significant New Use Rules) in order to limit production or importation of 88          
PFOS-related chemicals. 183 additional compounds were added to the list in 2007. 
Similarly to European Directive 2006/122/EC, these regulations permitted the 
continuation of a limited number of extremely technical applications of these 
substances, resulting in very low volumes and negligible releases, since no alternatives 
exist. In the event of any other use, manufacturers and importers are required to 
notify the US EPA a minimum of 90 days before it occurs (US EPA, 2010). 
In Canada, after the insertion of PFOS and its related substances in the list of toxic 
compounds of the 1999 Canadian Environmental Protection Act (whose purpose was 
to prevent pollution and protect the environment), a regulation of 2009 added these 
molecules to the Virtual Elimination List. This means that Canada is the first Country 
proposing a complete ban of PFOS (SOR/2009-15). 
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“Kashinhou” is the name of the in use regulation law for chemicals and dangerous 
substances in Japan. Being hazardous compounds for human health, based on this law 
PFOS and PFOA were designated as Type II Monitoring Chemicals, therefore 
manufacturers and importers need to annually report their production or import 
volume. However, after the insertion of PFOS in Annex B of the Stockholm Convention, 
it has been classified as Class I Specified Chemical: as a consequence, similarly to what 
happens in Europe and in the United States, its manufacturing and use is prohibited 
except for specific essential uses (Yamazaki, 2009). 
 
 
1.5  Methods of analysis 
 
Perfluoroalkylated substances may significantly differ from each other concerning their 
chemical and physical features, therefore multiple analytical methods exist for their 
determination. 
When performing analysis on these substances, the adoption of few simple but 
effective measures it’s suggested in order to reduce the risk of contaminations or 
losses and to guarantee the reliability of the results. During sample processing, 
laboratory equipment made of glass or Teflon should not be used, since the former can 
absorb PFASs while the latter represents a source of contamination (Hansen et al., 
2001); polypropylene is thus preferable, being a non-interacting material. Similarly, 
contamination can occur during instrumental analysis, for this reason it’s advisable to 
use also polypropylene vials and, if PTFE (polytetrafluoroethylene) tubing are mounted 
on the LC system, to replace them with PEEK (polyether ether ketone) or stainless steel 
tubing (Tittlemier and Braekevelt, 2011). 
Samples are usually stored in refrigerators and, when performing analysis of volatile 
compounds such as some PFCs precursors, it’s suggested to place them in completely 
filled tubes and then in freezers, as to prevent evaporation. Fresh or thawed samples 
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are generally analyzed, but in some studies food have been freeze-dried prior to 
extraction, without causing analyte losses. 
To reduce the matrix-effect, complex samples are often pretreated: protein 
precipitation, for example, can be achieved through the addition of acetonitrile, formic 
acid or trifluoroacetic acid, followed by centrifugation. 
Sample extraction can be performed in many ways, including solid phase extraction 
(SPE), liquid-liquid extraction (LLE), pressurized liquid extraction (PLE), ion pairing 
extraction (IPE) and solid phase microextraction (SPME, only for gas chromatography 
analysis). It may be followed by a further purification of the extract, generally involving 
SPE cartridges or SPE dispersive phase, aimed at the elimination of residual 
interferents. 
Neutral volatile perfluoroalkylated substances, presenting high vapor pressures, can be 
measured with gas chromatography (GC) using medium or high polarity columns, while 
anionic PFCs need to be derivatized prior to analysis with this technique. Some of the 
anionic compounds have low vapor pressure and their derivatization proved to be 
poorly reproducible, therefore liquid chromatography (LC) resulted a better choice for 
these substances (EFSA, 2008). LC separation is performed in most cases on reversed 
phase C18 columns, using a mixture of an organic solvent (such as methanol or 
acetonitrile) and an aqueous solvent (typically ammonium acetate, at concentrations 
between 1-20 mM) as mobile phase (de Voogt and Sáez, 2006). 
Mass spectrometry (MS) has allowed relevant improvement in the analysis of 
perfluoroalkylated substances, in particular since the introduction of triple quadrupole 
mass spectrometers (MS/MS), which are considered the most suitable detectors for 
this purpose. For PFASs detection in LC-MS(MS) systems, the most commonly used 
interface is electrospray ionization (ESI), working in negative mode to generate the 
pseudomolecular ions [M-H]-. In GC-MS instruments, depending on the molecules, 
electronic impact (EI) as well as chemical ionization (CI) sources can be employed, in 
both positive and negative mode, with methane or ammonia as reagent gas; however, 
negative chemical ionization is the most widespread configuration, due to its 
sensitivity. 
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Other detectors have been tested with both LC (time of flight, ion trap, fluorescence 
and conductometric detectors) and GC (flame ionization and electron capture 
detectors), but triple quadrupole mass spectrometer was preferred in most of cases.  
Besides mass spectrometry, also other analytical techniques have been used for PFASs 
analysis, including combustion methods, neutron activation and x-ray fluorescence (all 
three proving to be non-specific), and later nuclear magnetic resonance (quite 
unreliable in quantifications), ion exclusion chromatography (only on PFCAs) and 
Fourier transform infrared spectroscopy (EFSA, 2008; de Voogt and Sáez, 2006). 
To this day, not many methods have been specifically developed for the determination 
of these substances in food; however, most of the techniques employed for the 
analysis of biological samples can generally be used also with food items (Tittlemier et 
al., 2007). One of the most frequently applied is the ion pairing extraction into methyl 
tert-butyl ether (MTBE) proposed by Hansen et al. (2001), which showed great 
flexibility in terms of matrices analyzed (liver, muscle, egg and others), but results 
laborious and requires considerable time. Also SPE cartridges (often weak anion 
exchange type) are employed in many studies; Powley et al. (2005) proposed a time 
saving alternative for the detection of PFCAs based on dispersive solid phase extraction 
with graphitized carbon, significantly reducing matrix-effect and maintaining good 
recovery values. Taniyasu et al. (2005a) introduced the extraction by alkaline digestion 
with potassium hydroxide (KOH), later modified by other Authors employing, for 
example, sodium hydroxide (NaOH) (Haug et al., 2010b). A simple and rapid 
pretreatment technique using pressurized liquid extraction was recently introduced by 
Llorca et al. (2009): the Authors suggested that this method improves LOQs and at the 
same time allows to easily process a large number of samples. Lastly, Luque et al. 
(2010) developed a new approach based on solvent microextraction, which allows 
simple and fast PFCs extraction with reduced solvent consumption. 
LC-MS/MS resulted the analytical technique of choice for the detection of anionic PFCs 
in food matrices, working in MRM (multiple reaction monitoring) mode and using 
negative electrospray ionization, due to the strong electronegative character of the 
fluorinated chain (Tittlemier et al, 2007). 
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1.5.1  PFCs determination in milk 
 
Most of the works available in literature investigating the presence of perfluorinated 
compounds in milk referred to human breast milk rather than milk from cow, goat or 
other animals. This is easily understandable considering what described in the previous 
sections: given their long half-life, PFCs enter the body through multiple routes 
accumulating for years and, during lactation, migrate in relevant amounts to breast 
milk, which therefore represents an alarming source of exposure for infants. 
All the proposed methods were able to detect PFOS and PFOA, being the two most 
found and studied molecules of the group, but in many cases other perfluoroalkyl 
sulfonates (mainly PFHxS and PFDS) and carboxylic acids (in particular PFHxA, PFNA 
and PFDA) were monitored as well. Moreover, also FOSA (PFOS precursor) is often 
included among the target analytes, due to its recurrent non-negligible presence in 
food matrices. 
Various techniques have been used for the extraction of these analytes from milk. 
Several methods employed weak anion exchange SPE cartridges, preceded by a 
protein precipitation step through formic acid (So et al., 2006; Nakata et al., 2006; 
Kärrman et al., 2007 and 2011; Tao et al., 2008a and b; Liu et al., 2010; Wang et al., 
2010), acetonitrile (Völkel et al., 2008; Thomsen et al., 2010) or methanol (Bernsmann 
and Fürst, 2008; Ericson et al., 2008 Haug et al., 2010a). Some Authors performed also 
a final clean up by dispersive solid phase extraction with EnviCarb (Ericson et al., 2008; 
Haug et al., 2010a). Moreover, others among the cited methods included initial 
enzymatic digestion through lipase and protease addition and overnight incubation at 
37°C (Bernsmann and Fürst, 2008; Mosch et al., 2010) or alkaline digestion (Haug et al., 
2010a; Llorca et al., 2010). 
The ion pairing extraction technique, introduced by Hansen et al., has been used for 
the detection of PFOS and PFOA in human breast milk samples by Guerranti et al. 
(2011). 
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A recently proposed approach employs an extraction with formic acid, acetonitrile, 
magnesium sulfate and sodium chloride, followed by the already mentioned clean up 
with dispersive EnviCarb (Lacina et al., 2011). 
All the existing methods employ LC systems: more in particular, HPLC (high 
performance liquid chromatography) results the standard equipment for this kind of 
analysis being used in most of cases, even if few of the most recent works the method 
was optimized for UHPLC (ultra high performance liquid chromatography) instruments, 
significantly reducing the time of analysis (Haug et al., 2010a; Liu et al., 2010; Kärrman 
et al., 2011; Lacina et al., 2011). 
Separation was generally achieved through C18 columns, due to their versatility and 
efficiency; the only exception is the method proposed by Lacina et al., which employed 
a T3 column, specifically conceived for the retention of polar organic compounds. 
Also the choice of the mobile phase is a common point between the various 
techniques: a mixture of methanol and ammonium acetate aqueous buffer (at 
different concentrations, generally in the range 1-20 mM) was used by all the Authors 
except for Nakata et al., who chose acetonitrile as organic phase. 
As for the detector, triple quadrupole mass spectrometer (equipped with ESI source in 
negative mode) working in MRM mode was the shared choice in almost all cases. 
Some Authors employed quadrupole-linear ion trap (Q-LIT) mass spectrometers as 
well, but always working in MRM mode; however Llorca et al. (2010) tested also the 
enhanced production ion (EPI) and MS3 modes that this kind of instrument offers, 
reporting its limitation given by the low stability of fragment ions in the LIT. 
Concerning the performances of the different approaches, various Authors reported 
limits of detection in the range of 0,01-0,1 ng/mL, depending on the compound; few 
works declared even better performances, with limits of detection <0,01 ng/mL 
(Thomsen et al., 2010; Liu et al., 2010; Lacina et al., 2011). 
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1.5.2  Analysis of PFCs volatile precursors 
 
FOSES and FTOHs are more difficult to ionize than PFCs and tend to form adducts 
easily, therefore their analysis in LC-MS/MS it’s quite difficult and requires all buffers 
to be removed from the system (Taniyasu et al., 2005b; Szostek et al., 2006). 
Perfluorooctane sulfonamido ethanols (N-MeFOSE and N-EtFOSE) have been 
investigated mainly in air (Martin et al., 2002; Barber et al., 2007; Jahnke et al., 2007; 
Loewen et al., 2008) and house dust samples (Shoeib et al., 2005; Haug et al., 2011b), 
while no studies on food matrices have been performed. Analytes extraction was 
obtained using glass/quartz-fiber filters and XAD-2 resin inserted between 
polyurethane foam plugs or through Isolute ENV+ solid phase extraction cartridges. 
GC-MS/MS systems, equipped with chemical ionization sources, were employed for 
the analysis. 
Fluorotelomer alcohols have often been investigated in air and house dust samples 
together with FOSEs by the previously cited Authors. However, FTOHs have been 
analyzed also in other matrices, such as water (Taniyasu et al., 2005b; Szostek et al., 
2006; Motegi et al., 2010), soil (Ellington et al., 2009), plants (Yoo et al., 2011), food 
contact materials (Fengler et al., 2011) and biological matrices including plasma, liver, 
muscle and egg (Szostek and Prickett, 2004; Taniyasu et al., 2005b; Chu and Letcher, 
2008). Different types of SPE cartridges (often Oasis® WAX and Oasis® HLB) were used 
for the extraction, while Szostek and Prickett, as well as Ellington et al., employed 
methyl tert-butil ether (MTBE). Gas chromatography was generally chosen for the 
analysis, but in some cases they were performed in LC-MS/MS systems; in particular, 
Chu and Letcher reported very good results employing a LC-APPI-MS/MS system 
(atmospheric pressure photoionization), which showed increased ionization capability 
and decreased matrix-effect, resulting in higher sensitivity and linearity compared to 
ESI (Chu and Letcher, 2008). 
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2. Objectives of the experiment 
 
Perfluorinated compounds are a group of chemicals that have been largely employed 
during the last 60 years in several applications, widely spreading and accumulating in 
the environment due to their extreme resistance to degradation. As a consequence, 
they have been found also in various types of food as well as in drinking water, proving 
that they can easily reach humans through the diet. The available information 
concerning their adverse effects on health has recently increased the interest towards 
these contaminants and highlighted the importance of investigating all the potential 
sources of human exposure, among which diet was proved to be the most relevant. 
This need has been underlined by the European Union through Recommendation 
2010/161/EU: in this document, Member States were called to monitor the presence 
of perfluoroalkylated substances in food, in order to produce accurate estimations of 
exposure. 
In consideration of the above, the purpose of the research presented in this thesis was 
to develop efficient tools for the analysis of these pollutants in food, to be used for 
generating useful data on potentially contaminated matrices. 
This work is the result of a partnership between two laboratories: CABA-Lab – 
Laboratorio di Chimica Analitica e Bio-Agroalimentare (Department of Veterinary 
Medical Sciences, University of Bologna, Italy) and LABERCA – Laboratoire d’Etude des 
Résidus et Contaminants dans les Aliments (Oniris Nantes Atlantique, France). 
The first phase of the project consisted of a 3 months period at LABERCA, during which 
an analytical method for the quantification of several perfluorinated compounds in 
cow milk, human breast milk and powder milk by means of liquid chromatography 
(HPLC) coupled to tandem mass spectrometry (MS/MS) and high resolution mass 
spectrometry (HRMS) was optimized and validated in compliance with European 
Regulations. Moreover, within this experiment, data on PFCs presence in some French 
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milk samples were collected in order to be compared to those from other countries 
and also to estimate the risk of exposure for breastfed infants. 
The second work package was carried out in the following months at CABA-Lab and its 
purpose was to transfer the previously developed method to the instrumentation 
available in the Italian laboratory, an ultra high performance liquid chromatography 
(UHPLC)-tandem mass spectrometry (MS/MS) system. Then, the same technique was 
used for the quantification of the two most important and frequently found PFCs 
(PFOS and PFOA) in a number of cow and human breast milk samples from Italy, in 
order to obtain data on these matrices also for this country. 
The third part of the activity was conducted during another 3 months at LABERCA and 
was focused not on the already investigated substances, but rather on their 
precursors. In fact, as reported by the previously mentioned European Commission 
Recommendation 2010/161/EU, in order to make complete and reliable evaluations of 
the presence of PFCs in food matrices also other molecules, which can break down to 
give PFCs, should be considered. Therefore, preliminary tests were conducted for the 
detection of these precursors in fish (which is indicated as the most contaminated food 
by perfluoroalkylated substances), leading to the development of one of the first 
methods ever for their analysis in food matrices. 
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3. Material and methods 
 
3.1  PFCs analysis at LABERCA 
 
The purpose of this first work package was to optimize and validate a method for the 
detection of a wide range of PFCs in milk, comparing two different analytical 
approaches: liquid chromatography coupled to tandem mass spectrometry on a triple 
quadrupole instrument and liquid chromatography coupled to high resolution mass 
spectrometry on a LTQ-Orbitrap™ system. On the one hand, MS/MS is considered the 
current standard for this kind of analysis (EFSA, 2008), while on the other hand, the 
presence of some matrix effect using this kind of detectors and the interest in 
monitoring an increasing number of contaminants, make it interesting to evaluate the 
potential of HRMS instruments in this field. 
Target compounds belonged to different families, as shown in Table 3.1: 
Family Chemical structure 
Monitored 
compounds 
Perfluoroalkyl carboxylic acids 
(PFCAs) 
 
9 
Perfluoroalkyl sulfonates 
(PFSAs) 
 
5 
Perfluoroalkyl sulfonamides 
(FASAs) 
 
1 
Perfluoroalkyl sulfinates 
(PFSiAs) 
 
1 
Table 3.1 Groups of investigated compounds and relative chemical structure 
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The analysis of various cow milk, human breast milk and powder milk samples from 
France, carried out during method development and validation, provided also 
preliminary data on PFCs contamination of these three matrices in this country.   
 
 
3.1.1  Material 
 
Standards 
All standards employed were from Wellington Laboratories (Wellington, Canada) with 
a purity grade >98% in methanol. Standards of the following PFCs were used: 
 PFBA Perfluoro-n-butanoic acid a 
 PFPA Perfluoro-n-pentanoic acid a 
 PFHxA Perfluoro-n-hexanoic acid a 
 PFHpA Perfluoro-n-heptanoic acid a 
 PFOA Perfluoro-n-octanoic acid a 
 PFNA Perfluoro-n-nonanoic acid a 
 PFDA Perfluoro-n-decanoic acid a 
 PFUnA Perfluoro-n-undecanoic acid a 
 PFDoA Perfluoro-n-dodecanoic acid a 
 PFBS Potassium perfluoro-1-butanesulfonate b 
 PFHxS Sodium perfluoro-1-hexanesulfonate b 
 PFHpS Sodium perfluoro-1-heptanesulfonate b 
 PFOS Sodium perfluoro-1-octanesulfonate b 
 PFDS Sodium perfluoro-1-decanesulfonate b 
 FOSA Perfluoro-1-octane sulfonamide c 
 PFOSi Sodium perfluoro-1-octanesulfinate acid c 
a
  in “PFC-MXA” mixture solution in methanol at a concentration of 2 μg/mL (1.2 mL) 
b
  in “PFS-MXA” mixture solution in methanol at a concentration of 2 μg/mL (1.2 mL) 
c
  in individual solution in methanol at a concentration of 50 μg/mL (1.2 mL) 
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As internal standards, these 13C-labeled compounds in individual methanol solutions 
(50 μg/mL, 1.2 mL) were purchased: 
 M-PFBA Perfluoro-n-[1,2,3,4-13C4]butanoic acid 
 M-PFOA Perfluoro-n-[1,2,3,4-13C4]octanoic acid 
 M-PFNA Perfluoro-n-[13C9]nonanoic acid 
 M-PFDA Perfluoro-n-[1,2-13C2]decanoic acid 
 M-PFUnA Perfluoro-n-[1,2,3,4,5,6,7-13C7]undecanoic acid 
 M-PFDoA Perfluoro-n-[1,2-13C2]dodecanoic acid 
 M-PFHxS Sodium perfluoro-1-[18O2]hexanesulfonate 
 M-PFOS Sodium perfluoro-1-[1,2,3,4-13C4]octanesulfonate 
 M-FOSA Perfluoro-1-[13C8]octane sulfonamide 
 M-PFOSi Sodium perfluoro-1-[1,2,3,4-13C4]octanesulfinate 
After preparing 10 μg/mL stock solutions for all the compounds, the following working 
solutions were obtained by dilution: 
o MIX PFC 10 ng/mL and MIX PFC 1 ng/mL, containing all the 16 PFCs listed above 
o MIX M-PFC 10 ng/mL, containing the 10 M-PFCs listed above 
A fluorometholone solution in methanol, at 10 μg/mL, was used as external standard. 
All solutions were stored in the refrigerator at 4 °C and away from light. 
 
Reagents and chemicals 
Solvents employed for sample preparation and LC analysis: 
 Methanol Picograde® (Promochem) 
 Acetone Picograde® (Promochem) 
 Ammonium acetate, Reag. Ph Eur (Merck) 
 Ammonia solution 32%, extrapure (Merck) 
 Glacial acetic acid (SDS) 
 Formic acid, reagent grade (Sigma Aldrich) 
 Ultrapure water (produced directly in the laboratory) 
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To extract the analytes from milk, two different solid phase extraction (SPE) cartridges 
were used: 
 Oasis® HLB cartridges: 6 cc, 500 mg, 60 µm (Waters, Milford MA, USA) 
 Supelclean™ ENVI-Carb™ cartridges: 6 cc, 500 mg, 120-400 mesh (Supelco, 
Bellefonte PA, USA) 
 
Prepared solutions 
o Ammonium acetate solution 20 mM: 1.54 g of ammonium acetate was 
dissolved in 1 L of ultrapure water and shaken vigorously 
o Formic acid 0.1 M: 3.8 mL of formic acid and 996.2 mL of pure water were 
mixed in a 1 L bottle and shaken vigorously 
 
Samples 
Milk samples employed for method development and validation included: 
 Human breast milk: 11 samples, obtained from a hospital in Nantes  
 Cow milk: 9 commercial samples, purchased from various large retailers in the 
area of Nantes 
 Powder milk: 4 samples, purchased from large retailers in the Nantes area 
(diluted 1:3 in ultrapure water) 
Collected samples were transferred into polypropylene bottles, in order to prevent the 
risk of PFCs contamination caused by the original packaging material, and then stored 
in a freezer at -18 °C until analysis. 
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3.1.2  Equipment 
 
HPLC-MS/MS system 
An Agilent HP 1200 series HPLC pump (Agilent Technologies, Santa Clara CA, USA), 
provided with binary LC-pump (G1312B), vacuum degasser (G1379B), temperature 
controlled autosampler (G1367D) and thermostated column compartment (G1316B), 
was interfaced with an Agilent 6410 triple quadrupole mass spectrometer, equipped 
with ESI interface (Agilent Technologies, Santa Clara CA, USA). 
A Phenomenex Gemini® reversed-phase C18 column (50 x 2.0 mm, 3.0 µm), fitted with 
a Phenomenex guard column with the same packing (10 x 2.0 mm, 3.0 µm) 
(Phenomenex, Torrance CA, USA), was employed for chromatographic separation. 
Agilent Mass Hunter Workstation software was used for data acquisition and 
processing (Agilent Technologies, Santa Clara CA, USA). 
A Schmidlin N2-Mistral-4 generator (Schmidlin Labor & Service, Neuheim, Switzerland) 
supplied the nitrogen needed for the ion source and used as collision gas. 
 
HPLC-HRMS system 
The HPLC system was an Agilent HP 1200 binary pump (Agilent Technologies, Santa 
Clara CA, USA), equipped with binary LC-pump (G1312B), vacuum degasser (G1379B), 
temperature controlled autosampler (G1367D) and thermostated column 
compartment (G1316B). This separation module was interfaced with a Thermo LTQ-
Orbitrap™ Discovery system, consisting of a linear ion trap coupled with an orbital 
trap, equipped with an ESI ion source (Thermo Fisher Scientific, Bremen, Germany). 
Chromatographic separation was achieved using a Phenomenex Gemini® reversed-
phase C18 column (50 x 2.0 mm, 3.0 µm), fitted with a Phenomenex guard column 
with the same packing (10 x 2.0 mm, 3.0 µm) (Phenomenex, Torrance CA, USA). 
Data were acquired and processed using Thermo Xcalibur™ 2.0 software (Thermo 
Fisher Scientific, Bremen, Germany). 
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Nitrogen required for instrument operation was produced by a Schmidlin N2-Mistral-4 
generator (Schmidlin Labor & Service, Neuheim, Switzerland). 
 
Other equipment 
The following equipment was used during the development of the method and for 
samples preparation: 
 Solid phase extraction manifold (Supelco, Bellefonte PA, USA) 
 Centrifuge (Jouan, Winchester VA, USA) 
 Microcentrifuge (Thermo Fisher Scientific, Bremen, Germany) 
 Water purification system (Barnstead, Germany) 
 Nitrogen sample concentrator 
 Thermostated dry bath (Fisher Scientific, Illkirch, France) 
 Automatic pipettes (Eppendorf, Hamburg, Germany) 
 Vortex mixer 
 Ultrasonic bath 
 
 
3.1.3  Instrumental conditions 
 
LC conditions 
The mobile phase consisted of: 
 Phase A: ammonium acetate solution 20 mM 
 Phase B: methanol 
Analysis were carried out under programmed conditions, at flow rate of 0.6 mL/min. 
After 2 min at 70% A and 30% B, the gradient switched linearly to 0% A and 100% B 
over 5 min, remained in this conditions for 4 min and then returned to 30% A and 70% 
B in 4 min. A further 5 min at the starting conditions were needed to equilibrate the 
column before the following injection. 
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The following table resumes the chromatographic gradient. 
Time (min) Phase A (%) Phase B (%) 
0 70 30 
2 70 30 
7 0 100 
11 0 100 
15 70 30 
20 70 30 
Table 3.2 Mobile phase gradient program 
Column was thermostated at 40 °C in order to keep not too high back pressure values, 
while samples were kept at 6 °C in the autosampler during the day of analysis. 
Injection volume varied between the two systems, being 5 µL on the triple quadrupole 
and 20 µL on the LTQ-Orbitrap. 
 
MS/MS conditions 
The device operated in negative electrospray ionization (ESI-) mode. 
Acquisitions were performed in MRM (multiple reaction monitoring) mode, following, 
when possible, two transitions for each molecule. 
The table on the next page shows the precursor-to-product transitions, with relative 
cone voltage and collision energy values, expressed in eV. 
Mass spectrometer settings: 
 Capillary voltage: 3.00 kV 
 Source temperature: 250 °C 
 Desolvation temperature: 300 °C 
 Desolvation gas flow: 10 L/min 
 Nebulization gas flow: 45 psi 
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Analyte 
Transition 1 
(m/z) 
Cone 
voltage 
Collision 
energy 
Transition 2 
(m/z) 
Cone 
voltage 
Collision 
energy 
PFBA 212.9 > 168.9 60 5    
M-PFBA 216.9 > 171.9 60 5    
PFPA 262.9 > 218.9 60 5    
PFHxA 312.9 > 268.9 60 5 268.9 > 118.9 100 15 
PFHpA 362.9 > 318.9 70 5 318.9 > 168.9 100 10 
PFOA 412.9 > 368.9 80 5 412.9 > 169.1 80 15 
M-PFOA 416.9 > 371.9 80 5    
PFNA 462.9 > 418.9 90 5 418.9 > 168.9 120 15 
M-PFNA 471.9 > 426.9 90 5    
PFDA 512.9 > 468.9 90 5 468.9 > 218.9 130 15 
M-PFDA 514.9 > 469.9 90 5    
PFUnA 562.9 > 518.9 80 5 562.9 > 268.9 120 15 
M-PFUnA 569.9 > 524.9 80 5    
PFDoA 612.9 > 568.9 100 5 612.9 > 168.9 120 25 
M-PFDoA 614.9 > 569.9 100 5    
PFBS 298.9 > 99.0 120 40 298.9 > 80.0 120 40 
PFHxS 398.9 > 99.0 80 50 398.9 > 80.0 80 50 
M-PFHxS 402.9 > 84.0 80 50    
PFHpS 448.9 > 99.0 60 45 448.9 > 80.0 60 45 
PFOS 498.9 > 80.0 60 45 498.9 > 99.0 60 45 
M-PFOS 502.9 > 502.9 60 15    
PFDS 598.9 > 80.0 80 50 598.9 > 99.00 80 50 
FOSA 497.9 > 78.1 150 35 497.9 > 219.0 150 25 
M-FOSA 506.0 > 78.1 150 35    
PFOSi 483.0 > 419.0 80 15 483.0 > 219.0 80 5 
M-PFOSi 487.0 > 423.0 80 15    
Table 3.3 Monitored transitions and their individual parameters 
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HRMS conditions 
The instrument operated in negative electrospray ionization mode (ESI-), recording 
mass spectra from 200 to 900 m/z in full scan mode, with a resolution of 15000 FWHM 
at 400 m/z in centroid mode. 
For each analyte and the corresponding internal standard, the pseudomolecular ion 
[M-H]- at its exact mass was extracted from full scan recording, using the m/z values 
reported in Table 3.4. 
Mass spectrometer parameters: 
 Capillary voltage: 4.00 kV 
 Cone voltage: -14 V 
 Nebulization gas temperature: 280 °C 
 Sheath gas flow (nitrogen): 6 (arbitrary unit) 
 Tube lens voltage: -85 V 
Analyte 
[M-H]- exact mass 
(m/z) 
Analyte 
[M-H]- exact mass 
(m/z) 
PFBA 212.9792 PFDoA 612.9536 
M-PFBA 216.9926 M-PFDoA 614.9603 
PFPA 262.9760 PFBS 298.9429 
PFHxA 312.9728 PFHxS 398.9366 
PFHpA 362.9696 M-PFHxS 402.9450 
PFOA 412.9664 PFHpS 448.9334 
M-PFOA 416.9798 PFOS 498.9302 
PFNA 462.9632 M-PFOS 502.9302 
M-PFNA 471.9934 PFDS 598.9238 
PFDA 512.9600 FOSA 497.9462 
M-PFDA 514.9667 M-FOSA 505.9730 
PFUnA 562.9568 PFOSi 482.9353 
M-PFUnA 569.9803 M-PFOSi 486.9487 
Table 3.4 Pseudomolecular ions HRMS diagnostic signals 
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3.1.4  Extraction procedure 
 
First of all 3 mL of milk were transferred into a polypropylene tube and spiked with    
50 μL of MIX M-PFC (0.01 μg/mL) solution, then 9 mL of acetone were added to 
perform a protein precipitation. 
After vortex shaking for 30  sec, the sample was placed during 5 min in an ultrasonic 
bath to facilitate the extraction and centrifuged at 2000 g for 10 min at room 
temperature. 
The supernatant was transferred to a new polypropylene tube and evaporated to 
around 3 mL under gentle nitrogen stream at 45 °C, then 8 mL of formic acid 0.1 M 
solution were added in order to adjust the pH for the first purification step on the 
Oasis HLB® cartridge. 
After conditioning the cartridge with 10 mL of methanol and 10 mL of formic acid      
0.1 M, always avoiding the solid phase to go dry, the sample was loaded. 
Once all the solution had passed through the column, two washings were performed 
with 5 mL of formic acid 0.1 M and with 5 mL of formic acid 0.1 M/methanol 50/50 
solution, then vacuum was applied for 5 min to remove eventual residual drops. 
The analytes were eluted with 6 mL of a mixture of methanol/ammonia solution 32% 
99/1 and subsequently concentrated to around 2 mL under nitrogen. 
A second purification was achieved using a Supelclean™ ENVI-Carb™ cartridge, 
previously activated with 10 mL of methanol. 
After placing a new tube under the column, the sample was loaded and then an elution 
with 6 mL of a methanol/glacial acetic acid 80/1 solution was performed. 
The eluate was evaporated to dryness under nitrogen and reconstituted in 100 μL of 
fluorometholone methanolic solution. After vortex shaking for 30 sec, 100 μL of 
ammonium acetate solution 20 mM were added and the solution was agitated for 
another 15 sec. 
The content of the tube was transferred into a microtube and centrifuged at 12000 
rpm during 45 min, then 150 μL were collected and added to 50 μL of ammonium 
acetate solution 20 mM in a polypropylene vial. 
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1st purification                      
SPE Oasis™ HLB 
2nd purification                        
SPE ENVI-Carb™ 
Evaporation to dryness          
and reconstitution 
Addition of     
external standard 
 
Injection in LC-HRMS 
 
Precipitation with acetone 
Addition of 
13
C 
internal standards 
 
The final solution, thus consisting of methanol/ammonium acetate 20 mM 
37.5%/62.5%, was injected in the two instruments. 
The procedure is schematically resumed in Figure 3.1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1 Extraction procedure  
3 mL of milk 
Injection in LC-MS/MS 
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3.1.5  Method validation 
 
The described method was validated on both LC-MS/MS and LC-HRMS systems 
according to current European regulations (Commission Decision 2002/657/EC). 
10 different 13C-labeled internal standards were employed, so that each compound 
was quantified calculating the ratio between its area and the area of the relative 
internal standard. 
 
Specificity 
In order to assess the specificity of the method, the analysis of milk samples presenting 
low levels of contamination (8 of human breast milk, 4 of cow milk and 4 of powder 
milk) was carried out. The screening was performed twice, changing the starting 
amount of milk: 1 mL and 3 mL. 
 
Identification criteria 
In accordance with 2002/657/EC guidelines, requirements for mass spectrometric 
detection were verified. These included: 
 Retention time: for a sample analyzed in LC, the relative retention time of the 
analyte shall correspond to that of the standard solution at a tolerance of ±2.5% 
 Relative ion intensity: tolerances, depending on the ratio between the intensity of 
the two monitored transitions, are reported in the following table 
Ratio Tolerance (%) 
R ≤10% 50 
10%< R <20% 30 
20%< R <50% 25 
R ≥50% 20 
Table 3.5 Maximum permitted tolerances for relative ion intensities 
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Linearity 
Linearity was evaluated on each matrix through the analysis of calibration curves, 
prepared during three different days: 1 mL milk samples were spiked at 7 different 
levels of concentration (plus blank), following the scheme reported in Table 3.6. 
A linear regression model was applied, associating the relative response of target 
compound to the concentration. 
Name 
Concentration 
(ng/mL = ppb) 
µL MIX M-PFC 
(10 ng/mL) 
µL MIX PFC 
(1 ng/mL) 
µL MIX PFC 
(10 ng/mL) 
G 0 0 50 - - 
G 0.025 0.025 50 25 - 
G 0.05 0.05 50 50 - 
G 0.1 0.1 50 100 - 
G 0.2 0.2 50 200 - 
G 0.5 0.5 50 - 50 
G 1 1 50 - 100 
G 2 2 50 - 200 
Table 3.6 Calibration curve preparation 
 
Limits of detection 
Limits of detection were determined for both systems taking into account the 
chromatograms resulting from the analysis of cow milk’s calibration curve. 
For LC-MS/MS system, limits were calculated as the concentration giving a signal-to-
noise ratio of 3; for LC-HRMS system, being important that no noise is observed in the 
chromatograms, limits were evaluated on the basis of the differences between peaks 
areas. 
 
Recovery 
To verify the recovery of the analytical procedure, for each matrix two samples spiked 
at 0.5 ng/mL, one before extraction and the other immediately after, were compared.  
 86 
Precision 
Taking into account the contamination levels likely to be found in the considered 
matrices, precision was evaluated with two different approaches depending on the 
type of milk. 
For cow and powder milk, the 4 less contaminated samples were employed, 
performing two tests at different spiking levels (0.1 ng/mL and 0.5 ng/mL, n = 2*4); for 
human breast milk, 8 samples taken from a pool prepared using the 8 less 
contaminated samples available were spiked at 0.5 ng/mL (n = 8). 
Relative standard deviation to the mean (CV%) should be lower than the value 
calculated by the Horwitz equation: 
                 
being C the mass fraction expressed as a power of 10. For mass fractions lower than 
100 µg/kg this formula generates excessively high values, therefore in those cases CV% 
shall be as low as possible. 
 
Trueness 
Since to this day no milk reference material with certified PFCs concentrations is 
available, it was decided to verify trueness using 2 human breast milk samples from an 
international ring test, one from Sweden and one from Germany. 
In addition, being available in the laboratory an optimized protocol for the analysis of 
perfluorinated compounds in serum implying a similar extraction and purification 
procedure to that developed for milk, a certified serum sample (NIST SRM 1957) was 
analyzed twice to obtain further data on trueness. 
Trueness was expressed as bias, that is the difference between the mean measured 
value and the reference value.  
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Uncertainty 
Measurement uncertainty for PFOA and PFOS was evaluated on the LC-HRMS system, 
considering precision, trueness and standards purity. 
 Uncertainty in precision (Uprecision) was calculated on the basis of the repeatability 
data obtained from the analyzed samples and from three further series of eight 
human breast milk samples (spiked at 0.1, 0.25 and 0.75 ng/mL), added to increase 
the statistical significance of the value. To calculate CV% the following formula was 
used:  
                
          
            
    
                
 
 For trueness, uncertainty (Utrueness) was evaluated as a ratio between the bias and 
the certified value (in this case, the mean of the values obtained for the 2 ring test’s 
human breast milk samples was used): 
          
                                    
               
 
 Uncertainty related to standard solutions purity (Upurity) was calculated through this 
formula: 
        
              
  
 
Combining the obtained factors, relative combined uncertainty (URC) resulted from this 
equation: 
                                           
Then, final uncertainty (UF), with a 95% confidence interval, was calculated as twice 
the relative combined uncertainty: 
        
 
 
 
  
 88 
3.1.6  Samples quantification 
 
For each day of analysis, a calibration curve in ultrapure water (to avoid potential 
interferences due to milk contamination) was prepared following the same procedure 
described for calibration curves in milk, employed to verify method’s linearity (see 
Section 3.1.5). Moreover, in compliance with 2002/657/EC guidelines, the previously 
mentioned identification criteria were verified. 
In order to perform a correct quantification of perfluoroalkyl sulfonates and 
perfluoroalkyl sulfinates, a specific correction factor was applied to each molecule (see 
Table 3.7), since they are sold in salt form and thus their concentrations are always 
referred to those of the anionic form. This specific factor was calculated as the ratio 
between the molar mass of the anionic form of the compound and that of its salt. 
Compound Correction factor 
PFBS- 0,929 
PFHxS- 0,945 
PFHpS- 0,951 
PFOS- 0,956 
PFDS- 0,963 
PFOSi- 0,952 
Table 3.7 Corrections factors for sulfonic acids 
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3.2  PFCs analysis at CABA-Lab 
 
During this second work package the method developed at LABERCA was transferred 
to CABA-Lab to verify its performances in the analysis of PFOA and PFOS in milk, being 
the two most important molecules of this group, using the UHPLC-MS/MS system 
available in the laboratory. 
Once the efficiency of the method had been ascertained, it was employed for the 
analysis of several cow milk and human breast milk samples from Italy, in order to 
obtain some preliminary data on PFCs contamination also for this country. Moreover, 
taking into account the available information on such samples, the monitoring tried to 
reveal potential correlations between the characteristics of each kind of milk and its 
level of contamination. 
 
 
3.2.1  Material 
 
Standards 
To verify the method performance and for samples quantification, PFOA, PFOS and 
relative 13C4-labeled M-PFOA e M-PFOS standards (employed as internal standards) 
were used. 
All standards solutions were purchased from Wellington Laboratories (Guelph, Canada) 
with a purity grade >98% in methanol: 
 PFOA Perfluoro-n-octanoic acid: 50 μg/mL, 1.2 mL 
 PFOS Sodium perfluoro-1-octanesulfonate: 50 μg/mL, 1.2 mL 
 M-PFOA Perfluoro-n-[1,2,3,4-13C4]octanoic acid: 50 μg/mL, 1.2 mL 
 M-PFOS Sodium perfluoro-1-[1,2,3,4-13C4]octanesulfonate: 50 μg/mL, 1.2 mL 
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Starting from these products, the following standard solutions were prepared: 
o Stock solutions: for each compound a 5 μg/mL solution was prepared diluting 
1:10 in methanol the relative 50 μg/mL standard 
o PFC stock solution (0.5 μg/mL): 20 μL of PFOS (50 μg/mL) and 20 μL of PFOA (50 
μg/mL) were dissolved in 2 mL of methanol. 
Thereafter, diluting this PFC stock solution in methanol, the following working 
solutions were obtained: 
o PFC working solution (50 ng/mL) 
o PFC working solution (5 ng/mL) 
o M-PFC working solution (50 ng/mL): 100 μL of M-PFOA tune solution (5 μg/mL) 
and 100 μL of M-PFOS tune solution (5 μg/mL) were dissolved in 10 mL of 
methanol 
All solutions were stored in refrigerator at 4 °C and away from light. 
 
Reagents and chemicals 
All solvents used for mass spectrometry analysis were LC-MS grade: 
 Methanol (Sigma Aldrich) 
 Ammonium acetate (Fluka) 
 Ultrapure water (produced directly in the laboratory) 
Solvents employed during sample treatment were all analytical grade: 
 Acetone (VWR) 
 Ammonia solution 33% (Sigma Aldrich) 
 Methanol (Sigma Aldrich) 
 Glacial acetic acid (Sigma Aldrich) 
 Formic acid (Sigma Aldrich) 
 Pure water (produced directly in the laboratory) 
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Two different solid phase extraction (SPE) cartridges were used to extract the analytes 
from milk: 
 Oasis® HLB cartridges: 6 cc, 500 mg, 60 μm (Waters, Milford MA, USA) 
 Supelclean™ ENVI-Carb™ cartridges: 6 cc, 500 mg, 120-400 mesh (Supelco, 
Bellefonte PA, USA) 
Prepared solutions 
o Ammonium acetate solution 20 mM: 1.54 g of ammonium acetate was 
dissolved in 1 L of ultrapure water and shaken vigorously 
o Formic acid 0.1 M: 3.8 mL of formic acid and 996.2 mL of pure water were 
mixed in a 1 L bottle and shaken vigorously 
 
Samples 
To test and optimize at CABA-Lab the previously developed method, milk purchased in 
a store located in the province of Bologna was used, being stored in the refrigerator 
for a limited number of hours prior to analysis. 
The preliminary monitoring included cow and human breast milk: 
 Human breast milk: 13 samples, provided by the Department of Gynecology, 
Obstetrics and Pediatrics of Bologna University. Sampling was authorized by the 
Independent Ethics Committee of Bologna University Hospital Authority 
Sant’Orsola-Malpighi Polyclinic (clinical trial # 49/2011/U/Tess). 
 Cow milk: 22 samples, including 16 different varieties of milk purchased from 
large retailers in the province of Bologna, 1 raw milk purchased at a vending 
machine in the province of Bologna and 5 milk samples provided by the 
experimental farm of Ozzano dell’Emilia (Bologna, Italy), owned by the Faculty 
of Veterinary Medicine of Bologna University. 
Collected samples were transferred into polypropylene bottles, in order to prevent the 
risk of PFCs contamination caused by the original packaging material, and then stored 
in freezer at -18 °C until analysis.  
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Sample Primipara / Multipara Sample Primipara / Multipara 
A Primipara I Multipara 
B Primipara J Multipara 
C Primipara K Multipara 
D Primipara L Multipara 
E Primipara M Multipara 
F Primipara   
G Primipara   
H Primipara   
Table 3.8 Human milk samples and relative mother’s primipara/multipara status 
 
Sample Type Sample Type 
A UHT whole L High Quality* whole 
B Pasteurized whole M 
Microfiltered partially 
skimmed 
C Microfiltered whole N High digestibility 
D Organic whole O UHT partially skimmed 
E Organic whole P 
Pasteurized partially 
skimmed 
F Organic whole Q Raw 
G Pasteurized whole R Sampled during milking 
H UHT skimmed S Sampled during milking 
I 
Pasteurized partially 
skimmed 
T Sampled during milking 
J Whole U Sampled during milking 
K Organic whole V Sampled during milking 
* According to Italian D.M. 185/91, a milk can be given the “High Quality” appellation if the 
following requirements are satisfied: 
- fat content not lower than 3.50% 
- protein content not lower than 32.0 g/L 
- bacteria count at 30 °C lower than 100000/mL (mean value monitored during two months at 
least twice per month) 
- somatic cell count lower than 300000/mL (mean value monitored during two months at least 
twice per month) 
- lactic acid content lower than 30 ppm 
Table 3.9 Cow milk samples and type specifications 
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3.2.2  Equipment 
 
UHPLC-MS/MS system 
The system employed for PFCs analysis consisted of a Waters Acquity UPLC® binary 
pump (provided with degasser, thermostated autosampler and column compartment), 
coupled with a Waters Quattro Premier XE™ triple quadrupole mass spectrometer 
equipped with an ESCi™ Multi-Mode Ionization Source (Waters Corporation, Milford 
MA, USA). 
Chromatographic separation was achieved using a Waters Acquity UPLC® BEH C18 
reversed-phase column (50 x 2.1 mm, 1.7 µm), fitted with a Waters VanGuard™ guard 
column with the same packing (5 x 2.1 mm, 1.7 µm) (Waters Corporation, Milford MA, 
USA). 
Data were acquired and processed using Waters MassLynx™ 4.1 software (Waters 
Corporation, Milford MA, USA). 
The nitrogen needed for the operation of mass spectrometer’s interface was produced 
by a DBS N2-Mistral-4 generator (DBS Strumenti Scientifici, Padova, Italy). 
 
Other equipment 
During method transfer and milk samples preparation, the following equipment was 
employed: 
 Solid phase extraction manifold (Waters Corporation, Milford MA, USA) 
 Centrifuge (Hettich, Kirchlengern, Germany) 
 Water purification system (Human Corporation, Seoul, Korea) 
 Nitrogen sample concentrator 
 Waterbath (Grant Instruments, Cambridge, GB) 
 Automatic pipettes (Gilson, Middleton WI, USA) 
 Vortex mixer (Velp Scientifica, Monza e Brianza, Italy) 
 Ultrasonic bath (AGE Elettronica, Milano, Italy) 
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3.2.3  Instrumental conditions 
 
LC conditions 
The mobile phase consisted of: 
 Phase A: ammonium acetate solution 20 mM 
 Phase B: methanol 
Analysis were carried out under programmed conditions, at flow rate of 0.5 mL/min. 
The gradient started with 30 sec at 70% A and 30% B, switched to 0% A and 100% B 
over 1 min and hold for 1.5 min. Then conditions went back to 30% A and 70% B in 0.5 
min and hold for further 1.5 min, in order to equilibrate the column before the 
following injection. 
The chromatographic gradient is resumed in the following table: 
Time (min) Phase A (%) Phase B (%) 
0 70 30 
0.5 70 30 
1.5 0 100 
3 0 100 
3.5 70 30 
5 70 30 
Table 3.10 Mobile phase gradient program 
Injection volume was 10 µL, in “full loop” mode; samples were kept at 6°C in the 
autosampler during the day of analysis, while the column was kept at 45 °C to avoid 
excessive backpressures. 
 
MS/MS conditions 
Mass spectrometer operated in negative electrospray ionization (ESI-) mode. 
Analysis were performed in MRM (multiple reaction monitoring) mode, following two 
transitions for PFOS and PFOA and one for each internal standard. Argon was used as 
collision gas. 
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In Table 3.11 the precursor-to-product transitions are reported, with the 
correspondent cone voltage and collision energy, expressed in eV. 
Analyte 
Transition 1 
(m/z) 
Cone 
voltage 
Collision 
energy 
Transition 2 
(m/z) 
Cone 
voltage 
Collision 
energy 
PFOA 412.82 > 368.97 12 10 412.82 > 168.98 12 17 
PFOS 498.64 > 498.64 52 10 498.64 > 79.98 52 43 
M-PFOA 416.93 > 372.00 11 10    
M-PFOS 502.86 > 502.86 50 11    
Table 3.11 Monitored transitions and their relative specific parameters 
Mass spectrometer settings: 
 Capillary voltage: 2.00 kV 
 Extractor voltage: 3.00 V 
 Source temperature: 150 °C 
 Desolvation temperature: 220 °C 
 Cone gas flow: 50 L/h 
 Desolvation gas flow: 700 L/h 
 
 
3.2.4  Extraction procedure 
 
The previously described extraction procedure (refer to Section 3.1.4) was transferred 
to CABA-Lab without significant changes, except for the different amount of internal 
standard added to the samples, being in this case 30 µL of M-PFC working solution at 
50 ng/mL. 
Moreover, it was chosen not to use an external standard, therefore after evaporation 
to dryness the sample was reconstituted in methanol/ammonium acetate. 
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3.2.5  Performances of the transferred method 
 
An apparently not contaminated cow milk sample was employed for the preparation of 
an 8 levels matrix-matched calibration curve, in order to assess linearity and limits of 
detection of the transferred method.  
To this purpose, starting with 3 mL fractions of milk, 30 µL of M-PFC working solution 
were added as internal standard, followed by increasing amounts of the two PFC 
working solutions according to the scheme reported in Table 3.12. 
The 8 solutions obtained, with concentrations from 0 to 2 ng/mL, were then injected in 
the UHPLC-MS/MS system. 
Name 
Concentration 
(ng/mL = ppb) 
µL M-PFC 
(50 ng/mL) 
µL PFC 
(5 ng/mL) 
µL PFC 
(50 ng/mL) 
C 0 0 30 - - 
C 0.025 0.025 30 15 - 
C 0.05 0.05 30 30 - 
C 0.1 0.1 30 60 - 
C 0.2 0.2 30 120 - 
C 0.5 0.5 30 - 30 
C 1 1 30 - 60 
C 2 2 30 - 120 
Table 3.12 Calibration curve preparation 
 
 
3.2.6  Samples quantification 
 
As well as during the analysis carried out at LABERCA, quantification at CABA-Lab was 
performed in accordance with 2002/657/EC criteria (see Section 3.1.6). 
An 8 levels calibration curve in ultrapure water was prepared each day of analysis to 
quantify samples, following the above scheme used for the linearity test. 
To perform a correct quantification, a correction factor was applied to PFOS. 
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3.3  PFCs precursors analysis at LABERCA 
 
With Recommendation 2010/161/EU, the European Commission called Member States 
to monitor the presence of perfluoroalkylated substances in food, in order to detect 
the presence of PFOA and PFOS, but also, when possible, their precursors, such as 
perfluorooctane sulfonamide (FOSA), perfluorooctane sulfonamido ethanols (FOSEs) 
and fluorotelomer alcohols (FTOHs). 
Having already included FOSA in the list of molecules monitored with the previously 
developed method for PFCs analysis (see Section 3.1), during this third work package 
preliminary tests were performed in order to investigate other precursor compounds 
(see Table 3.13) in fish, trying if possible to include them in the range of 
perfluoroalkylated substances monitored with the already existing LABERCA 
procedures. 
Family Chemical structure 
Monitored 
compounds 
Perfluorooctane sulfonamido ethanols 
(FOSEs) 
 
2 
Fluorotelomer alcohols 
(FTOHs)  
3 
Table 3.13 Groups of precursors considered and relative chemical structure 
On the basis of the few works available in literature and of some experiments 
conducted in the laboratory, gas chromatography was considerate the most suitable 
technique for the analysis of these molecules, which are extremely volatile. 
  
 98 
3.3.1  Material 
 
Standards 
The employed standards solutions of FOSEs and FTOHs were from Wellington 
Laboratories (Wellington, Canada), with a concentration of 50 μg/mL in ethanol and a 
purity grade >98%: 
 N-MeFOSE 2-(N-methylperfluoro-1-octanesulfonamido)-ethanol 
 N-EtFOSE 2-(N-ethylperfluoro-1-octanesulfonamido)-ethanol 
 FHET 2-Perfuorohexyl ethanol (6:2 FTOH) 
 FOET 2-Perfuorooctyl ethanol (8:2 FTOH) 
 FDET 2-Perfuorodecyl ethanol (10:2 FTOH) 
As internal standards, one labeled standard for FOSEs and one for FTOHs (50 μg/mL in 
methanol, purity grade >98%) were purchased from Wellington Laboratories 
(Wellington, Canada): 
 d7-N-MeFOSE 2-(N-deuteriomethylperfluoro-1-octanesulfonamido)-1,1,2,2-
tetradeuterioethanol 
 M-FOET 2-Perfuorooctyl-[1,1,-2H2]-[1,1,-
13C2]-ethanol (M-8:2 FTOH) 
Stock solutions at 10 μg/mL of all the compounds were prepared in methanol; the 
following working solutions were obtained by dilution: 
o FOSE+FTOH 1 μg/mL, FOSE+FTOH 0.1 μg/mL and FOSE+FTOH 0.01 μg/mL, 
containing the all the 5 analytes investigated 
o IS FOSE+FTOH 0.1 μg/mL, containing both internal standards employed 
All solutions were stored in the refrigerator at 4 °C and away from light. 
 
Reagents and chemicals 
In addition to solvents already described in Section 3.1.1, Dichloromethane Picograde® 
(Promochem) was employed. 
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Other chemicals needed for sample extraction: 
 Supelclean™ ENVI-Carb™ SPE bulk packing 120-400 mesh (Supelco) 
 Silica gel 70-230 mesh (Fluka) 
 
Preparation of silica column 
The required hydrated silica (1.5%) was obtained shaking several times during one day, 
each time for 5 min, a flask containing 98.5 g of silica gel and 1.5 mL of water. 
After placing a thick layer of glass wool on the bottom of the column, previously 
positioned on the manifold, two washings with 5 mL of acetone and 5 mL of 
dichloromethane were performed, then 4 g of hydrated silica were added. 
 
 
3.3.2  Equipment 
 
GC-MS/MS system 
FOSE and FTOH analysis were performed using a system composed of an Agilent 7890 
gas chromatographer coupled to an Agilent 7000 triple quadrupole mass spectrometer 
(equipped with chemical ionization interface) and provided with an Agilent 7693 
autosampler (Agilent Technologies, Santa Clara CA, USA). 
A Varian CP-WAX 57CB capillary column (25 m, 0.25 mm I.D., 0.20 µm film thickness) 
(Varian, Palo Alto CA, USA) was used for chromatographic separation. 
Data were acquired and processed with Agilent Mass Hunter Workstation software 
(Agilent Technologies, Santa Clara CA, USA). 
 
Other equipment 
The same equipment described in Section 3.1.2 was employed, with the addition of: 
 Grinder 
 Horizontal mechanical shaker 
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3.3.3  Instrumental conditions 
 
GC-MS/MS conditions 
A volume of 2 µL was injected in pulsed splitless mode at a temperature of 225 °C, with 
helium as carrier gas (1 mL/min flow). 
The oven temperature gradient started with 4 min at 60 °C, increased to 70 °C in 2 min 
and then to 200 °C at 15 °C/min, held for 6 min, as resumed in the following table: 
Time (min) Temperature (°C) Ramp (°C/min) 
0 60 - 
4 60 0 
6 70 5 
14.7 200 15 
20.7 200 0 
Table 3.14 Oven temperature gradient program 
The detector operated in positive chemical ionization (CI+), with source temperature 
set at 200 °C and methane employed as reagent gas. 
Acquisition was performed in MRM (multiple reaction monitoring) mode; collision gas 
consisted of a mixture of nitrogen and helium, at a flow of 1.5 and 2.25 mL/min 
respectively. In Table 3.15 the monitored transitions and the relative collision energy 
values, expressed in eV, are reported. 
Analyte 
Transition 1 
(m/z) 
Collision 
energy 
Transition 2 
(m/z) 
Collision 
energy 
N-EtFOSE 571.7 > 553.7 10 571.7 > 571.7 1 
N-MeFOSE 557.7 > 539.7 10 557.7 > 557.7 1 
d7-N-MeFOSE 564.7 > 546.7 10 564.7 > 564.7 1 
6:2 FTOH 364.6 > 326.7 10 364.6 > 364.6 1 
8:2 FTOH 464.6 > 426.7 10 464.6 > 464.6 1 
10:2 FTOH 564.6 > 526.7 10 564.6 > 564.6 1 
M-8:2 FTOH 468.6 > 430.7 10 468.6 > 468.6 1 
Table 3.15 Monitored transitions and corresponding collision energy 
 101 
3.3.4  Extraction procedure 
 
1 g of freeze-dried fish was transferred to a polypropylene tube, added of 100 µL of IS 
FOSE+FTOH solution and 15 mL of methanol, then mechanically shaken for 15 min and 
centrifuged at 4000 g during 15 min. 
In a new tube, 800 mg of ENVI-Carb™ phase were activated with 1 mL of glacial acetic 
acid, then the supernatant was transferred and the tube agitated for 1 min and 
centrifuged at 4000 g for 5 min. 
After transferring the extract into another tube, it was reduced to around 500 µL being 
heated at 35 °C under gentle nitrogen stream and added of 3 mL of dichloromethane. 
The solution was then loaded onto a self-prepared silica column (see Section 3.3.1), 
previously activated with 10 mL of dichloromethane. 
Then, a washing with 15 mL of dichloromethane was performed and the analytes were 
eluted with 30 mL of acetone. 
The eluate was placed into a dry bath at 35 °C and carefully evaporated to 200 µL by a 
delicate nitrogen stream, then transferred to a microtube and centrifuged at 12000 
rpm during 45 min. 
Finally, 150 µL were transferred into a polypropylene GC vial and injected. 
A scheme resuming the whole procedure is presented on next page. 
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1st purification                      
SPE dispersive ENVI-Carb™ 
2nd purification                        
Hydrated silica gel column 
Evaporation and 
centrifugation 
Liquid-solid extraction 
with methanol 
Addition of 
internal standards 
 
Injection in GC-MS/MS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2 Extraction procedure 
  
1 g of freeze-dried fish 
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3.3.5  Performances of the method 
 
After optimizing the detection of all the target compounds, some preliminary tests 
were performed to assess the performances of the method. 
Concerning linearity and limits of detection, a 6 points matrix-matched calibration 
curve ranging from 0 to 50 μg/kg of dry matter was prepared, as reported in the 
following table: 
Name 
Concentration 
(μg/kg d.m.) 
μL IS 
FOSE+FTOH 
(0.1 μg/mL) 
μL 
FOSE+FTOH 
(0.01 μg/mL) 
μL 
FOSE+FTOH 
(0.1 μg/mL) 
μL 
FOSE+FTOH 
(1 μg/mL) 
F 0 0 100 - - - 
F 0.5 0.5 100 50 - - 
F 1 1 100 100 - - 
F 5 5 100 - 50 - 
F 10 10 100 - 100 - 
F 50 50 100 - - 50 
Table 3.16 Calibration curve preparation 
In order to evaluate absolute extraction recovery for FOSEs, two samples were 
prepared with the addition of 50 µL of FOSE+FTOH 1 µg/mL solution, the first being 
spiked at the beginning of the extraction procedure and the other being spiked at the 
end, during the final evaporation prior to injection. 
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4. Results and discussion 
 
4.1  PFCs analysis at LABERCA 
 
A method based on liquid chromatography coupled to two different mass 
spectrometry detectors for the quantification of perfluorinated compounds in milk was 
optimized and fully validated in accordance with European regulations (2002/657/EC). 
This technique allows to simultaneously measure 16 different analytes at ultra-trace 
levels and is currently under evaluation for ISO 17025 accreditation. 
LC-MS/MS is nowadays the technique of election for the analysis of these substances, 
but the LC-HRMS system resulted even more performing in terms of sensitivity and 
specificity for some compounds. This instrument thus represents a useful alternative 
for both quantitative and confirmatory purposes, especially considering the low 
concentrations at which these analytes are often measured. 
 
 
4.1.1  Instrumental analysis 
 
Chromatographic separation 
The chromatographic part was in common between the two systems and the choice of 
the column fell on a reversed phase C18 Gemini column, due to its high stability and 
efficiency at variable gradients and pH. The interactions between the silica phase and 
target analytes allowed to successfully separate the latter, whose retention time 
increased with increasing polarity. 
The mobile phase, as well, has a major role when trying to obtain a good 
chromatographic separation and the choice of its components must take into account 
both the characteristics of the compounds investigated and the detector’s interface. 
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Similarly to what indicated in previous works on PFCs analysis, in order to improve the 
elution of the molecules and their ionization, ammonium acetate was added to the 
methanol/water mobile phase: the concentration of 20 mM in aqueous solution was in 
line with various studies, however also lower concentrations (between 2 and 20 mM) 
have been reported as well. This salt interacts with target compounds to form ion-
pairs, helping their passage through the column; at the same time it facilitates their 
deprotonation, and consequently the formation of pseudo-molecular ions. 
From the initial methanol/ammonium acetate 30%/70% mixture, mobile phase 
gradually switched to 100% methanol and held like that for 4 min, in order to let all the 
compounds elute from the column. 
These conditions allowed to satisfactorily separate 26 different molecules (16 
perfluorinated compounds and 10 relative internal standards) with a 20 min 
chromatographic run, including column re-equilibration. 
 
Ionization 
Once they have been eluted from the column and before they enter the detector, 
target analytes undergo ionization, which can be operated by different types of 
sources. Concerning perfluorinated compounds, the most employed technique is 
electrospray ionization, which is based on the effects of a strong electric field (at kV 
levels) applied to the chromatography eluate exiting from a capillary at controlled flow 
and atmospheric pressure. By means of a nebulization gas (nitrogen), the mixture of 
mobile phase and produced ions is transformed into spray droplets, which move 
towards the entrance cone of the detector being simultaneously hit by the desolvation 
gas (again, nitrogen). This causes a progressive evaporation of the solvent, until the 
droplets explode releasing the highly charged molecules, which finally enter the 
detector. Depending on the polarity of the applied potential difference, positive or 
negative ions can be generated: in the case of perfluorinated compounds, negative 
ionization is generally used, since they tend to give up protons forming pseudo-
molecular ions [M-H]-. Thus, ESI- was employed on both systems. 
 107 
MS/MS detection 
The principle of operation of tandem mass spectrometry, operating in MRM mode, is 
illustrated if Figure 4.1 and is based on a linear series of 3 quadrupoles. The first one 
(Q1) filters ions coming from the source according to their mass-to-charge ratio (m/z), 
then a collision gas (an inert gas, such as argon or nitrogen) collides with selected ions 
in Q2 generating fragments, which are then filtered in Q3. Fragmentation pathways 
are characteristic for each compound, thus this technique allows a selective 
identification of target analytes since only specific fragments reach the detector. 
 
Figure 4.1 Scheme of a triple quadrupole mass spectrometer 
In the proposed method, when possible, for an unambiguous determination of the 
investigated substances, 2 transitions (parent ion giving fragment ion) were monitored 
for each compound, the most abundant being used for quantification and the other for 
confirmatory purpose. This was achieved optimizing for each transition the energy 
applied to the analytes before the entrance of the detector and to the selected parent 
ion in the collision cell, on which the generation of product ions depends. 
However, the high stability of perfluorinated compounds causes in some cases a 
relatively poor and non-specific fragmentation pathway, resulting in parent-to-parent 
or parent-to-small fragment transitions to be used for the identification of certain 
analytes. The consequence of this is a lack of specificity of MS/MS detectors, which is 
the main limit of this kind of instrument in PFCs analysis, potentially causing in some 
matrices overestimations due to interfering co-eluting compounds. 
Moreover, performing MRM analysis on such a large number of molecules and their 
relative internal standards (40 transitions in total) implies significantly decreased dwell 
time values, resulting in a loss of sensitivity. 
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In more detail, 4 different families of perfluorinated compounds were considered in 
this study, each of them showing a characteristic fragmentation pathway depending 
on the chemical structure. The analysis of their product ions mass spectrum provided 
useful information about the fragments generated after precursor ion’s break up. 
Perfluoroalkyl carboxylic acids fragmentation is easily obtained even at relatively low 
collision energy values, producing mainly the loss of a CO2 group and secondly parts of 
the chain constituted by 3 or 4 fluorinated carbons (see Figure 4.2). 
 
Figure 4.2 Product ions scan for PFOA, applying a collision energy of 15 eV 
Perfluoroalkyl sulfonates showed higher stability than PFCAs, having the sulfonate 
group a stronger interaction with the alkyl chain, due to its greater electronegativity. 
Applying high collision energy, [SO3]
- and [FSO3]
- are the two most detected product 
ions, proving that PFSAs fragmentations lacks in specificity (see Figure 4.3). 
 
Figure 4.3 Product ions scan for PFOS, applying a collision energy of 45 eV  
[M-H]- 
 
[SO3]
- 
 
[FSO3]
- 
 
[CF3-CF2]
- 
 
[CF3-CF2-CF2]
- 
 
[M-H]- 
 
[CF3-CF2-CF2-CF2]
- 
 
[CF3-CF2-CF2]
- 
 
[M-CO2-H]
- 
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Also perfluoroalkyl sulfonamide’s predominant product ion is a small fragment, given 
by a [SO2N]
- group; however, also fragments of the alkyl chain are observed, mainly 
constituted by 3 fluorinated carbons (see Figure 4.4). 
 
Figure 4.4 Product ions scan for FOSA, applying a collision energy of 35 eV 
Concerning perfluoroalkyl sulfinates, they show the loss of a [SO2]
- group and chain 
fragments of different lengths, as shown in Figure 4.5 (in this work the transition      
[M-H]- > [CF3-(CF2)3]
- was chosen for confirmatory purpose); their fragmentation 
requires a lower energy compared to PFSAs, indicating the lower stability of these 
family of compounds. 
 
Figure 4.5 Product ions scan for PFOSi, applying a collision energy of 15 eV 
[M-H]- 
 
[CF3-CF2-CF2]
- 
 
[SO2N]
- 
 
[M-H]- 
 
[M-H-SO2]
- 
 
[CF3-CF2-CF2-CF2]
- 
 
[CF3-CF2-CF2]
- 
 
[CF3-CF2-CF2-CF2-CF2]
- 
 
[FSO2]
- 
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HRMS detection 
The term “resolution” in mass spectrometry indicates the mass filter capacity to 
distinguish two ions having very close mass-to charge (m/z) ratios. Triple quadrupole 
mass spectrometers are often employed to resolve ions differing by a single atomic 
mass unit, being thus considered low resolution instruments. High resolution mass 
spectrometers, such as the LTQ-Orbitrap™ employed in this study, allow much higher 
resolution, achieving resolving power >100000 FWHM (meaning the ratio between the 
measured value and the width of the peak measured at half of its height) and mass 
accuracy <5 ppm. 
In Figure 4.6 the principle of operation of the LTQ-Orbitrap™ is resumed. This system 
combines a linear ion trap, based on the quadrupole principle but capable to perform 
MSn analysis, with an Orbitrap™. After exiting the linear trap, ions are orientated by a 
curved trap (c-trap) and reach the Orbitrap™, within which are trapped beginning to 
move in circular trajectories around the central electrode and back and forth along its 
axis, due to the form of this device and the inside electric field. Their oscillation 
frequency is inversely proportional to the square root of their m/z and is converted 
into a signal by means of the Fourier transform. 
 
Figure 4.6 Scheme of the LTQ-Orbitrap™ system 
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After optimizing ionization parameters for the detection of the various target  
compounds, analysis were performed in full scan mode. From the acquired mass 
spectrum, the exact masses of the pseudo-molecular ions [M-H]- were extracted with a 
resolution of 15000 FWHM at 400 m/z. The high mass accuracy of this instrument 
provided a great specificity, allowing extremely selective identification even in this kind 
of complex multi-residue analysis. 
 
 
4.1.2  Extraction procedure 
 
The extraction procedure is essentially based on a LLE (liquid-liquid extraction) 
followed by two purifications on SPE (solid phase extraction). 
The LLE step is very important when analyzing milk samples, since perfluorinated 
compounds tend to bind to proteins, whose content in this matrix is relevant. In order 
to separate them, an extraction with acetone was performed, denaturing proteins and 
causing their precipitation. This could have been achieved in many ways, but acetone 
was chosen due to its low boiling point, which is an advantage considering that 
samples should be concentrated before being loaded on the SPE cartridge. 
Waters Oasis® HLB was the first SPE cartridge employed for sample purification 
because of the macroporous copolymer constituting its stationary phase, which 
combines hydrophilic and lipophilic properties, providing strong interactions with PFCs. 
The mechanisms underlying their retention are both dipole-dipole and cation exchange 
interactions, the latter being facilitated by sample acidification obtained through 
addition of formic acid solution before loading. 
The second SPE step is a modification of the technique proposed by Powley et al. 
(2005), but instead of using dispersive graphitized carbon phase, in this case 
purification was carried out on columns containing the same sorbent. 
For both types of cartridges, elution profiles were studied to optimize sample 
preparation, decreasing as much as possible the amount of eluting solutions 
employed. In more detail, 2mL fractions of formic acid/methanol mixture (for Waters 
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Oasis® HLB) and methanol/glacial acetic acid mixture (for Supelclean™ ENVI-Carb™) 
were loaded one after the other on the respective cartridge and collected separately, 
in order to quantify the amount of analytes eluted by each fraction. This experiment 
proved that 6 mL volume of the above mentioned solutions were sufficient to 
completely elute the analytes, which translates into, besides reduced solvents 
consumption, shorter time required for the following evaporation steps. 
Some tests were conducted also to decide the initial amount of sample to process, 
extracting 1, 2 and 5 mL milk samples (added of proportional volumes of acetone, to 
ensure protein precipitation). 3 mL was considered the optimum compromise to 
obtain very good limits of detection without generating relevant matrix effect. 
Prior to injection, a centrifugation was performed in order to further reduce the risk of 
potential residual components of the matrix being present in the injected solution. 
During all the experiments that have been conducted, glass tubes and vials were 
replaced by polypropylene ones, as well as Teflon lined caps and septa (potentially 
releasing small amounts of residual perfluorinated compounds), to prevent from 
alterations and interferences affecting the analysis. Moreover, standards solutions and 
samples were stored away from light and at refrigerator or freezer temperature. 
 
 
4.1.3  Method validation 
 
Validation of the described method for the identification and quantification of 16 PFCs 
was performed on both systems as described in Section 3.1.5, in compliance with 
Commission Decision 2002/657/EC, concerning the performances of analytical 
methods and establishing the required parameters. 
 
Specificity 
No significant differences were observed between samples processed starting from 1 
mL of milk and those starting from 3 mL. Both instruments allowed to efficiently 
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separate target analytes but, in general, the LC-HRMS system generated better signals, 
with low to no background noise, demonstrating a higher specificity. 
PFOS and PFOA were detected without relevant problems, while PFUnA analysis was 
affected by the presence of a coeluting compound, interfering with its quantification at 
low concentrations. However, according to data available in literature, this 
contaminant seems not to be present in milk. The short retention time of PFBA and 
PFPA, together with the availability of only one MS/MS transition, negatively 
influenced the specificity of their analysis. 
In the following figure it’s possible to appreciate the higher S/N ratio obtained with LC-
HRMS compared to LC-MS/MS for the detection of PFOA in a milk sample spiked at a 
concentration of 0.020 ng/mL. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.7 Chromatograms of the most representative transitions of PFOA (412.9 > 368.9) and 
M-PFOA (416.9 > 371.9), resulting from the analysis of a milk sample spiked at 0,020 ng/mL in 
LC-MS/MS (left) and LC-HRMS (right)  
PFOA 
M-PFOA 
PFOA 
M-PFOA 
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Identification criteria 
The results obtained analyzing 16 milk samples spiked with PFCs standards and 
corresponding internal standards at 0.5 ng/mL are reported in the following table. 
Analyte 
Relative retention time Transitions ratio 
Mean (min) CV (%) Mean (min) CV (%) 
PFBA 1.00 0.49 n/a n/a 
PFPA 0.55 1.22 n/a n/a 
PFBS 0.64 4.09 26.15 11.10 
PFHxA 0.85 0.15 3.90 12.74 
PFHpA 0.94 0.63 5.09 10.49 
PFHxS 1.00 0.04 32.32 10.45 
PFHpS 0.96 0.19 44.56 9.02 
PFOA 1.00 0.01 28.16 5.15 
PFNA 1.00 0.01 9.77 24.14 
PFOS 1.00 0.04 52.76 8.86 
PFDA 1.00 0.01 7.54 20.21 
PFDS 1.07 0.31 2.63 6.09 
PFUnA 1.00 0.03 n/a n/a 
PFDoA 1.00 0.02 8.39 21.29 
PFOSi 1.00 0.03 6.22 11.10 
FOSA 1.00 0.16 n/a n/a 
Table 4.1 Results for the required identification criteria in LC-MS/MS analysis 
Concerning relative retention time, only for PFBS it didn’t fell within the established 
range (±2.5%). This was due to the non negligible differences between this analyte, 
whose alkyl chain is constituted by 4 carbon atoms, and the internal standard to which 
it was associated (13C4-PFOS, whose chain presents 8 carbon atoms), resulting in PFBS 
having an extremely shorter and highly variable retention time. This could probably be 
solved with the adoption of labeled PFBS as internal standard. 
No problem was observed for the relative ion intensity, with CV% values resulting 
lower than the maximum allowed tolerance for all compounds.  
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Linearity 
Coefficient of determination (R2) and slope (a) values obtained from the injection of 
calibration curves prepared for each type of milk are shown in Tables 4.2, 4.3 and 4.4. 
Results were very satisfying, with R2 values >0.99 in almost all cases; in particular, for 
PFOS and PFOA they were generally around 0.999 even in LC-MS/MS. 
As for FOSA, significantly lower values were observed in LC-MS/MS compared to LC-
HRMS. Also in this case, the reason was that the labeled internal standard 13C4-FOSA 
wasn’t available in the laboratory at the time when this experiment was conducted. 
Analyte 
LC-MS/MS signal 1 LC-MS/MS signal 2 LC-HRMS 
R² a R² a R² a 
PFBA 0.9989 2.00 n/a n/a 0.9988 1.81 
PFPA 0.9996 0.48 n/a n/a 0.9988 3.20 
PFBS 0.9791 0.01 0.9995 0.06 0.9914 1.55 
PFHxA 0.9998 0.81 0.9961 0.03 0.9962 1.75 
PFHpA 0.9982 1.68 0.9952 0.08 0.9975 1.78 
PFHxS 0.9971 1.00 0.9920 3.69 0.9999 2.33 
PFHpS 0.9996 0.04 0.9968 0.09 0.9988 1.73 
PFOA 0.9979 2.98 0.9963 0.80 0.9997 2.01 
PFNA 0.9996 1.60 0.9982 0.12 0.9999 1.60 
PFOS 0.9963 0.09 0.9996 0.05 0.9998 1.98 
PFDA 0.9993 1.65 0.9933 0.06 0.9998 1.44 
PFDS 0.9950 0.06 0.9950 0.03 0.9323 0.73 
PFUnA 0.9968 0.16 n/a n/a 0.9979 1.59 
PFDoA 0.9978 1.56 0.9987 0.13 1.000 1.52 
PFOSi 0.9996 7.08 0.9950 0.40 0.9999 2.29 
FOSA 0.9758 0.02 n/a n/a 0.9998 4.22 
Table 4.2 Regression parameters of calibration curves in cow milk  
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Analyte 
LC-MS/MS signal 1 LC-MS/MS signal 2 LC-HRMS 
R² a R² a R² a 
PFBA 0.9985 1.89 n/a n/a 0.9997 1.69 
PFPA 0.9998 0.50 n/a n/a 0.9995 2.74 
PFBS 0.9968 0.02 0.9961 0.07 0.9930 1.33 
PFHxA 0.9975 0.89 0.9915 0.04 0.9894 1.44 
PFHpA 0.9997 1.57 0.9995 0.07 0.9990 1.64 
PFHxS 0.9988 1.16 0.9955 3.76 0.9997 2.34 
PFHpS 0.9936 0.04 0.9963 0.10 0.9992 1.73 
PFOA 0.9984 3.05 0.9990 0.82 0.9995 2.07 
PFNA 0.9998 1.67 0.9990 0.12 0.9997 1.59 
PFOS 0.9916 0.09 0.9924 0.05 0.9998 2.01 
PFDA 0.9997 1.67 0.9950 0.07 0.9994 1.46 
PFDS 0.9929 0.07 0.9809 0.05 0.9915 1.49 
PFUnA 0.9983 0.16 n/a n/a 0.9997 1.63 
PFDoA 0.9997 1.61 0.9878 0.12 0.9994 1.50 
PFOSi 0.9998 7.12 0.9972 0.42 0.9995 2.29 
FOSA 0.9832 0.04 n/a n/a 0.9992 4.24 
Table 4.3 Regression parameters of calibration curves in human breast milk  
Analyte 
LC-MS/MS signal 1 LC-MS/MS signal 2 LC-HRMS 
R² a R² a R² a 
PFBA 0.9932 2.06 n/a n/a 0.9980 1.75 
PFPA 0.9995 0.53 n/a n/a 0.9991 2.97 
PFBS 0.9992 0.02 0.9986 0.07 0.9928 1.99 
PFHxA 0.9970 0.94 0.9902 0.04 0.9945 1.82 
PFHpA 0.9953 1.88 0.9870 0.09 0.9953 1.82 
PFHxS 0.9835 1.18 0.9956 3.23 0.9998 2.33 
PFHpS 0.9993 0.04 0.9948 0.09 0.9996 2.08 
PFOA 0.9977 3.30 0.9961 0.91 0.9999 2.05 
PFNA 0.9997 1.68 0.9924 0.13 0.9999 1.65 
PFOS 0.9994 0.09 0.9991 0.04 0.9998 2.00 
PFDA 0.9988 1.70 0.9941 0.07 0.9999 1.49 
PFDS 0.9953 0.05 0.9943 0.02 0.9882 0.40 
PFUnA 0.9982 0.13 n/a n/a 0.9993 1.73 
PFDoA 0.9989 1.68 0.9855 0.11 0.9997 1.52 
PFOSi 0.9992 7.57 0.9980 0.48 0.9998 2.28 
FOSA 0.9222 0.01 n/a n/a 0.9921 4.81 
Table 4.4 Regression parameters of calibration curves in powder milk  
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Limits of detection 
Predictably, due to its higher sensitivity, the LC-HRMS system showed lower limits of 
detection, varying between 0.002 and 0.025 ng/mL (see Table 4.5). 
Concerning PFOS and PFOA, LOD resulted identical with the two instruments for the 
former (0.005 ng/mL), while for the latter it was slightly lower with the LTQ-Orbitrap™ 
system (0.002 ng/mL against 0.010 ng/mL). These values are extremely significant in 
consideration of the levels of contamination likely to be found in milk. 
For some compounds the obtained values were not so good, as for PFUnA, whose limit 
of detection is affected by the presence of an interferent with the same retention 
time, as previously mentioned. 
Analyte 
LC-MS/MS LC-HRMS 
Analyte 
LC-MS/MS LC-HRMS 
ng/mL ng/mL ng/mL ng/mL 
PFBA 0.040 0.015 PFNA 0.010 0.005 
PFPA 0.100 0.025 PFOS 0.005 0.005 
PFBS 0.050 0.002 PFDA 0.010 0.010 
PFHxA 0.025 0.015 PFDS 0.025 0.010 
PFHpA 0.025 0.010 PFUnA 0.040 0.025 
PFHxS 0.020 0.003 PFDoA 0.050 0.025 
PFHpS 0.010 0.002 PFOSi 0.010 0.002 
PFOA 0.010 0.002 FOSA 0.050 0.025 
Table 4.5 Limits of detection of the two instruments 
 
Recovery 
Although the use of internal standards significantly increases the reliability of the 
results, extraction recoveries were evaluated to assess the efficiency of the extraction 
procedure, giving satisfying results. 
Measured values were between 30 and 111%, with mean recoveries varying from 69 
to 87%. Concerning PFOS and PFOA, the obtained values were in the ranges 56-95% 
and 69-89%, respectively. 
The results for each of the 3 matrices are reported in the table presented on the next 
page.  
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Analyte 
Cow milk (%) Human breast milk (%) Powder milk (%) 
LC-MS/MS LC-HRMS LC-MS/MS LC-HRMS LC-MS/MS LC-HRMS 
PFBA 75 73 92 97 68 66 
PFPA 85 82 85 97 83 87 
PFBS 92 90 99 106 87 92 
PFHxA 91 88 85 96 81 88 
PFHpA 89 81 74 84 81 89 
PFHxS 82 89 83 87 101 96 
PFHpS 92 92 69 76 86 90 
PFOA 84 86 69 77 88 89 
PFNA 84 86 58 61 82 85 
PFOS 95 89 56 57 91 89 
PFDA 83 86 61 55 92 87 
PFDS 89 78 38 30 88 86 
PFUnA 85 86 48 51 93 85 
PFDoA 87 82 59 51 83 83 
PFOSi 86 81 58 56 74 90 
FOSA 57 54 69 35 111 48 
Table 4.6 Extraction recoveries in milk, expressed as percentages 
 
Precision 
Coefficients of variation were globally very good on both systems (see Table 4.7, for 
the LC-MS/MS instrument the most abundant transition was considered). 
In particular, for PFOS and PFOA they ranged between 1.1-20.8% and 1.0-5.5%, 
respectively. Moreover, except for PFDS and FOSA, all compounds showed values 
lower than 20.4% in samples fortified at 0.5 ng/mL and up to 30.3% in milk spiked at 
0.1 ng/mL. 
As it can be observed, compounds which were associated to the correspondent 
labeled internal standard generally presented very low CV%, proving that the use of 
molecules with highly similar characteristics and behaviors allows to significantly 
reduce response variability. 
This aspect explains the poor results shown by the previously mentioned PFDS and 
FOSA, whose internal standards were not available at the time of validation; however, 
the LC-HRMS system demonstrated good repeatability even for FOSA. 
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As for PFBA, the decreased precision reported in cow and powder milk samples spiked 
at 0.1 ng/mL can depend on the already described difficulties in the separation and 
detection of this compound, being extremely rapidly eluted. 
In general, the higher precision observed in human breast milk was probably due to 
the fact that analysis in this matrix were conducted on a pool and not on individual 
samples. 
Analyte 
Cow + powder milk 
CV% (0.1 ng/mL, n=4+4) 
Cow + powder milk 
CV% (0.5 ng/mL, n=4+4) 
Human breast milk 
CV% (0.5 ng/mL, n=8) 
LC-MS/MS LC-HRMS LC-MS/MS LC-HRMS LC-MS/MS LC-HRMS 
PFBA 22.8 25.8 8.3 3.0 8.6 3.4 
PFPA 5.74 4.2 7.1 5.7 4.2 3.0 
PFBS 16.2 15.7 8.1 8.8 2.0 7.3 
PFHxA 9.9 13.9 6.6 6.4 5.0 18.0 
PFHpA 5.4 8.0 4.3 1.7 4.7 9.5 
PFHxS 7.8 1.6 8.0 1.7 8.3 6.0 
PFHpS 7.4 8.3 8.9 6.5 4.7 7.0 
PFOA 5.5 2.9 2.9 1.0 3.1 1.4 
PFNA 7.5 1.1 3.8 1.2 4.4 1.8 
PFOS 20.8 3.7 7.7 1.3 4.6 1.1 
PFDA 4.8 3.6 3.3 1.1 4.1 1.2 
PFDS 50.9 50.1 34.0 41.3 11.6 17.7 
PFUnA 28.8 4.9 20.4 1.7 6.3 1.9 
PFDoA 15.9 30.3 9.2 6.7 4.5 2.8 
PFOSi 10.9 1.6 4.4 1.0 4.8 1.6 
FOSA 23.1 8.3 51.3 4.5 53.7 4.2 
Table 4.7 Precision (CV%) in milk, calculated in cow and powder milk spiked at 0,1 and 0.5 
ng/mL and in human breast milk spiked at 0.5 ng/mL 
 
Trueness 
The 2 milk samples analyzed showed satisfying results: deviations of 13.8% and 11.8% 
were measured for PFOS, while for PFOA  they were of 21.9% and 25.8%. 
In Tables 4.8 and 4.9, trueness data for the monitored compounds, obtained 
comparing concentrations measured in LC-HRMS to those reported in the international 
ring test, are shown. 
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Analyte 
Reported values Measured values 
Median 
(ng/mL) 
SD 
(ng/mL) 
Conc. 
(ng/mL) 
Bias 
(%) 
PFHpA 0.007 0.006 0.005 28.6 
PFOA 0.146 0.137 0.114 21.9 
PFHxS 0.086 0.042 0.116 34.9 
PFOS 0.094 0.102 0.081 13.8 
Table 4.8 Comparison between measured values and other labs median values in the human 
breast milk sample from Sweden 
Analyte 
Median values Measured values 
Median 
(ng/mL) 
SD 
(ng/mL) 
Conc. 
(ng/mL) 
Bias 
(%) 
PFOA 0.066 0.080 0.049 25.8 
PFOS 0.051 0.245 0.045 11.8 
Table 4.9 Comparison between measured values and other labs median values in the human 
breast milk sample from Germany 
 
As for the analysis of the certified serum, the deviations of the mean measured 
concentrations fell in the range indicated by InterCal. In particular, PFOS and PFOA 
showed a bias of 0.7% and 15.7%, respectively. 
Analyte 
Reported values Measured values 
Mean 
(ng/mL) 
SD 
(ng/mL) 
Mean 
(ng/mL) 
Bias 
(%) 
PFHpA 0.318 0.405 0.544 71.1 
PFOA 2.976 0.634 0.114 15.7 
PFNA 0.815 0.233 0.116 10.9 
PFDA 0.225 0.078 0.116 9.0 
PFHxS 3.281 0.804 0.116 13.9 
PFOS 9.952 3.294 0.081 0.7 
Table 4.10 Comparison between measured values and reported concentrations of the certified 
serum sample (NIST SRM 1957) 
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Uncertainty 
Measure uncertainty was evaluated for PFOS and PFOA correlating various factors 
resulting from the validation process, as described in Section 3.1.5; it was estimated 
only on the LC-HRMS system, since it showed better performances. 
Concerning uncertainty in trueness, it was evaluated on the basis of the data obtained 
for milk, being the range of concentrations of certified serum significantly different. 
Sample n PFOS CV (%) PFOA CV (%) 
Cow + powder milk (0.1 ng/mL) 8 3.7 2.9 
Cow + powder milk (0.5 ng/mL) 8 1.3 1.0 
Human breast milk (0.5 ng/mL) 8 1.1 1.4 
Human breast milk (0.1 ng/mL) 5 7.3 11.0 
Human breast milk (0.25 ng/mL) 5 0.6 1.2 
Human breast milk (0.75 ng/mL) 5 1.4 2.0 
            3.2 4.2 
Table 4.11 Uncertainty in precision 
Sample PFOS bias (%) PFOA bias (%) 
Ring test sample (Sweden) 13.8 21.9 
Ring test sample (Germany) 11.8 25.8 
          12.8 23.8 
Table 4.12 Uncertainty in trueness 
Standard solution purity 
(according to Wellington Labs) 
PFOS (%) PFOA (%) 
>98 >98 
        1.2 1.2 
Table 4.13 Uncertainty in trueness 
Combining the uncertainty factors expressed in the above tables, relative combined 
uncertainty resulted of 13.2% for PFOS and 24.2% for PFOA.  
Based on these values, final uncertainty (95% confidence interval) in LC-HRMS was 
calculated equal to 26.5 and 48.5%, respectively for PFOS and PFOA. Considering the 
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extremely low levels at which these compounds are found in milk (<1 ng/mL), results 
were judged satisfying. 
In conclusion, the described method for the analysis of 16 different PFCs was 
successfully validated in compliance with current European guidelines, demonstrating 
very good performances with both LC-MS/MS and LC-HRMS systems. However, the 
latter showed higher sensitivity and specificity, and resulted more suitable for those 
compounds presenting a difficult and unspecific fragmentation, since the extracted 
mass signal corresponds unambiguously to that of the target analyte while MS/MS 
transitions can be common to those of interfering substances. 
PFOS and PFOA, the two most important analytes of the group, showed extremely 
good results in all the considered parameters, but also for the majority of the other 
target molecules the obtained values were satisfying.  
In particular, the very low limits of detection measured for most of the compounds are 
suitable with the concentrations that are generally measured in milk and comparable 
to those reported by the most performing methods described in literature. 
Finally, the adoption of a wider range of specific internal standards (when available) 
could lead to a further improvement of the performances of the method. 
 
 
4.1.4  Samples analysis 
 
All the available samples at the time of validation were processed applying the 
developed method, in order to assess perfluorinated compounds contamination in the 
three types of milk. 
The choice of preparing for each day of analysis a calibration curve in ultrapure water 
was due to the difficulty in finding milk containing negligible PFCs levels: instead of 
risking to affect quantifications with an unreliable matrix-matched calibration curve, it 
was preferred to prepare one processing a non-milk solution, spiked at the same 
previously described levels, after verification of its non-contamination.  
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4.1.4.1  Human breast milk from France 
The analysis of the 11 samples available at the time of validation highlighted the 
predominance of PFOS and PFOA in human breast milk. They were found in all the 
samples, with mean concentrations of 139 pg/mL (median 127 pg/mL) for PFOS and of 
121 pg/mL (median 116 pg/mL) for PFOA. Measured levels ranged from 32 to 433 
pg/mL for the former, and from 43 to 297 pg/mL for the latter. 
Even if at lower concentrations, PFHxS and PFNA were detected at quantifiable levels 
with a frequency of 91% and 82%, respectively. PFHxS highest concentration was 77 
pg/mL, while for PFNA it was 69 pg/mL. 
PFBA, PFPA and PFDA were found in some samples at trace levels: in one case PFBA 
was quantified at 33 pg/mL and PFDA at 20 pg/mL. 
These data were obtained with the LC-HRMS system, but comparing PFOS and PFOA 
concentrations with those resulting from the analysis in LC-MS/MS a strong correlation 
was observed (0.91 and 0.87, respectively). 
 
4.1.4.2  Cow milk from France 
PFCs levels observed in the analyzed cow milk samples resulted significantly lower 
compared to those found in human breast milk.  
PFOS was quantified in 4 out of 9 samples, with the highest measured concentration 
equal to 40 pg/mL, and detected at trace levels in 2 cases; slightly lower values were 
reported for PFOA, which was quantifiable in only 3 samples, at a maximum 
concentration of 23 pg/mL, and detected with just a weak signal in 1 further sample. 
The higher sensitivity of LC-HRMS allowed to detect PFOA at levels that couldn’t 
otherwise have been observed with the LC-MS/MS instrument. 
In addition, PFHxS and PFNA were detected in few cases, at levels up to 11 and 24 
pg/mL, respectively. All the other target analytes weren’t found, except for one sample 
presenting trace levels of PFDA. 
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4.1.4.3  Powder milk from France 
A part for one sample, for which a PFOS concentration of 17 pg/mL was reported, in 
the few powder milks analyzed PFCs were absent or detected at trace levels (PFOS, 
PFOA and PFNA). 
 
Measured levels of PFCs which showed relevant presence in the processed milk 
samples are summarized in the following table. 
Sample PFOS PFOA PFHxS PFNA 
H
u
m
an
 b
re
as
t 
m
ilk
 
A 32 43 Traces Traces 
B 152 142 26 26 
C 140 115 21 19 
D 127 152 77 69 
E 105 94 20 23 
F 71 66 18 22 
G 48 53 16 Traces 
H 209 155 24 38 
I 108 101 12 20 
J 433 297 50 30 
K 92 116 28 25 
C
o
w
 m
ilk
 
L 37 23 <LOD <LOD 
M Traces <LOD <LOD <LOD 
N 25 <LOD 11 24 
O <LOD <LOD Traces <LOD 
P 19 16 <LOD Traces 
Q <LOD <LOD <LOD <LOD 
R 40 Traces <LOD Traces 
S 21 17 <LOD 16 
T Traces <LOD <LOD <LOD 
P
o
w
d
er
 U Traces <LOD <LOD <LOD 
V <LOD Traces <LOD <LOD 
W 17 Traces <LOD Traces 
X <LOD <LOD <LOD <LOD 
Table 4.14 Concentrations (pg/mL for human breast and cow milk; pg/g for powder milk) of 
the detected PFCs analyzing milk samples with the LC-HRMS system. “Traces” means that 
value resulted >LOD and <LOQ (calculated as 3 times the LOD)  
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4.2  PFCs analysis at CABA-Lab 
 
The developed method for PFCs detection in milk was transferred to the CABA-Lab 
laboratory, adapting it to the UHPLC-MS/MS system of which that structure is 
provided. During this first experiment, it was chosen to reduce the range of target 
compounds to PFOS and PFOA, being the two most important PFCs. 
The good performances obtained after the optimization of the analytical procedure 
allowed to conduct a preliminary monitoring on the levels of contamination by these 
pollutants in several cow milk and human breast milk samples collected in Italy. 
 
 
4.2.1  Method transfer 
 
4.2.1.1  Instrumental analysis 
The most critical aspect of the transfer concerned the liquid chromatography system. 
The method was in fact initially developed on a HPLC (high performance liquid 
chromatography) instrument, while analysis at CABA-Lab were conducted on a UHPLC 
(ultra high performance liquid chromatography) system. The latter is the result of the 
recent technological implementations in liquid chromatography, which led to produce 
stationary phases containing much smaller particles and mechanical components able 
to operate at higher pressure, allowing a more efficient chromatographic separation 
and significantly reduced injected volume and analysis time. 
In order to reproduce as much as possible the chromatographic conditions, a Waters 
Acquity BEH C18 column was chosen, having very similar properties to the column 
used for HPLC separation at LABERCA; moreover, the same column was employed also 
in most of the few available studies on PFCs detection in milk through UHPLC 
instruments (Haug et al., 2010a; Liu et al., 2010; Kannan et al., 2011). 
Ammonium acetate 20 mM (A) and methanol (B) were kept as mobile phases, with a 
gradient that similarly started from 70% A and 30% B, switching to 100% B and then 
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going back to the initial conditions. Thanks to the performances of the UHPLC system, 
the analysis time was significantly reduced from 20 to 5 min: in this way it’s thus 
possible to process a larger number of samples, which can be useful in case of large 
scale monitoring. 
Concerning the detector part, negative electrospray ionization was employed and all 
the parameters of the mass spectrometer were optimized using the standard solutions 
of the two analytes and of their corresponding labeled compounds.  
For PFOS, the parent-to-parent transition (498.64 > 498.64 m/z) was chosen for 
quantification, since on this instrument it showed a slightly better signal compared to 
the 498.64 > 80.00 m/z transition previously used. 
 
4.2.1.2  Extraction procedure 
Concerning samples extraction, the developed procedure was reproduced following all 
the steps and critical points previously underlined. 
To reduce potential interferences, polypropylene tubes and vials were preferred to 
glass-made ones, and Teflon septa and caps were avoided. 
In order to prevent alterations, all collected samples were stored in the freezer at          
-18 °C before processing; similarly, prior to injection vials were stored away from light 
in the refrigerator at 4 °C and kept at 6 °C during analysis. 
A slightly higher amount of internal standards was added when preparing both 
standard solutions and samples, without affecting the results in any way. 
Unlike previously described for the analysis conducted at LABERCA, it wasn’t employed 
the external standard (fluorometholone, added just before sample injection) since it 
was not considered necessary. 
 
4.2.1.3  Performances of the transferred method 
Some tests were performed to verify the performances of the transferred procedure 
before employing it for the analysis of milk samples. 
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The analysis of fresh cow milk purchased from a local store was conducted in order to 
verify if it was contaminated with PFOS and PFOA: it didn’t contain any of the analytes, 
demonstrating the specificity of the method (chromatograms of the detected signals 
for PFOS and PFOA in that sample are reported in Figures 4.8 and 4.9). 
 
Figure 4.8 Chromatogram of the diagnostic ion of PFOS in a blank cow milk sample 
 
Figure 4.9 Chromatogram of the diagnostic ion of PFOA in a blank cow milk sample 
Fractions of this milk were subsequently fortified at different concentrations of PFOS 
and PFOA in order to obtain a matrix-matched calibration curve. The injection of the 
curve proved the good linearity of the method, with R2 values greater than 0.99 for 
both PFOS and PFOA, as shown in Figures 4.10 and 4.11.  
Moreover, limits of detection, calculated as the concentrations showing a signal-to- 
noise ratio of 3, were extremely good. For PFOS, LOD was equal to that obtained 
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during method validation at LABERCA (0.005 ng/mL); as for PFOA, it was of 0.008 
ng/mL, resulting comprised between those of the two previously used instruments. 
These values were therefore comparable to those of the most sensitive methods in 
literature and compatible with concentrations potentially measured in milk. 
 
Figure 4.10 Matrix matched calibration curve for PFOS 
 
Figure 4.11 Matrix matched calibration curve for PFOA 
 
 
4.2.2  Samples analysis 
 
The preliminary monitoring consisted in the analysis of 22 cow milk samples and 13 
human breast milk samples, previously listed in Section 3.2.1. As described in Section 
3.2.6, freshly prepared calibration curves in water (which confirmed the excellent 
linearity of the method) allowed to perform accurate quantifications.  
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4.2.2.1  Human breast milk from Italy 
Table 4.15 shows the concentrations of PFOS and PFOA found in human breast milk. 
Both compounds were detected at quantifiable levels (≥15 pg/mL for PFOS, ≥24 pg/mL 
for PFOA) in all the analyzed samples. 
Sample PFOS (pg/mL) PFOA (pg/mL) 
A 44 25 
B 98 103 
C 102 65 
D 86 94 
E 68 84 
F 76 50 
G 63 33 
H 143 181 
I 40 63 
J 92 57 
K 106 77 
L 60 62 
M 42 24 
Table 4.15 PFOS and PFOA concentrations in human breast milk samples from Italy 
PFOS mean concentration was 78 pg/mL (median 76 pg/mL), with values comprised 
between 40 and 143 pg/mL. 
In Figure 4.12 the chromatograms of the most representative transition of PFOS 
(498.64 > 498.64 m/z) and of the internal standard M-PFOS (502.86 > 502.86 m/z) in a 
human breast milk sample are presented. 
As for PFOA, measured levels were in the range 24-281 pg/mL, with a mean 
concentration of 71 pg/mL (median 63 pg/mL). 
Figure 4.13 shows the signals obtained for the diagnostic ions of PFOA (412.82 > 
368.97 m/z) and of its correspondent internal standard M-PFOA (416.93 > 372.00 m/z) 
analyzing a human breast milk sample. 
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Figure 4.12 Chromatograms of the human breast milk sample “C”  
(PFOS concentration = 102 pg/mL): diagnostic ions for PFOS and M-PFOS 
 
 
 
Figure 4.13 Chromatograms of the human breast milk sample “L”  
(PFOA concentration = 181 pg/mL): diagnostic ions for PFOA and M-PFOA 
PFOS 
M-PFOS 
PFOA 
M-PFOA 
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4.2.2.2  Cow milk from Italy 
PFOS and PFOA levels measured in cow milk samples are reported in Table 4.16. 
Concentrations higher than the LOD but lower than the LOQ (calculated as 3 times the 
LOD) were reported as traces. 
Sample PFOS (pg/mL) PFOA (pg/mL) 
A Traces <LOD 
B 26 25 
C 29 24 
D Traces Traces 
E Traces Traces 
F 22 32 
G 21 Traces 
H Traces Traces 
I 15 Traces 
J 31 27 
K 32 29 
L 17 <LOD 
M 18 Traces 
N 16 <LOD 
O 15 <LOD 
P 26 Traces 
Q 67 Traces 
R Traces Traces 
S Traces Traces 
T 16 Traces 
U 22 Traces 
V 25 <LOD 
Table 4.16 PFOS and PFOA concentrations in cow milk samples from Italy 
As it can be seen, PFOS was the predominant substance, having been always detected 
at least at trace levels. In 73% of samples it was found with concentrations in the range 
15-67 pg/mL, with an arithmetic mean of 25 pg/mL (median 22 pg/mL). The most 
contaminated sample resulted a raw milk purchased at a local vending machine. 
PFOA was present in almost all samples, but could only be quantified in 6 out of 22 
(27%). The mean concentration was 27 pg/mL, with a maximum level of 32 pg/mL, 
measured in a pasteurized whole milk sample.  
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4.3  Data interpretation 
 
4.3.1  Human breast milk 
 
A comparison between PFCs levels in the human breast milk samples processed during 
the present study (collected in 2010) and those reported in other works available in 
literature so far is presented in the table on the next page.  
Even if the various analytes gave a variable contribution to total PFCs content, PFOS 
was the most detected compound, being found in almost all samples, with median 
concentrations around 100 pg/mL but reaching also values in the order of ng/mL in 
some cases. PFOA was measured at levels generally slightly lower compared to PFOS 
and showed great variability in terms of frequency among the different studies, 
probably partially due to the fact that also limits of detection for this analyte varied 
significantly. In particular, in the case of the present work, the high sensitivity of the 
employed instruments allowed to confirm its presence in all the samples, even at very 
low concentrations. PFHxS was often detected as well, in some cases even in a greater 
percentage of samples and at higher concentrations than PFOA. No correlation was 
observed between the concentrations of the various compounds. 
Although during this research project only a limited number of samples were analyzed, 
these data are among the first information available on the presence of these 
contaminants in human breast milk from France and Italy. 
A research group at LABERCA laboratory recently analyzed 30 samples of French 
human breast milk employing the analytical method here described and performing 
analysis in LC-HRMS, reporting the presence of PFOS and PFOA in 100% of the samples 
and at levels in line with previous data (Kadar et al., 2011). 
In Italy, Guerranti et al. reported in 2011 the results of an investigation on PFOS and 
PFOA presence in human breast milk form the Siena area (Italy), which gave out of 
average results: PFOS concentrations ranged between the LOD of 0.5 ng/mL and 4.28 
ng/mL, while PFOA was found in 1 case at 7.78 ng/mL.  
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Country # 
PFOS 
(pg/mL) 
PFOA 
(pg/mL) 
PFHxS 
(pg/mL) 
PFNA 
(pg/mL) 
Reference 
France 11 
32-433(127) 
[100%] 
43-297(116) 
[100%] 
<12-77(22.5) 
[91%] 
<19-69(25) 
[82%] Present 
study 
Italy 13 
40-143(76) 
[100%] 
24-281(63) 
[100%] 
- - 
France 30 
24-171(74) 
[100%] 
18-102(57) 
[100%] 
0 
[0%] 
- 
Kadar et al. 
(2011) 
Spain 20 
<28-865(84) 
[95%] 
<21-907(nd) 
[40%] 
- 
0 
[0%] 
Llorca et al. 
(2010) 
Germany 203 
<50-284(82) 
[55%] 
<80-610(137) 
[56%] 
<160-180(nd) 
[1%] 
0 
[0%] 
Bernsmann and 
Fürst (2008) 
Germany 57 
28-309(119) 
[100%] 
<201-460(nd) 
[19%] 
- - 
Völkel et al. 
(2008) 
Germany 201 
<30-110(40) 
[72%] 
<150-250(nd) 
[2%] 
<20-30(nd) 
[3%] 
- 
Fromme et al. 
(2010) 
Hungary 13 
96-639(330) 
[100%] 
0 
[0%] 
- - 
Völkel et al. 
(2008) 
Sweden 12 
60-470(166) 
[100%] 
<209-492(nd) 
[6%] 
31-172(70) 
[100%] 
<5-20(nd) 
[17%] 
Kärrman et al. 
(2007) 
USA 45 
<32-617(106) 
[96%] 
<30-161(36) 
[89%] 
<12-64(12) 
[51%] 
<5-18(7) 
[64%] 
Tao et al. 
(2008b) 
China 19 
45-360(110) 
[100%] 
47-210(110) 
[100%] 
4-100(11) 
[100%] 
6-62(18) 
[100%] 
So et al. 
(2006) 
China 24* 
6-137(49) 
[100%] 
<LOQ-814(35) 
[88%] 
<LOQ-15(6) 
[83%] 
6-76(13) 
[100%] 
Liu et al. 
(2010) 
Japan 51 
8-401(nd) 
[100%] 
<LOQ-339(nd) 
[44%] 
<LOQ-25(nd) 
[64%] 
<LOQ-150(nd) 
[86%] 
Nakata et al. 
(2007) 
Japan 24 
140-523(196) 
[100%] 
<43-170(67) 
[92%] 
<2-18(6) 
[92%] 
<9-24(nd) 
[13%] 
Tao et al. 
(2008a) 
Malaysia 13 
49-350(111) 
[100%] 
<43-90(nd) 
[23%] 
<2-13(7) 
[85%] 
<9-15(nd) 
[8%] 
Tao et al. 
(2008a) 
Philippines 24 
27-208(104) 
[100%] 
<43-183(nd) 
[29%] 
<2-59(13) 
[92%] 
<9-25(nd) 
[17%] 
Tao et al. 
(2008a) 
Indonesia 20 
25-256(67) 
[100%] 
0 
[0%] 
<2-6(nd) 
[45%] 
<9-135(nd) 
[5%] 
Tao et al. 
(2008a) 
Vietnam 40 
17-393(59) 
[100%] 
<43-89(nd) 
[3%] 
<2-27(4) 
[73%] 
<9-11(nd) 
[5%] 
Tao et al. 
(2008a) 
Cambodia 24 
17-327(40) 
[100%] 
<43-132(nd) 
[4%] 
<2-19(nd) 
[13%] 
<9-12(nd) 
[13%] 
Tao et al. 
(2008a) 
India 39 
<11-120(39) 
[85%] 
<43-335(nd) 
[8%] 
<2-13(nd) 
[36%] 
0 
[0%] 
Tao et al. 
(2008a) 
Developing 
countries 
19 
<9-65(nd) 
[84%] 
<80-192(nd) 
[31%] 
<9-14(nd) 
[11%] 
<25-55(nd) 
[21%] 
Kärrman et al. 
(2011) 
Table 4.17 Comparison between measured levels of the most found PFCs in human breast milk 
samples and other published data: range, (median) and [frequency] 
*  24 pooled samples, consisting of 1237 individual samples  
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Taking into account the primipara/multipara status of the Italian donors, it was 
observed that mean concentration for PFOS in milk from primiparous mothers was 85 
pg/mL (median 81 pg/mL), while in that from multiparas it decreased to 68 pg/mL 
(median 60 pg/mL). Similarly, PFOA mean level in primiparas was 79 pg/mL (median 75 
pg/mL), decreasing to 57 pg/mL (median 62 pg/mL) in women nursing for at least the 
second time. Figure 4.14 resumes graphically the described results. 
Even if the number of analyzed samples is rather low to draw statistically significant 
conclusions, it can be observed a trend for both compounds to decrease in breast milk 
after the first lactation, as reported also by Tao et al. (2008b). This suggests the role of 
breast feeding as a route of gradual elimination of perfluorinated compounds, which 
entails a potentially higher exposure for first-born infants. 
 
Figure 4.14 Graphic representation of measured levels of PFOS and PFOA in human breast milk 
samples from Italy  
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Based on the data obtained for France and Italy, PFOS and PFOA daily intakes (DIs) for 
newborns, whose diet consists almost exclusively of breast milk, were calculated using 
this formula (expressed as ng/kg b.w./day): 
             
                                                    
               
 
The resulting values, considering an average milk consumption of 780 mL/day during 
the first 6 months of infant’s life, with a mean body weight of 5 kg (SCF, 2003), are 
reported in Table 4.18. For each compound, DIs were calculated on the basis of the 
lowest, highest and mean concentrations measured in the two Countries.  
Country 
PFOS PFOA 
Min DI Max DI Mean DI Lower DI Upper DI Mean DI 
France 4.99 67.5 21.53 6.71 46.33 18.88 
Italy 6.24 22.31 12.17 3.74 43.84 11.08 
Table 4.18 PFOS and PFOA daily intake (ng/kg b.w./day)  
Daily intakes were then related to TDIs suggested by EFSA (150 ng/kg b.w. for PFOS, 
1500 ng/kg b.w. for PFOA) in order to estimate the risk index (RI) for newborns: 
            
  
   
 
Country 
PFOS PFOA 
Min RI Max RI Mean RI Lower RI Upper RI Mean RI 
France 0.03 0.45 0.14 <0.01 0.03 0.01 
Italy 0.04 0.15 0.08 <0.01 0.03 0.01 
Table 4.19 Risk index for PFOS and PFOA 
Higher risk index values were observed for PFOS, but even the maximum RIs were 
significantly lower than 1, meaning that no toxicological risk should be expected to 
derive from PFOS and PFOA intake through breastfeeding. At the same time, it must be 
also observed that RIs are based on TDIs, which for these contaminants have not yet 
been defined, existing rather different values suggested by various authorities and 
referred to adult population. Therefore, what the preliminary results of this study 
bring out is that the daily intake of these substances for infants via breast milk seems 
to be several times higher than those reported for adults through diet. 
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These first outcomes suggest the interest in further investigations on the existence of 
potential correlations between PFCs levels in breast milk and mother’s history, not 
only concerning lactation, but taking into account also other possible influencing 
factors, such as age at delivery, length of the interval between two deliveries, diet 
habits and place of origin, in order to better define the real exposure for newborns. 
 
 
4.3.2  Cow milk 
 
In general, according to data available in literature, PFCs concentrations measured in 
cow milk are significantly lower than those found in human breast milk. This was 
confirmed also by the results of both the investigations performed in the present work. 
One possible explanation for this difference is that these contaminants have a reduced 
possibility to accumulate, in terms of years of life before the first lactation, in bovines 
compared to humans. Moreover, the continuous lactation, interrupted only by the dry 
period, leads to an almost constant elimination over time in these animals. 
In Table 4.20, the results of the current experiment are compared to data reported in 
the previously mentioned works on cow milk. 
Country # 
PFOS 
(pg/mL) 
PFOA 
(pg/mL) 
PFHxS 
(pg/mL) 
PFNA 
(pg/mL) 
PFHpA 
(pg/mL) 
Reference 
France 9 
<19-40 
[56%] 
<16-23 
[33%] 
<LOQ-11 
[11%] 
<16-24 
[22%] 
0 
[0%] Present 
Study 
Italy 22 
<15-67 
[73%] 
<24-32 
[27%] 
- - - 
Norway 1 
7 
[100%] 
5 
[100%] 
<LOQ 
[0%] 
<LOQ 
[0%] 
<LOQ 
[0%] 
Haug et al. 
(2010) 
Spain 4 
<19 
[0%] 
<55-58 
[50%] 
- - 
<14-16 
[50%] 
Ericson et al. 
(2008a) 
UK 11 <1000 <1000 - - - 
Mortimer et al. 
(2009) 
USA 12 
<11 
[0%] 
<48 
[0%] 
<1-4 
[67%] 
<2 
[0%] 
<1 
[0%] 
Tao et al. 
(2008a) 
China 84 
<5-695 
[36%] 
<18-178 
[46%] 
- 
<27-476 
[68%] 
<13-312 
[68%] 
Wang et al. 
(2010) 
Table 4.20 Comparison between measured levels of the most found PFCs in cow milk samples 
and other published data: range and [frequency]  
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Measured levels show a certain variability, depending on the Country but often also on 
the sensitivity of the employed methods.  
Although also other PFCs were detected in some cases (PFHxA and PFDA, Haug et al.; 
PFDA and PFUnA, Wang et al.), the global cow milk contamination by these pollutants 
appears negligible. This was recently confirmed also by EFSA, on the basis of the 
results of the European monitoring on perfluoroalkylated substances in food, reporting 
PFOS presence in only 2 sheep milk samples out of 121 analyzed samples (including 
cow, sheep and goat milk). However, in the cited work Mortimer et al. estimated a 
total PFASs upper bound concentration of 11 ng/g. Therefore, further investigations 
are needed in order to ascertain the potential risks deriving from the consumption of 
different types of milk in the various Countries. 
Moreover, surveys should include also cheese and other dairy products, since they 
represent an important component of the diet for most of the population and are 
likely to concentrate PFCs, which seem to have high affinity for proteins. 
Within the monitoring of Italian cow milk samples, no significant correlations were 
observed between the type of milk and its level of contamination by perfluorinated 
compounds. 
 
 
4.3.3  Powder milk 
 
The importance of evaluating potential PFCs contaminations in powder milk is evident 
considering the fact that, sometimes by choice but most of the times by necessity (in 
case of mothers unable to produce milk), it can have a major role in newborns diet. 
Among all the surveys that have been conducted on the presence of these 
contaminants in food, only three included powder milk in the monitored matrices, 
reporting extremely different results. 
After analyzing 21 samples (diluted 1:1 in water) from 5 different brands available in 
the United States, representing 99% of the US market, Tao et al. (2008a) reported 
PFOS presence above the LOQ (10 pg/mL) with a frequency of 24% and a maximum 
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concentration of 11 pg/mL; PFHxS was found in 48% of samples, with measured levels 
lower than 4 pg/mL. 
Higher levels were observed by Wang et al. (2010) within a monitoring on 36 Chinese 
powder milk samples, reporting the presence of PFOS, PFOA and PFNA with 
frequencies of 33, 25 and 22%, respectively. Mean concentration in quantifiable 
samples was 46 pg/g (range <36-482 pg/g) for PFOS, 22 pg/g (<10-175 pg/g) for PFOA 
and 30 pg/g (<54-192 pg/g) for PFNA. 
In the 4 powder milk samples processed in the presented work, only PFOS was 
quantified in one sample (at 17 pg/g), while it was present in some cases at trace 
levels, as well as PFOA and PFNA. 
Comparing the above data, even if a certain variability in the presence of the various 
analytes can be observed, PFCs concentrations result globally about an order of 
magnitude lower than those likely to be found in human breast milk. Therefore, purely 
in terms of exposure for newborns, these results suggest that powder milk may be 
potentially less dangerous for newborns. 
Nevertheless, in the study conducted by Llorca et al. (2010) 3 infant formulas were 
analyzed, showing surprisingly high PFCs concentrations. PFDA was the predominant 
substance, with concentrations between 693 and 1289 pg/g; also PFOS and PFOA 
(ranges 229-1098 and 374-723 pg/g, respectively) were found at relevant levels. 
On the contrary, Fromme et al. could not quantify any of the PFCs monitored in the 4 
different infant formula samples included in their study (Fromme et al., 2010). 
It’s difficult to explain the reasons for such big differences, however when comparing 
this kind of food products, it must be considered that the various items can be 
extremely different from each other in terms of composition (e.g. milk- or soy-based), 
state of conservation (e.g. powder or concentrated liquid) and packaging material (e.g. 
glass, plastic, cardboard). All these factors can therefore translate into different 
amounts of contaminants deriving from various sources. 
However, further data, on a wider range of samples, are needed to draw reliable 
conclusions on perfluorinated compounds presence in this matrix.  
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4.4  PFCs precursors analysis at LABERCA  
 
As previously reported, fluorotelomer alcohols and perfluorooctane sulfonamido 
ethanols have been mainly analyzed in air and house dust, few Authors investigated 
their presence in water as well, but little information is available to this day concerning 
their potential contamination of food items. For this reason, in compliance with what 
expressed by Recommendation 2010/161/EU, a method for the detection of some of 
these PFCs precursors in fish (which is considered the most affected food item by 
perfluoroalkylated substances) was developed. 
Within this work package, various tests were performed also on another group of 
perfluorinated compounds precursors, the so-called PAPS (polyfluoroalkyl phosphate 
surfactants), which were mentioned in the above EU Recommendation as well. These 
compounds were detected in LC-MS/MS, but various problems have been encountered 
trying to optimize their extraction, which needs further experiments, and for this 
reason they will not be discussed in this thesis. 
 
 
4.4.1  Instrumental analysis 
 
Some initial experiments were conducted to detect FOSEs and FTOHs on the               
LC-MS/MS system in negative electrospray mode. Even after the removal of all the 
buffer solutions, acetate adducts were the only detected signals for N-MeFOSE and    
N-EtFOSE, and neither specificity nor sensitivity were satisfying; as for fluorotelomer 
alcohols, they are known to be difficult to ionize in ESI and weren’t detected at all. 
Optimization on GC-MS/MS was therefore preferred. 
The initial tests were performed using a medium-high polarity column (50% phenyl / 
50% dimethylpolysiloxane), but it showed a lack of retention for FTOHs, whose peaks 
overlapped with the solvent front. For this reason it was replaced by a Varian CP-WAX 
57CB column: the extreme inertness of this highly polar column, made of 100% 
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chemically-bonded polyethylene glycol, allowed an accurate separation and very good 
peak shapes for all compounds. 
Pulsed splitless mode was chosen as injection technique, since it combines the 
advantages of splitless, which allows a higher amount of sample to deposit on the 
column resulting in a greater response, and split, which provides better 
chromatographic resolution thanks to a greater number of theoretical plates. 
Also for the ionization technique various options have been weighed up. Electron 
impact (EI), based on a beam of electrons which collide with the vaporized sample 
transforming its molecules in ions, appeared a too strong method especially for FTOHs: 
they were in fact subjected to on-source fragmentations generating small and non-
specific ions. Chemical ionization (CI) was thus tested, in both negative and positive 
mode. In this technique the electron impact is applied to a reagent gas (in this case 
methane) which then interacts with the target molecules, causing a softer ionization 
that results in the formation of pseudo-molecular ions. These species are ions of the 
type [M+H]+ or [M-H]-, depending if a positive or a negative ionization has been 
employed, and tend to be relatively more stable than their corresponding molecular 
ions. As a consequence, their fragmentation is sparse and it’s easier to detect them. In 
this case positive CI was preferred, since it allowed to detect all compounds in full scan 
mode and to produce two specific fragments for each analyte after fragmentation in 
the collision cell. Figure 4.15 and Figure 4.16 show the full scan mass spectrum of N-
EtFOSE and 8:2 FTOH, respectively, obtained after positive chemical ionization. 
 
Figure 4.15 Mass spectrum of N-EtFOSE in full scan GC-(CI+)-MS  
 141 
 
Figure 4.16 Mass spectrum of 8:2 FTOH in full scan GC-(CI+)-MS 
For the unambiguous identification of the compounds, two transitions were monitored 
in MRM mode. The most intense signal was given for all the analytes by a big fragment 
obtained applying a relatively low collision energy (10 V): for example, for N-EtFOSE 
and 8:2 FTOH the observed transitions were 571.7 > 554.0 m/z and 464.6 > 426.7 m/z, 
respectively. Parent-to-parent transitions (obtained with the lowest collision energy, 
equal to 1 V) were used for confirmatory purposes, being preferred to the significantly 
less intense secondary fragments produced with a high collision energy (30 V). 
The following picture shows the peak of the most representative transition and its 
retention time for each compound, analyzed in gas chromatography (using the 
previously mentioned column) coupled to tandem mass spectrometry, operating 
positive chemical ionization and acquiring in multiple reaction monitoring mode. 
 
Figure 4.17 Separation of the diagnostic ions of the 3 FTOHs and the 2 FOSEs monitored. 0.02 
ng injected in GC-(CI+)-MS/MS  
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4.4.2  Optimization of the extraction procedure 
 
The performed preliminary tests aimed at the inclusion of these substances in the 
range of analytes extracted through an already existing procedure developed at 
LABERCA for PFCs in fish. This method is basically an evolution of that proposed by 
Powley et al. (2005), which was based on an extraction with methanol followed by 
graphitized carbon clean up. Here, a further purification through hydrated silica gel 
was added, followed by centrifugation. 
In order to balance the effects of the natural variability deriving from the different 
phases of the extraction procedure, an internal standard for each family was added at 
the beginning of the procedure. In particular, being extremely similar molecules, both 
FOSEs were associated to deuterated N-MeFOSE, while labeled 8:2 FTOH was used for 
the 3 FTOHs. 
Due to the extreme volatility of both FTOHs and FOSEs, it resulted impossible to 
extract them from the samples with this technique without causing their almost total 
evaporation, therefore some changes have been made to try to reduce losses during 
the various concentration steps. Instead of evaporating to dryness, the volume of the 
extracts were just reduced to around 500 µL after the ENVI-Carb™ purification and to 
200 µL before the injection. In addition, decreasing the temperature of the dry bath 
from 45 to 35 °C and applying a more gentle nitrogen flow significantly increased the 
recovery for N-MeFOSE and N-EtFOSE; as for FTOHs, even after these preventive 
measures the efficiency of the extraction remained unsatisfactory. 
To reduce fluorotelomer alcohols losses, some tests using a keeper solvent were 
performed as well, but without improvements. 
The extraction procedure previously described for PFCs in milk was tested on these 
molecules as well but, even if elution profile assays seemed encouraging, the analytical 
results were poor and thus the method was discarded. 
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4.4.3  Performances of the method 
 
The performances of the developed method for N-EtFOSE and N-MeFOSE were 
evaluated through the injection of a 6 levels matrix-matched calibration curve (0, 0.5, 
1, 5, 10 and 50 μg/kg of dry matter). 
Linearity was very good for both compounds, with R2 (coefficient of determination) 
values higher than 0.99, as highlighted in Figure 4.18. 
 
 
Figure 4.18 Calibration curves obtained for N-EtFOSE and N-MeFOSE in a fish sample 
As for the limits of detection, they were evaluated as the concentrations showing a 
signal-to-noise ratio of 3, resulting equal to 0.03 ng/g of wet matter (corresponding to 
0.118 ng/g of dry matter) for N-EtFOSE and 0.04 ng/g of wet matter (0.156 ng/g of dry 
matter) for N-MeFOSE. 
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The chromatograms in Figure 4.19 show the signals obtained monitoring the most 
representative transitions of N-EtFOSE, N-MeFOSE and of their internal standard     
(d7-N-MeFOSE) in a spiked fish sample, demonstrating, besides the sensitivity at this 
level of contamination (0.25 ng/g of wet matter), also the specificity of the signal. 
 
 
 
Figure 4.19 Diagnostic ion chromatograms for N-EtFOSE, N-MeFOSE and d7-N-MeFOSE in a fish 
sample spiked at 0.25 ng/g (2.5 ng/g for d7-N-MeFOSE) of wet matter 
 145 
Absolute extraction recoveries were calculated comparing two samples processed in 
parallel, of which one had been spiked at the beginning and the other at the end of the 
extraction procedure, and resulted between 40 and 50% for both compounds. 
Further tests are needed to confirm the reliability of the method and to evaluate all 
the parameters required for its complete validation. However, a preliminary 
monitoring on 15 fish samples using the described technique has been recently 
performed by Pollono et al. (2011), who reported the presence of N-EtFOSE in certain 
samples at concentrations up to 5 ng/g of wet matter. 
In conclusion, a promising method for perfluorooctane sulfonamido ethanols detection 
in fish was developed, allowing to monitor the presence of these PFOS precursors even 
at trace levels in what is considered the most relevant contributor to perfluoroalkyl 
substances dietary intake. This is a further achievement meeting the requests 
expressed by Commission Recommendation 2010/161/EU on the monitoring of these 
substances in food. 
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5. Conclusions 
 
An efficient method based on liquid chromatography-mass spectrometry for the 
detection of 16 different perfluorinated compounds in milk has been validated in 
accordance with current European regulation guidelines (2002/657/EC) and is 
currently under evaluation for ISO 17025 accreditation. 
The analytical part was optimized at the French laboratory LABERCA and was 
developed in parallel on a HPLC-MS/MS system, which is considered the standard 
solution for PFCs measurement, and on a HPLC-HRMS instrument (the Thermo 
Scientific LTQ-Orbitrap™), which proved to be a good alternative, providing in some 
cases even better performances in terms of specificity and sensitivity. In fact, the 
accurate extracted mass signal obtained with this high resolution detector allowed 
ultra trace level quantification of such a large number of analytes despite their difficult 
and unspecific fragmentation. 
The described method represents a useful instrument for large-scale surveys on the 
contamination of this matrix and was applied to cow, powder and human breast milk 
samples from France to produce a limited and preliminary monitoring. Subsequently, 
the procedure was successfully transferred to the Italian laboratory CABA-Lab and 
employed for a similar pilot survey on PFOS and PFOA levels in cow and human breast 
milk samples collected in Italy.  
The obtained data, among the first produced in these two Countries, resulted in line 
with those of most of the studies available in literature, proving the presence of PFOS 
and PFOA in all the human breast milk samples analyzed, at concentrations (range 30-
400 pg/mL) several times higher than those measured in cow milk. These early results 
thus confirmed the importance of breastfeeding as a major route of exposure for 
infants and were used to perform an evaluation of the risk index, calculated as the 
ratio between the daily intake and the TDI (tolerable daily intake) suggested by EFSA, 
for 0-6 months old subjects, whose diet is constituted almost exclusively by breast 
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milk. Calculated risk indices suggested that there’s apparently no risk related to PFCs 
intake via breastfeeding for newborns, but it must be noticed that a number of 
different TDIs have been proposed for these contaminants and they all referred to the 
adult population. 
Moreover, the analysis of the Italian milk samples, for which the primipara/multipara 
status of the donor was known, suggested that milk produced by mothers 
breastfeeding for the first time was more contaminated, highlighting the role of 
lactation as elimination route. 
In consideration of the above, further investigations on larger numbers of samples are 
needed to completely understand health risks for infants deriving from breast milk 
consumption and to define potential correlations between measured PFCs levels and 
individual parameters related to the mother. 
In accordance with the recent European Commission Recommendation 2010/161/EU 
on the monitoring of perfluoroalkylated substances in food, in which Member States 
are required to focus not only on PFOS and PFOA but as well on their precursors, this 
project led also to the development of a promising technique for the quantification on 
N-MeFOSE and N-EtFOSE (perfluorooctane sulfonamido ethanols, precursors of PFOS) 
in fish. This method showed extremely satisfying performances in terms of linearity 
and limits of detection, allowing to measure these two contaminants at ultra trace 
levels in this matrix, and will be a useful tool for future surveys. 
The increasing interest on these emerging contaminants and on their adverse effects 
on human health has led to the need for extensive monitoring of their presence in 
food, in order to enable an accurate hazard evaluation deriving from dietary exposure. 
The research project presented in this thesis is in line with this aim, providing some 
preliminary data and reliable methods to be employed for further investigations. 
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